TABLE OF CONTENTS
WELCOME ADDRESS
PATRONAGES
CO-SPONSORSHIPS
COMMITTEES
ABSTRACT REVIEWING COMMITTEE
ACKNOWLEDGEMENTS
CME CREDITS
GENERAL INFORMATION
Congress Venue
Congress and Exhibition Office
Congress Counter
Exhibition
Congress Language
Name Badges
Poster Exhibition
Press Center
Kiosks For Snacks and Beverages
Restaurants
Cloakroom
First Aid
Car Park
Taxis
Tours
SOCIAL AND CULTURAL EVENTS
INTRODUCTION TO THE CONGRESS PROGRAM
PALACE’S MAPS
SCIENTIFIC PROGRAM OVERVIEW
FORMAT DESCRIPTIONS OF THE SCIENTIFIC PROGRAM
COURSES
p. 6
p. 8
p. 10
p. 11
p. 14
p. 15
p. 16
p. 17
p. 17
p. 17
p. 17
p. 19
p. 19
p. 19
p. 19
p. 19
p. 19
p. 20
p. 21
p. 21
p. 21
p. 21
p. 22
p. 23
p. 24
p. 25
p. 25
p. 37
p. 40
CLINICAL CONSULTATION BREAKFASTS
SCIENTIFIC PROGRAM
Saturday, 25th August 2007
Sunday, 26th August 2007
Monday, 27th August 2007
Tuesday, 28th August 2007
Wednesday, 29th August 2007
POSTER PRESENTATION
DONALD COHEN FELLOWSHIP
ERICE
ROME GROUP
CHILD HELPLINE INTERNATIONAL
LIST OF EXHIBITORS
DISCLOSURES OF INTEREST
INDEX BY NAME
PROGRAM PLANNER
p. 42
p. 43
p. 43
p. 44
p. 63
p. 84
p. 104
p. 114
p. 169
p. 169
p. 170
p. 171
p. 172
p. 173
p. 188
p. 212
WELCOME ADDRESS
Dear Colleagues and Friends,
It is with great pleasure that I welcome you to the 13th International Congress of
the European Society for Child and Adolescent Psychiatry. The wonderful city of
Florence will host us during our five days of discussions about the most important
present and emerging topics in Child and Adolescent Psychiatry.
This ESCAP Congress has been created by the work of each participant, clinician
or researcher, working in the field of the welfare and mental health of children
and adolescents. Each of our colleagues has a genuine interest in developing a
contemporary and appropriate culture for children, focused on the individual rights
and environmental needs of each child. The advancements in neuroscience, as well
as the growing imperative for evidence-based medicine have created dramatic,
new challenges for Child and Adolescent Psychiatry.
The Congress program is especially sensitive to the fact that the developmental
periods of childhood and adolescence represent a crucial time for timely diagnostic
evaluations and the implementation of effective treatments. Our growing
knowledge of the magnitude of the problems facing children, as well as our
growing recognition of the early age of onset of most mental disorders, is raising,
for all health workers, an awareness of the urgent need for timely interventions with
the genuine hope that these interventions will also change long-term outcomes.
At the same, it is also hoped that the new knowledge and our collective experience
will offer extraordinary opportunities for prevention.
The themes for the Congress include, among others, developmental neuroscience,
assessment instruments, treatments and treatment effectiveness. Many other
important issues will be addressed at a highly scientific, yet clinically relevant level
so that there are many opportunities for discourse and learning for all attendees.
We are pleased that you are joining us in Florence to address the contemporary
challenges to Child and Adolescent Psychiatry.
During our time together, we hope to “bridge” widely disparate knowledge and
disciplines by sharing models and developing integrated perspectives. Perhaps, the
most demanding challenge will be to bridge the gaps between mind and body and
between differing approaches and professions, to arrive at a common pathway for
research and clinical practise. By the end of the Congress, we hope we will have
enhanced our collective understanding of the causes and consequences of child
and adolescent psychiatric illness, as well as how to evaluate, treat and prevent
these illnesses effectively.
The content and your participation in the 13th International Congress of ESCAP
offers great promise. We look forward to joining with you as we approach a new
scientific and cultural approach for European Child and Adolescent Psychiatry.
Prof. Ernesto Caffo
President of ESCAP and Congress President
PATRONAGES
PRESIDENCY OF THE REPUBLIC
PRESIDENCY OF THE COUNCIL OF MINISTERS
SENATE OF THE REPUBLIC
CHAMBER OF DEPUTIES
MINISTRY OF FOREIGN AFFAIRS
MINISTRY OF YOUTH POLICIES AND SPORTS
MINISTRY OF WELFARE
MINISTRY OF HEALTH
MINISTRY OF THE POLICIES FOR THE FAMILY
NATIONAL INSTITUTE OF HEALTH
NATIONAL RESEARCH COUNCIL
NATIONAL COUNCIL OF ECONOMY AND WORK
UNIVERSITY OF MODENA AND REGGIO EMILIA
UNIVERSITY OF FLORENCE
HOSPITAL-UNIVERSITY SERVICE OF MODENA
MEYER PEDIATRIC HOSPITAL
REGIONE
TOSCANA
TUSCANY REGION
PROVINCE OF FLORENCE
MUNICIPALITY OF FLORENCE
CO-SPONSORSHIPS
WORLD HEALTH ORGANIZATION (EUROPE)
INTERNATIONAL ASSOCIATION FOR CHILD AND ADOLESCENT
PSYCHIATRY AND ALLIED PROFESSIONS (I.A.C.A.P.A.P.)
WORLD ASSOCIATION FOR INFANT MENTAL HEALTH
INTERNATIONAL SOCIETY FOR ADOLESCENT PSYCHIATRY AND
PSYCHOLOGY
WORLD PSYCHIATRIC ASSOCIATION
EUROPEAN UNION OF MEDICAL PROFESSIONALS
AUTISM EUROPE
EUROPEAN BRAIN COUNCIL
ITALIAN SOCIETY FOR CHILD AND ADOLESCENT
NEUROPSYCHIATRY
ITALIAN SOCIETY OF PSYCHIATRY
ITALIAN SOCIETY OF NEUROLOGY
10
COMMITTEES
Congress President: Ernesto Caffo (Italy)
Honorary Presidents:
Giovanni Bollea (Italy)
Colette Chiland (France)
Sir Michael L. Rutter (United
Kingdom)
Organizing Committee:
Dante Besana (Italy)
Filippo Calamoneri (Italy)
Giovanni Camerini (Italy)
Giovanni De Girolamo (Italy)
Elisa Checcacci (Italy)
Anna Fabrizi (Italy)
Barbara Forresi (Italy)
Francesca Neri (Italy)
Nadia Micali (United Kingdom)
Giancarlo Rigon (Italy)
Enzo Sechi (Italy)
Cecilia Sighinolfi (Italy)
Mario Speranza (France)
Luisa Strik Lievers (Italy)
Maria Cristina Stefanini (Italy)
ESCAP BOARD
President: Ernesto Caffo (Italy)
Past President: Philippe Jeammet (France)
Vice Presidents: Bruno Hägglöf (Sweden)
Ruud Minderaa (The Netherlands)
Eugenia Soumaki (Greece)
Tuula Tamminen (Finland)
Martina Tomori (Slovenia)
Andreas Warnke (Germany)
Ruedi Zollinger (Switzerland)
Treasurer: Paul McCarthy (Ireland)
Secretary: Susan Bailey (United Kingdom)
11
International Scientific Committee
Thomas M. Achenbach (United
States)
Dean Ajdukovic (Croatia)
Thomas F. Anders (United States)
Alan Apter (Israel)
Myron L. Belfer (United States)
Boris Birmaher (United States)
Hanne Børner (Denmark)
Jacques Constant (France)
Fusun Cuhadaroglu (Turkey)
Vojislav Curcic (Serbia and
Montenegro)
Miroslaw Dabkowski (Poland)
Dirk Deboutte (Belgium)
Véronique Delvenne (Belgium)
Ivana Drtilkova (Czech Republic)
Wilhelm Felder (Switzerland)
Peter Fonagy (United Kingdom)
Joaquin Fuentes (Spain)
Dimitrios Georgiadis (Greece)
Ian Goodyer (United Kingdom)
Philip J. Graham (United Kingdom)
Virginija Karaliene (Lithuania)
Robert King (United States)
Rachel Klein (United States)
Kirsti Kumpulainen (Finland)
Peter S. Jensen (United States)
Nathaniel Laor (Israel)
James F. Leckman (United States)
Bennett L. Leventhal (United States)
12
Mario Maj (Italy)
María Jesús Mardomingo (Spain)
Andres Martin (United States)
Beatriz Pena (Portugal)
Bradley Peterson (United States)
Helmut Remschmidt (Germany)
Benedetto Saraceno (Switzerland)
Michael Schulte-Markwort
(Germany)
Anatoly Severny (Russia)
David H. Shaffer (United States)
Dimiter Tersiev (Bulgaria)
John Tsiantis (Greece)
Ágnes Vetró (Hungary)
Fred Volkmar (United States)
Herman van Engeland (The
Netherlands)
National Scientific Committee:
Umberto Balottin (Italy)
Mario Bertolini (Italy)
Teresa Iole Carratelli (Italy)
Fabio Canziani (Italy)
Carlo Cianchetti (Italy)
Antonio Condini (Italy)
Giuseppe Cossu (Italy)
Paolo Curatolo (Italy)
Bernardo Dalla Bernardina (Italy)
Maurizio De Negri (Italy)
Francesco Maria Guzzetta (Italy)
Franco Nardocci (Italy)
Giovanni Lanzi (Italy)
Carlo Lenti (Italy)
Gabriel Levi (Italy)
Domenico Mazzone (Italy)
Roberto Militerni (Italy)
Massimo Papini (Italy)
Antonio Pascotto (Italy)
Pietro Pfanner (Italy)
Cristina Ricciardi (Italy)
Roberto Rigardetto (Italy)
13
ABSTRACT REVIEWING COMMITTEE
Giovanni B. Camerini (Italy)
Colette Chiland (France)
Joaquin Fuentes (Spain)
Laurence L. Greenhill (United States)
Philippe Jeammet (France)
Bennett L. Leventhal (United States)
Paul McCarthy (Ireland)
Massimo Papini (Italy)
Eliana Parente (Italy)
Neil Ryan (United States)
Luisa Strik Lievers (Italy)
Sumire Yamaguchi (Italy)
14
AKNOWLEDGMENTS
The organizers of the 13th International Congress of the European Society for Child and
Adolescents Psychiatry (ESCAP) acknowledge the support of the following companies
and organizations:
MAJOR SPONSORS
Gold-Level Sponsors
- Eli Lilly and Company
Bronze-Level Sponsors
- Janssen-Cilag EMEA
General-Level Sponsors
- Shire
- UCB Pharma
FURTHER SPONSORS
- Qbtech
- Wisepress Online Bookshop
- Wiley-Blackwell
- British Embassy, NHS, SEPT
We are also grateful to the following contributors:
- Tuscany Region
- Province of Florence
- Municipality of Florence
- Hotel JKPlace
- Starhotels
- Istituto degli Innocenti
- Officina Profumo-Farmaceutica di Santa Maria Novella
- Questura di Firenze
- Securitas Metronotte S.p.A.
- Istituto Nutrizionale Carapelli Fondazione Onlus
- Giunti Editore S.p.a.
- Giffoni Film Festival
- Agenzia per il turismo di Firenze
- SO.CO.TA. Società Cooperativa Tassisti
- Istituto Professionale “Francesco Datini” di Prato
- O.A.S.I. Comunità di accoglienza dei Padri Mercedari a Firenze
- S.O.S. Il Telefono Azzurro Onlus
- Foundation Child for study and research into childhood and adolescence
“A special thank you to our volunteers for their hard work and great contributions.”
15
CME CREDITS
CONTINUING MEDICAL EDUCATION (CME) CREDITS
CME credits, National and European, will be provided for all plenary sessions in the
Auditorium throughout the entirety of the Congress and for training courses. US
participants in the Congress can use the European Certificate of Attendance and CME
forms to apply for CME credits from their home institutions and licensing bodies.
CONGRESS: In order to obtain CME accreditation, we kindly ask you to complete
the evaluation form (which you will find in your delegate bag) and return it to the
Congress counter with the “CME” sign at the Secretariat Desk.
TRAINING COURSES: You will receive CME forms at the beginning of the Course
in front of the conference room. We kindly ask you to complete your evaluation at
the end of each educational activity and return it to the Congress counter with the
“CME” sign at the Secretariat Desk. CME Certificates will be mailed to the postal
address that you indicate on the CME Personal Form.
Italian CME:
n. 5797 – 286946 (Psycologists) Congress “13 INTERNATIONAL CONGRESS ESCAP
- EUROPEAN SOCIETY FOR CHILD AND ADOLESCENT PSYCHIATRY - BRIDGING THE
GAPS” : 17 Credits
n. 5797 – 286945 (Psychiatrists and Pediatrics) Congress “13 INTERNATIONAL
CONGRESS ESCAP - EUROPEAN SOCIETY FOR CHILD AND ADOLESCENT PSYCHIATRY
- BRIDGING THE GAPS” : to be determined.
n. 5797 – 286701 (Psychiatrists and Pediatrics) Course “ADHD: DIFFICULT QUESTIONS
AND PRACTICAL ANSWERS”: 5 Credits
n. 5797 – 286702 (Psycologists) Course “ADHD: DIFFICULT QUESTIONS AND PRACTICAL
ANSWERS”: to be determined
n. 5797 – 286737 (Psycologists) Course “INTERNATIONAL COURSE ON BULLYING AND
HEALTH RISKS” : 4 Credits
n. 5797 – 286736 (Psychiatrists and Pediatrics) Course “INTERNATIONAL COURSE ON
BULLYING AND HEALTH RISKS” : to be determined.
n. 5797 – 286746 (Psychiatry and Pediatrics) Course “PEDIATRIC PSYCOPHARMACOLOGY”
: 3 Credits
n. 5797 – 286747 (Psycologists) Course “PEDIATRIC PSYCOPHARMACOLOGY” : to be
determined.
Accreditation Value of the other courses: to be determined.
16
GENERAL INFORMATION
In order to gain entrance into the Congress or ANY Congress-sponsored
event, you must have your Congress badge and a government-issued
ID with information that is consistent with the information on your
badge.
CONGRESS VENUE
Palazzo dei Congressi, Florence
Palazzo degli Affari, Florence
CONGRESS AND EXHIBITION OFFICE
A.S.P.I.A.
Associazione per lo Studio in Psichiatria dell’Infanzia e dell’Adolescenza
Via Dei Giudei 6 - 40126 Bologna, Italy
tel. +39 051 5881869
e-mail: [email protected]
CONGRESS COUNTER
All congress materials and documentation will be available at the
congress counter located at the entrance of the Palazzo dei Congressi of
Florence.
Hours of operation:
Saturday, August 25, 2007
Sunday, August 26, 2007
Monday, August 27, 2007
Tuesday, August 28, 2007
Wednesday, August 29, 2007
08.00 - 19.00
08.00 - 19.00
08.00 - 19.00
08.00 - 19.00
08.00 - 14.00
17
During these hours the Congress counter can be reached at:
Telephone: +39 055 4973405
Telefax: + 39 055 4973406
E-mail: [email protected]; [email protected]
The Congress counter has been divided into the following sections:
Pre-Registration
Participants who have already registered for the Congress will receive
their documents here. The counter is divided alphabetically orders.
On-Site Registration
On-site registration and payment of pre-registration for those who have
not yet paid may be made here. Courses, Half-day Courses and Clinical
Consultation Breakfasts payment on site will also be available.
Social Events
Tickets are still available for:
• Concert at San Lorenzo Church on Monday, 27th August
• Social Dinner on Wednesday, 29th August
For Social Events list, see page 23.
Tours and Hotel Reservations
Tickets can still be purchased for the tours. For a list of tours, please see
page 22.
Assistance for the reservation of hotel rooms in Florence will be provided
here.
18
EXHIBITION
The exhibition area will be in the basement of Palazzo dei Congressi. For
further information, please see page 172
CONGRESS LANGUAGE
English will be the official language of the Congress.
NAME BADGES
Participants are requested to wear their name badge at all times during
all congress activities and social events.
The colours of the name badges have the following significance:
Blue - Delegates
Purple - Volunteers
Red - Press
Yellow - Accompanying Persons
Brown - Guests
Green - Exhibitors
Cyan - Staff
POSTER EXHIBITION
The poster exhibition will be located in the basement of Palazzo dei
Congressi. The posters will be arranged according to topics, see page 114
PRESS CENTER
The Press Center is set up in Palazzo dei Congressi, Room 105 on the 1st floor.
KIOSKS FOR SNACKS AND BEVERAGES
Sandwiches will be provided free-of charge in the Limonaia and drinks will
be on sale in in the same location. Other food and beverage items may be
purcased in the basement of Palazzo dei Congressi as well as on the first
floor of Palazzo degli Affari.
19
RESTAURANTS
Those in attendance of ESCAP’s 13th International Congress will receive
12% off of their meals at the restaurants listed below. When you arrive,
please mention that you are attending the Congress and present your
official Congress badge.
Ristorante “La Martinicca”
Via del Sole 27/r
Tel. 055 218928
Trattoria “Marione”
Via della Spada 27/r
Tel. 055 214756
Caffè Pitti
Piazza Pitti 9
Tel. 055 2399863
Ristorante “Angiolino”
Via Santo Spirito 36/r
Tel. 055 2398976
Ristorante “Boccanegra”
Via Ghibellina 124/r
Tel. 055 2001098
Ristorante-Pizzeria “La Greppia”
Lungarno Ferrucci 4/6/8
Tel. 055 6812341
Ristorante “Trattoria 13 Gobbi”
Via del Porcellana 9/r
Tel. 055 284015
Ristorante “Celestino”
Piazza S. Felicità 4/r
Tel. 055 2396574
Osteria “Belle Donne”
Via delle Belle Donne 16/r
Tel. 055 2382609
Trattoria “I’ Brindellone”
Piazza Piattellina 10
Tel. 055 217879
Trattoria “Il Trebbio”
Via delle Belle Donne 47/49 r
Tel. 055 287089
20
CLOAKROOM
An unguarded cloakroom is available at the entrance of the Congress
Center in the registration desk area.
FIRST AID
In case of emergency please call the number 118.
CAR PARK
The closest parking to the Congress site is:
FORTEZZA FIERA
Piazzale Caduti nei Lager
Tel.055 495969
Open 24 hours per Day
€ 1,50 pre hour for cars, € 0,50per hour for motos.
STAZIONE S.M.NOVELLA
Piazza della Stazione Tel. 055 2302655
Open 24 hours per Day
€ 2 the first hous, € 2 the second hour, € 3 from the 3rd hour onwards
5 day ticket € 140
TAXIS
Taxis are available at S.M.Novella Station’s exit. It is possible to reserve a
taxi by calling the following numbers: 4390 or 4242.
21
TOURS
The following tours have been confirmed for the Congress. Tickets can be
purchased at the Tour Desk. Cost and description of tours are available at
the Tour Desk as well.
Florentine Hills – half - day by bus
Sunday, August 26, 2007 – 14.00/17.30
The Uffizi Gallery – half - day on foot
Sunday, August 26, 2007 – 16.30/18.30
Tuesday, August 28, 2007 – 16.30/18.30
The Academy Gallery – half - day on foot
Sunday, August 26, 2007 – 16.30/18.30
Wednesday, August 29, 2007 – 16.30/18.30
City Centre – half - day on foot
Monday, August 27, 2007 – 09.30/12.30
Siena and San Gimignano – full - day by bus
Monday, August 27, 2007 – 09.30/12.30
Pisa and Lucca – full - day by bus
Tuesday, August 28, 2007 – 16.30/18.30
Chianti area – full - day by bus
Wednesday, August 29, 2007 – 16.30/18.30
22
SOCIAL AND CULTURAL EVENTS
Saturday, August 25
17.30-19.30 - OPENING CEREMONY
Auditorium, Palazzo Congressi
Free entrance for delegates
20.00 - WELCOME COCKTAIL
Cloister of Santa Maria Novella
Free entrance for delegates
Sunday, August 26
20.00 - MOVIE SESSION
Auditorium, Palazzo Congressi
Free entrance for delegates
Monday, August 27
19.45 - ORGAN CONCERT
San Lorenzo Church
Free entrance for delegates
20.00 - MOVIE SESSION
Auditorium, Palazzo Congressi
Free entrance for delegates
Tuesday, August 28
20.00 - SOCIAL DINNER
Palazzo Pitti
Tickets are available at the Registration Desk.
On Monday, Tuesday and Wednesday guided tours to the Pharmacy of Santa
Maria Novella, the only monastery pharmacy in Florence that still preserves
its unaltered original appearance, will be organized for the delegates. To book
your place, please get information at the Registration Desk.
23
INTRODUCTION TO THE CONGRESS PROGRAM
The congress program contains Opening and Closing Ceremonies, Clinical
Case Conferences, Clinical Consultation Breakfasts, Debates, Half-Day
Courses, Main Lectures, Meet the Experts, Poster Presentation Sessions,
Satellite Symposia, State of the Art Lectures, Symposia, Training Courses
and Workshops.
PROGRAM TRACKS
There are thirteen different types of presentations represented in the
Congress timetable by the following colors:
24
Clinical Case Conference
Clinical Consultation Breakfast
Debate
Half-Day Course
Main Lecture
Meet the Expert
Opening / Closing Ceremony
Poster Presentation
Satellite Symposium
State of the Art Lecture
Symposium
Training Course
Workshop
PALACE’S MAPS
Palazzo dei Congressi
Basement
Auditorium
Snack Bar
Exhibition Area
Poster Area
Ground Floor
Sala Onice
Sala 9
Sala 4
Slide Center
First Floor
Sala 101
Sala 104
Second Floor
Sala Verde
Second Floor
Sala Viola
Sala Bianca
Third Floor
Sala Gialla
Sala Nera
Palazzo degli Affari
Basement
Sala Arancione
Ground Floor
Sala Azzurra
First Floor
Snack Bar
Sala Rossa
Sala Adua 1
Fourth Floor
Sala Grigia
25
Volunteers
Sandwich distribution-free of chg
LIMONAIA MAP
A Message Center is located in the Limonaia where you will find updates
regarding Congress information
26
27
28
29
30
31
32
33
34
35
36
FORMAT DESCRIPTIONS OF THE SCIENTIFIC PROGRAM
The Scientific Program will consist of the following:
Main Lectures
Main Lectures will have a strong scientific focus. They will be mainly
theoretical and research-oriented. These lectures will be delivered by
leading psychiatrists, basic scientists or other mental health professionals
invited by the Scientific Committee.
They will cover major topics of the Congress theme. The Main Lectures will
last forty-five minutes, with at least fifteen minutes set aside for discussion
at the end of the lecture.
State of the Art Lectures
These lectures will present the recent developments in a certain area with
special focus on the Congress theme.
Symposia
Symposium sessions will focus on clinical issues and will constitute the
central element of the Congress. These high-quality symposia will bring
together people from different backgrounds and will encourage an active
and enriching interaction between speakers and participants. A symposium
is data-driven and presents perspectives of different aspects of a topic or
different views of the same topic. The symposia will last 120 minutes with
a maximum of four talks and a discussion; each symposium will reserve at
least thirty minutes at the end of the presentation for a discussion.
37
Training Courses
These programs last eight hours and provide a review of a topic area
rather than new research information. They also focus on “how to do it”
with respect to academic areas, clinical problems or a blending of the two.
Participants must purchase an extra ticket to attend such courses. These
formats are didactic and provide interaction and/or discussion between
presenters and participants.
Half- Day Courses
These programs last three hours and provide a review of a topic area
rather than new research information. They also focus on “how to do it”
with respect to academic areas, clinical problems or a blending of the two.
Participants must purchase an extra ticket to attend such courses. These
formats are didactic and provide for interaction and discussion between
presenters and participants.
Debates
These 120 minute events will include brief presentations lasting a total of
more than sixty minutes, followed by a minimum of sixty minutes of broad
interactive discussions. Topics will include important and controversial
issues such as the specific roles of various professionals in mental health
care and the role and prospects of special treatment.
Clinical Consultation Breakfasts
Clinical Consultation Breakfasts last for one-and-a-half hours and provide
a forum for experts to share clinical knowledge and discuss difficult cases
with attendees.
38
Clinical Consultation Breakfasts are scheduled at 8 - 9.30 every morning.
Participants must purchase an extra ticket to attend Clinical Consultation
Breakfasts and a continental buffet breakfast is included in the registration fee.
Workshops
The length of these sessions is 120 minutes. Workshops should deal with
topics of special interest to child and adolescent mental health, using
multiple brief presentation of no more than sixty minutes, followed by
approximately sixty minutes of discussion.
Clinical Case Conferences
During these 120 minute sessions, the presenter describes a clinical case
and discusses with the audience possible diagnoses and treatments. This
format gives clinicians the opportunity to present difficult cases or new
treatments.
Meet the Expert
In these sessions, a leading child and adolescent psychiatrist will interact
freely with a group of generally younger and less experienced members
of the same field. The session will focus on the expert’s career, research
interests and experience, as well as a on perspectives on future research. Facilitators of each session will be other experts in the field.
Poster Presentation Sessions
Posters are hypothesis driven and authors will present their new research
findings or important ongoing research. The three best posters will be
awarded Poster Prizes at the end of the Congress.
39
COURSES
Saturday, August 25
“PEDIATRIC PSYCHOPHARMACOLOGY”
Chaired by Laurence Greenhill (United States)
“AUTISM SPECTRUM DISORDERS”
Chaired by Joaquin Fuentes (Spain)
Sunday, August 26
“THE VALUE OF PSYCHOTHERAPY IN CHILD PSYCHIATRY”
Chaired by Peter Fonagy (United Kingdom)
Monday, August 27
“DEPRESSION IN YOUNG PEOPLE”
Chaired by Ian Goodyer (United Kingdom)
“BULLYING AND HEALTH RISKS”
Chaired by Jorge Srabstein (United States)
Tuesday, August 28
“UNDERSTANDING AND INTERVENING WITH CHILDREN, FAMILIES AND
COMMUNITIES EXPOSED TO TRAUMA AND DISASTER”
Chaired by William Yule (United Kingdom) and Nathaniel Laor (Israel)
“SUICIDE”
Chaired by Alan Apter (Israel)
40
“ADHD: DIFFICULT QUIESTIONS AND PRACTICAL ANSWERS”
Chaired by Eric Taylor (United Kingdom)
HALF-DAY COURSES
Saturday, August 25
“PEDIATRIC BIPOLAR DISORDER- CLINICAL PICTURE AND LONGITUDINAL
COURSE”
Chair: Boris Birmaher (United States)
CLINICAL CHARACTERISTICS AND DIAGNOSTIC ASSESSMENT OF
DEPRESSION AND MANIA IN PRESCHOOL CHILDREN”
Chair: Joan Luby (United States)
“AVENUES AND METHODS OF RESEARCH IN CHILD PSYCHIATRY”
Chair: Flora Vaccarino (United States)
Sunday, August 26
“DEFINITION AND EPIDEMIOLOGY OF PSYCHOPHARMACOLOGIC
TREATMENTS OF TICS AND ADHD. TS NEW DIRECTIONS IN BEHAVIORAL
INTERVENTIONS”
Chair: Lawrence Scahill (United States)
Monday, August 27
HOW TO WRITE AN ARTICLE FOR SCIENTIFIC JOURNALS”
Chair: Andres Martin (United States)
41
Tuesday, August 28
“GENOMICS, POST-GENOMICS AND CHILD NEUROPSYCHIATRIC DISEASES”
Chair: Fabio Macciardi (Italy)
“MEASURING AND VALIDATING OUTCOMES IN CHILD AND ADOLESCENT
PSYCHIATRY”
Chair: Bruno Falissard (France)
CLINICAL CONSULTATION BREAKFASTS
Sunday, August 26
AUTISM
Speakers: Peter Szatmari (Canada), Patricia Howlin (United States)
Monday, August 27
GENETICS
Speakers: Fabio Macciardi (Italy), Matthew State (United States)
Tuesday, August 28
ADHD
Speakers: Laurence Greenhill (United States), Joseph Sergeant (The
Netherlands)
Wednesday, August 29, 2007
TRAUMA
Speakers: Robert Pynoos (United States), Nathaniel Laor (Israel)
42
Training Course
8.30-17.00 Sala Rossa, Palazzo Affari - 1st Floor
PEDIATRIC PSYCHOPHARMACOLOGY
Chair: Laurence Greenhill (United States)
8.30-17.00 Sala Verde, Palazzo Congressi – 2nd Floor
AUTISM SPECTRUM DISORDERS
Chair: Joaquin Fuentes (Spain)
Saturday 25 August
SCIENTIFIC PROGRAM - SATURDAY, 25 AUGUST
Half - Day Course
9.00-12.00
Sala 4, Palazzo Congressi – Ground Floor
PEDIATRIC BIPOLAR DISORDER- CLINICAL PICTURE AND LONGITUDINAL
COURSE
Chair: Boris Birmaher (United States)
Sala 4, Palazzo Congressi – Ground Floor
14.00 - 17.00
AVENUES AND METHODS OF RESEARCH IN CHILD PSYCHIATRY
Chair: Flora Vaccarino (United States)
Speaker: Flora Vaccarino (United States), Paul Lombroso (United States), Fabio
Macciardi (Italy)
Opening Ceremony
17.30 -19.30
Auditorium, Palazzo Congressi - Basement Floor
GENETIC AND CULTURAL TRANSMISSION IN THE DEVELOPMENT OF
CHILDREN AND ADOLESCENTS
Speaker: Luigi Luca Cavalli Sforza (Italy)
Chair: Giovanni Bollea (Italy) - Co-Chair: Ernesto Caffo (Italy)
43
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
Clinical Consultation Breakfast
8.00-9.30 Sala 101, Palazzo Congressi – 1st Floor
AUTISM
Speakers: Peter Szatmari (Canada), Patricia Howlin (United Kingdom)
Training Course
8.30-17.00 Sala Verde, Palazzo Congressi – 2nd Floor
THE VALUE OF PSYCHOTHERAPY IN CHILD PSYCHIATRY: A TRAINING COURSE
IN PSYCHOTHERAPY
Chair: Peter Fonagy (United Kingdom)
State of the Art Lecture
9.00-10.00 Auditorium, Palazzo Congressi – Basement Floor
ADVANCES IN DIAGNOSIS AND MANAGEMENT OF ADHD
Speaker: Russel Barkley (United States)
Chair: Giuseppe Chiarenza (Italy)
9.00 – 10.00
Sala Adua 1, Palazzo Affari– 1st Floor
CLINICALLY EFFECTIVE TREATMENTS FOR PTSD IN CHILDREN AND
ADOLESCENTS: INDIVIDUAL AND GROUP FORMATS
Speaker: William Yule (United Kingdom)
Chair: Alexander McFarlane (Australia)
44
9.00-10.00
Sala Gialla, Palazzo Affari – 3rd Floor
The Concept of Neuro-PsycOhanalysis: advantages and
disavantages
Speaker: Bernard Golse (France)
Chair: Mary Target (United Kingdom)
9.00-10.00 Sala Nera, Palazzo Affari – 3rd Floor
PSYCHOSOMATIC DISORDERS IN CHILDREN AND ADOLESCENTS
Speaker: Bruno Hägglöf (Sweden)
Chair: Marco Rigatelli (Italy)
Sunday 26 August
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
9.00-10.00 Sala Rossa, Palazzo Affari – 1st Floor
CHILD AND ADOLESCENT TRAUMATIC STRESS: A DEVELOPMENT FRAMING
OF SCIENTIFIC GROWTH, TREATMENT ADVANCES AND TRAUMA-INFORMED
SERVICES
Speaker: Robert Pynoos (United States)
Chair: John Fayyad (Lebanon)
9.00-10.00 Sala Azzurra, Palazzo Affari – Ground Floor
ADMITTING OUR IGNORANCE: A CHANGE IN PERSPECTIVE IN PSYCHIATRY
Speaker: Flora Vaccarino (Italy)
Chair: Fabio Macciardi (Italy)
Sala Bianca, Palazzo Affari – 2nd Floor
9.00-10.00 WHO, ROLE AND RESPONSIBILITIES RELATED TO CHILDREN AND FAMILIES
Speaker: Matthijs Muijen (Denmark)
Chair: John Henderson (United Kingdom)
45
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
9.00-10.00 Sala Viola, Palazzo Affari – 2nd Floor
Advances in the Neurobiology of ADHD
Speaker: Joseph Biederman (United States)
Chair: Joaquin Fuentes (Spain)
9.00-10.00 Sala Onice, Palazzo Congressi – Ground Floor
Assessment of Suicidality, Antidepressants, and Ongoing
Public Health Implications: a view From the Front Lines
Speaker: Kelly Posner (United States)
Chair: John Sikorski (United States)
9.00-10.00 Sala Grigia, Palazzo Affari – 4th Floor
MENTAL HEALTH SERVICES
Speaker: Richard Williams (United Kingdom)
Chair: Giovanni De Girolamo (Italy)
9.00-10.00 Sala Arancione, Palazzo Affari – Basement Floor
PHYSIOPATHOLOGY AND REHABILITATION OF MENTAL RETARDATION IN
THE HIGHLIGHTS OF RECENT FINDINGS IN NEUROIMAGING
Speaker: Pietro Pfanner (Italy)
Chair: Catherine Barthélemy (France)
Half - Day Course
9.00 - 12.00 Sala 4, Palazzo Congressi – Ground Floor
CLINICAL CHARACTERISTICS AND DIAGNOSTIC ASSESSMENT OF
DEPRESSION AND MANIA IN PRESCHOOL CHILDREN
Chair: Joan L. Luby (United States)
46
9.00 - 12.00 Sala 104, Palazzo Congressi – 1st Floor
DEFINITION AND EPIDEMIOLOGY OF PSYCHOPHARMACOLOGIC
TREATMENTS OF TICS AND ADHD.
TS NEW DIRECTIONS IN BEHAVIORAL INTERVENTIONS
Speaker: Lawrence Scahill (United States)
Main Lecture
10.00 - 11.00 Auditorium, Palazzo Congressi – Basement Floor
CHILDHOOD ONSET SCHIZOPHRENIA: UPDATE 2007
Speaker: Judith Rapoport (United States)
Chair: James F. Leckman (United States)
Sunday 26 August
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
10.00 - 11.00 Sala Rossa, Palazzo Affari – 1st Floor
PROMOTION OF MENTAL HEALTH IN THE FUTURE: INTERNATIONAL
PERSPECTIVE
Speaker: Norman Sartorius (Switzerland)
Chair: Thomas Anders (United States)
Symposium
11.00 - 13.00 Auditorium, Palazzo Congressi – Basement Floor
BODY WEIGHT REGULATION IN EATING DISORDERS: WHAT DO WE KNOW
AND WHAT ARE THE IMPLICATIONS FOR FUTURE RESEARCH?
Chair: Johannes Hebebrand (Germany)
Co-Chair: Beate Herpertz - Dahlmann (Germany)
47
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
11.00 Synopsis of clinical findings on body weight during the premorbid
period, the acute stage and post-recovery in anorexia and bulimia
nervosa – Johannes Hebebrand (Germany)
11.30 Neuroendocrine regulation of body weight: findings in anorexia
and bulimia nervosa - Kristian Holtkamp (Germany)
12.00 Genetic findings in obesity and their implication for eating
disorders - Anke Hinney (Germany)
12.30 Discussion
11.00 - 13.00 Sala Gialla, Palazzo Affari – 3rd Floor
TREATMENT OF URBAN AND DELINQUENT YOUTH
Chair: John Sikorski (United States)
Co-Chair: Jörg Fegert (Germany)
11.00 Violence exposure and psychopathology in urban youth: the mediating
role of posttraumatic stress - Vladislav Ruchkin (United States)
11.30 Anger management – Lawrence Vitulano (United States)
12.00 Perspectives from Juvenile delinquency data and psychiatric
initiatives in the United States during the past decade - John B.
Sikorski (United States)
12.30 Discussion
11.00 - 13.00 Sala Rossa, Palazzo Affari – 1st Floor
EPIDEMIOLOGY, GENETICS, NEUROBIOLOGY AND PSYCHOPHARMACOLOGICAL INTERVENTIONS FOR ADHD: AN UPDATE FOR CLINICIANS
Chair: Luis Augusto Rohde (Brazil)
Co-Chair: Enzo Sechi (Italy)
48
11.00 Recent research on epidemiology of ADHD - Luis Rohde (Brazil)
11.30 Recent research on genetics and neurobiology of ADHD Tobias Banaschewski (United States)
12.00 Recent research from Europe on psychopharmacological
interventions for ADHD - David Coghill (United Kingdom)
12.30 Discussion
11.00 - 13.00 Sala Azzurra, Palazzo Affari – Ground Floor
BIOLOGICAL STUDIES OF AUTISM SPECTRUM DISORDERS – EXPERIENCE
OF KOREA AND JAPAN
Chair: Soo-Churl Cho (Korea)
Co-Chair: Nobumasa Kato (Japan)
Sunday 26 August
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
11.00 Opening comments - Soo-Churl Cho (Korea)
11.05 Genetic association studies of autism spectrum disorders in Korea
Hee Jeong Yoo (Korea)
11.25 Genetic study of autism in Japan – Eiji Nanba (Japan)
11.45 Assessment of prefrontal cortical function in pervasive developmental
disorders using near-infrared spectroscopy
Hitoshi Kuwabara (Japan)
12.05 Implications of diversity in genetic study of autism – In Hee Cho (Korea)
12.25 Concluding comments - Nobumasa Kato (Japan)
12.30 Floor Discussion - Soo-Churl Cho (Korea); Nobumasa Kato (Japan)
Symposium
11.00 - 13.00
Sala Arancione, Palazzo Affari – Basement Floor
MODELS OF ATTACHMENT AND COMMUNICATIVE STYLE IN EARLY MOTHERCHILD RELATIONSHIP
Chair: Roberto Militerni (Italy)
Co-Chair: Francisco Palacio Espasa (Switzerland)
49
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
11.00 Early predictors of social and adaptive outcomes in children with
autistic disorder – Roberto Militerni (Italy)
11.20 Mother-child interactive pattern and communicative style in
language impaired Children – Anna Fabrizi (Italy)
11.40 Does mental ill health impact on mothers’ mind-mindedness?
Elizabeth Meins (United Kingdom)
12.00 The relation between caregivers’ communications and children’s
attachment models during the strange situation – Lucia Carli (Italy)
12.20 Discussion
Workshop
11.00 - 13.00 Sala Onice, Palazzo Congressi – Ground Floor
Integrating spirituality into the model of strengths based
psychotherapy in working with traumatized children
Chair: Fred Michel (United States)
11.00 Historical and contemporary perspectives on key issues related to
the mind and soul of the child – Fred Michel (United States)
11.20 Overview of strengths based psychotherapy and the spectrum of
trauma in children - Charon Nelson (United States)
11.40 Adapting a model of spiritual support for use in clinical practice
and collaboration - Leanne Hadley (United States)
12.00 Impacting risk factors for mental illness through use of spiritual
metaphors to facilitate children’s resilience to trauma - Leanne
Hadley (United States)
12.20 Discussion
50
11.00 - 13.00 Sala Grigia, Palazzo Affari – 4th Floor
PROVIDERS AND PURCHASES IN MENTAL HEALTH OF DEVELOPMENTAL
POPULATION
Chair: Miroslaw Dabkowski (Poland)
Co-Chair: Susan Bailey (United Kingdom)
11.00 Treatment strategies for ADHD: European cost-effectiveness estimates
based on the NIMH MTA Study - Michael Schlander (Germany)
11.30 Providing a framework within which child mental health and
psychological wellbeing can be provided across Europe – Susan
Bailey (United Kingdom)
12.00 Eating disorders: dilemmas of classification and consequences Irena Namyslowska (Poland)
12.30 Discussion
Sunday 26 August
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
11.00 - 13.00 Sala 9, Palazzo Congressi – Ground Floor
TELEMEDICINE TRAINING AND SUPERVISION OF AN EVIDENCE-BASED
TREATMENT FOR TRAUMATIZED YOUTH: TRAUMA-FOCUSED COGNITIVE
BEHAVIOURAL THERAPY (TF-CBT)
Chair: Barry Nurcombe (Australia)
Co-Chair: Kirsten Djupesland (Finland)
Speaker: Craig L. Donnelly (United States)
Poster Session
12.30 - 14.30
51
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
Symposium
14.00 - 16.00 Auditorium, Palazzo Congressi – Basement Floor
ERICE (EMPOWERMENT AND RESILIENCE IN CHILDREN EVERYWHERE) :
THE FUTURE IS IN OUR HANDS
Chair: Ernesto Caffo (Italy)
Co-Chair: James F. Leckman (United States)
14.00 Professional dialogue in a time of conflict - Shafiq Masalha (Israel)
14.20 Capacity building and the development of child and family mental
health services in Palestine - Alan Apter (Israel).
14.40 War and the young: parent-child relationship, social-emotional
adaptation, and psychological well-being in Israeli and Palestinian
children exposed top war, terror and violence - Ruth Feldman (Israel).
15.00 How child mental health professionals can work together to foster
the wellbeing for children whose future is in jeopardy because of the
Israeli-Palestinian conflict – Ernesto Caffo (Italy), James F. Leckman
(United States)
15.20 Discussion
14.00 - 16.00 Sala Nera, Palazzo Affari – 3rd Floor
PERSONALITY DISORDERS IN CHILDREN AND ADOLESCENTS
Chair: Giancarlo Rigon (Italy)
Co-Chair: Mario Speranza (France)
14.00 The perfoms of personality disorders in preschool children and
babies - Francisco Palacio Espasa (Switzerland)
14.30 Comorbidity and developmental pathways: from ADHD syndrome
towards personality disorders - Maria Romani (Italy)
52
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
14.00 - 16.00 Sala Rossa, Palazzo Affari – 1st Floor
CHILDREN AND VIOLENCE IN POST-CONFLICT AFRICA: IMPERATIVES AND
INTERVENTIONS
Chair: Bawa Umesh (South Africa)
Co-Chair: Peter Riedesser (Germany)
14.00 Child and adolescent mental health services in Africa
Susan M. Hawkridge (South Africa)
14.20 Psychopathology and posttraumatic resilience of former Ugandan child soldiers- Fionna Klasen (Germany)
14.40 Psychotherapy with juvenile prisoners in Cape Town: why?
Kerstin Stellermann (Germany), Susan Hawkridge (South Africa)
15.00 Trauma and PTSD symptoms in former Congolese child soldiers implications for their feelings of revenge and willingness to reconcile
- Christophe Bayer (Germany), Fionna Klasen (Germany), Hubertus Adam (Germany)
15.20 Discussion
Sunday 26 August
15.00 Depressive personality and childhood experiences in eating
disorders - Mario Speranza (France)
15.30 Discussion
14.00 - 16.00 Sala Azzurra, Palazzo Affari – Ground Floor
RECENT CAP RESEARCH IN GREECE
Chair: Ioannis Tsiantis (Greece)
Co-Chair: Eugenia Soumaki (Greece)
14.00 Post-traumatic stress symptoms and stress hormones in children and
adolescent victims of traffic accidents - Gerasimos Kolaitis (Greece)
53
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
14.20 Needs assessment and awareness raising interventions on bullying:
preliminary results from a controlled study with students, teachers
and parents in Greece - Eugenia Soumaki (Greece)
14.40 Ethical dilemmas due to prenatal and genetic diagnostics: substudy
a: investigating women/couples that undertake prenatal diagnostics
Vasso Vassilopoulou (Greece)
15.00 Psychosocial outcome of two psychotherapies for early adolescence
depression: a european multicentre trial - Dimitrios Georgiadis
(Greece)
15.20 Discussion
14.00 - 16.00
Sala Bianca, Palazzo Affari – 2nd Floor
ORGANIZATION SERVICE IN CHILD MENTAL HEALTH IN EUROPE
Chair: Philippe Mazet (France)
Co-Chair: Maria Antonella Costantino (Italy)
14.00 Mental Health of Turkish adolescents reared in institutional
care - Nese Erol (Turkey)
14.20 Early signs of behaviour disorders: new knowledge and innovation
in the healthcare service for developmental age - Giovanni De Plato
(Italy)
14.40 Organization of perinatal and infant mental health services in
CAMHS in central Tuscany - Psychopathology and culture in infancy,
childhood and adolescence. An experimental research-action study
on migrant populations in the Prato area - Marco Armellini (Italy)
15.00 The Italian model of child neuropsychiatric services organization Maria Antonella Costantino (Italy)
15.20 Discussion
54
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
14.00 Affect recognising by children with HFA, as, ADHD and by normally
developed children - Irma Moilanen (Finland)
14.20 Psychiatric disorders in children and adolescents with Asperger
Syndrome or high-functioning autism - Marja-Leena Mattila (Finland)
14.40 Neuroimaging in autistic children with and without comorbid
hyperactivity and attention problems - Judith K. Sinzig (Germany)
15.00 Frankfurt social skills training for individuals with high-functioning
autism or Asperger Syndrome - E. Duketis (Germany)
15.20 Follow-up and enrichment-study of early communication and
interaction - Helena Haapsamo (Finland)
15.40 Discussion
Sunday 26 August
14.00 - 16.00
Sala Viola, Palazzo Affari – 2nd Floor
AUTISM: COMORBIDITY AND TREATMENT ISSUES
Chairs: Irma Moilanen (Finland)
Co-Chair: Fritz Poutska (Germany)
14.00 - 16.00 Sala Arancione, Palazzo Affari - Basement Floor
PERVASIVE DEVELOPMENTAL DISORDERS: FROM RESEARCH TO CLINICAL
PRACTICE
Chair: Roberto Rigardetto (Italy)
Co-Chair: Rutger Jan Van der Gaag (The Netherlands)
14.00 Pervasive developmental disorders: integrated diagnostic approach
trial with a new psychomotor evaluation instrument - Marina
Gandione (Italy)
14.20 From research to therapy - Antonella Monti (Italy)
14.40 Symptom development in autism: early and late detection in autism
Rutger Jan Van der Gaag (The Netherlands)
55
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
15.00 Autism: from clinics and cerebral imaging to therapies – Catherine
Barthélemy (France)
15.20 Recent developments in autism pathogenesis: genetics meets the
immune system – Antonio M. Persico (Italy)
Workshop
14.00 - 16.00 Sala Onice, Palazzo Congressi - Ground Floor
MENTAL HEALTH CONCERNS EVERYONE
Chair: Ingunn Skree (Norway)
Co-Chair: Bruno Hägglöf (Sweden)
14.00 Mental health concerns everyone: part 2: self-efficacy in adolescents
after a school intervention – Ingunn Skree (Norway)
14.30 Mental health concerns everyone - part 1: knowledge and coping in
adolescents after a school intervention - Lars Inge Johnsen (Norway)
15.00 Mental health concerns everyone - part 2: self-efficacy in adolescents
after a school intervention - Ragnhild Elise Magnus (Norway)
15.30 Discussion
14.00 - 16.00 Sala Grigia, Palazzo Affari – 4th Floor
SLEEP DISORDERS IN CHILDHOOD PSYCHOPATHOLOGY
Chair: Thomas Anders (United States)
Co-Chair: Samuele Cortese (Italy)
14.00 Pediatric insomnia: assessment and management - Judith Owens
56
(United States)
14.20 Sleep disturbances associated with ADHD - Samuele Cortese (Italy)
14.40 Sleep disturbances in childhood depression and anxiety - Anna
Ivanenko (United States)
15.00 Excessive daytime sleepiness and cognition - Michel Lecendreux (France)
15.20 Discussion
14.00 - 16.00 Sala 9, Palazzo Congressi – Ground Floor
TELEPSYCHIATRY: TECHNOLOGICALLY BRIDGING SERVICE GAPS-A GLOBAL
VIEW
Chair: Antonio Pignatiello (Canada)
Co-Chair: JoAnn Elizabeth Leavey (Canada)
Sunday 26 August
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
14.00 Accessing the great white north: paediatric telepsychiatry in Canada
Antonio Pignatiello, JoAnn Leavey (Canada)
14.20 Backing up the bush: the Australian view – Jean Starling (Canada),
Sue Foley (Canada)
14.40 Improving patient care using technology: view from the United Kingdom - Paramala Santos (United Kingdom)
15.00 Telepsychiatry models used to bridge service gaps: the US
experience Sharon Cain (United States)
15.20 Discussion
14.00 - 16.00 Sala 104, Palazzo Congressi - 1st Floor
RESEARCH TO PRACTICE: INTEGRATING PERSPECTIVES IN ADOLESCENT
PREVENTION OF EATING DISORDERS
Chair: Pedro Manuel Ruiz-Lázaro (Spain)
Co-Chair: Nadia Micali (United Kingdom)
57
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
14.00 A multicenter randomised controlled trial school-based program for
prevention of eating disorders - Pedro Manuel Ruiz-Lázaro (Spain)
14.20 A randomised trial of a psychoeducational intervention for improving
healthy eating and body image among Spanish secondary students
Ana Rosa Sepúlveda (United Kingdom)
14.40 Engaging teachers in an eating disorder preventive intervention
Tatiana Zanetti (Italy)
15.00 Applying new technologies (computer and the internet) for the
detection and prevention of eating disorders: a Spanish experience
Luis Rojo (Spain)
15.20 Discussion
Meet the Expert
16.00 – 17.00 Sala Adua 1, Palazzo Affari – 1st Floor
Norman Sartorius (Switzerland)
Chair: Giovanni De Girolamo (Italy)
Co-Chair: Per-Anders Rydelius (Sweden)
16.00 – 17.00 Sala Gialla, Palazzo Affari – 3rd Floor
Colette Chiland (France)
Chair: Philip J. Graham (United Kingdom)
Co-Chair: Paul McCarthy (Ireland)
16.00 – 17.00 Mary Target (United Kingdom)
Chair: Phyllis Cohen (United States)
Co-Chair: Alberto Lasa (Spain)
58
Sala Nera, Palazzo Affari - 3rd Floor
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
16.00 – 17.00 Flora Vaccarino (United States)
Chair: Bruno Falissard (France)
Co-Chair: Antonio Persico (Italy)
Sala Bianca, Palazzo Affari – 2nd Floor
16.00 – 17.00 Sala Onice, Palazzo Congressi – Ground Floor
Nancy Minshew (United States)
Chair: Paolo Curatolo (Italy)
Co-Chair: James Hudziak (The Netherlands)
Sunday 26 August
16.00 – 17.00 Sala Azzurra, Palazzo Affari – Ground Floor
David Brent (United States)
Chair: Maria Jesus Mardomingo (Spain)
16.00 – 17.00 Sala Arancione, Palazzo Affari – Basement Floor
Judith Rapoport (United States)
Chair: Ian Goodyer (United States)
Co-Chair: James F. Leckman (United States)
Janssen - Cilag Satellite Symposium
Auditorium, Palazzo Congressi – Basement Floor
16.00 – 18.00 DEVELOPMENTS AND DIRECTIONS IN ADHD: SHARING KNOWLEDGE AND
IDEAS ACROSS EUROPE, supported by Janssen-Cilag EMEA, a division of
Janssen Pharmaceutica NV.
Chair: David Coghill (United Kingdom)
59
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
16.00 Opening remarks - David Coghill (United Kingdom)
16.10 Impact of ADHD on the patient and family: results from a new
survey-Jan Buitelaar (The Netherlands)
16.50 Clinical guidelines for use of long-acting pharmacotherapy in
ADHD - David Coghill (United Kingdom)
17.15 Approaches to supporting academic success for children with
ADHD - Paul Cooper
17.40 Discussion
Debate
16.00 – 18.00 Sala Viola, Palazzo Affari – 2nd Floor
CONFLICT OF INTEREST
Chair: Ernesto Caffo (Italy)
Speakers: Thomas Anders (United States), Larry Cimino (United States),
Alessandro Liberati (Italy)
Meet the Expert
17.00 – 18.00
Sala Adua 1, Palazzo Affari – 1st Floor
Bruno Hägglöf (Sweden)
Chair: Marco Rigatelli (Italy)
Co-Chair: Philippe Jeammet (France)
60
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
17.00 – 18.00 William Yule (United Kingdom)
Chair: John Fayyad (Lebanon)
Co-Chair: Barbara Forresi (Italy)
Sala Nera, Palazzo Affari – 3rd Floor
17.00 – 18.00 Sala Bianca, Palazzo Affari – 2nd Floor
Matthijs Muijen (Denmark)
Chair: Ioannis Tsiantis (Greece)
Co-Chair: Benedetto Vitiello (United States)
Sunday 26 August
17.00 – 18.00
Sala Gialla, Palazzo Affari – 3rd Floor
Robert Pynoos (United States)
Chair: Alexander McFarlane (Australia)
Co-Chair: Nathaniel Laor (Israel)
17.00 – 18.00 Sala Onice, Palazzo Congressi – Ground Floor
Kelly Posner (United States)
Chair: John Sikorski (United States)
Co-Chair: Cesar Soutullo (Spain)
17.00 – 18.00
Sala Grigia, Palazzo Affari – 4th Floor
Richard Williams (United Kingdom)
Chair: Luis Augusto Rohde (Brazil)
Co-Chair: Maria Antonella Costantino (Itlay)
17.00 – 18.00
Sala Arancione, Palazzo Affari – Basement Floor
Pietro Pfanner (Italy)
Chair: Giovanni Camerini (Italy)
61
SCIENTIFIC PROGRAM - SUNDAY, 26 AUGUST
Main Lecture
18.00 – 19.00 Auditorium, Palazzo Congressi – Basement Floor
FROM GENERATION TO GENERATION: THE CONTINUING IMPACT OF DONALD
COHEN IN THE ENIGMATIC, INTERNAL WORLD THAT IS TOURETTE’S SYNDROME
Speaker: James F. Leckman (United States)
Chair: Ernesto Caffo (Italy)
20.00 – 22.00 Sunday Evening - MOVIE SESSION
62
Auditorium Palazzo dei Congressi
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
Clinical Consultation Breakfast
8.00 – 9.30 Sala 101, Palazzo Congressi – 1st Floor
GENETICS
Speakers: Fabio Macciardi (Italy), Matthew State (United States)
Training Course
Monday 27 August
8.30 – 17.00 Sala Verde, Palazzo Congressi – 2nd Floor
DEPRESSION IN YOUNG PEOPLE
Chair: Ian Goodyer (United Kingdom)
8.30 – 17.00 Sala Arancione, Palazzo Affari – Basement Floor
BULLYING AND HEALTH RISKS
Chair: Jorge C. Srabstein (United States)
Co-Chair: Bennett Leventhal (United States)
State of the Art Lecture
9.00 – 10.00 Auditorium, Palazzo Congressi – Basement Floor
PEDIATRIC BIPOLAR DISORDER-CLINICAL PICTURE AND LONGITUDINAL
COURSE
Speaker: Boris Birmaher (United States)
Chair: Jose R. Gutierrez-Casares (Spain)
63
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
9.00 – 10.00 Sala Adua 1, Palazzo Affari – 1st Floor
TRAUMA AND HALLUCINATORY STATES
Speaker: Barry Nurcombe (Australia)
Chair: Andreas Warnke (Germany)
9.00 – 10.00 Sala Gialla, Palazzo Affari – 3rd Floor
TREATMENT OF SSRI-RESISTANT DEPRESSION IN ADOLESCENT (TORDIA)
Speaker: David Brent (United States)
Chair: Maria Jesus Mardomingo (Spain)
9.00 – 10.00 Sala Nera, Palazzo Affari – 3rd Floor
GENETIC AND ENVIRONMENT INFLUENCES ON CHILD PSYCHOPATHOLOGY
AND WELLNESS
Speaker: James Hudziak (The Netherlands)
Chair: Giovanni Cioni (Italy)
Sala Rossa, Palazzo Affari – 1st Floor
9.00 – 10.00 CLINICAL IMPLICATIONS OF THE US GOVERNMENTAL AGENCY DEBATES
OVER THE SAFETY OF PSYCHOTROPIC MEDICATIONS FOR YOUTH
Speaker: Laurence Greenhill (United States)
Chair: Eric Taylor (United Kingdom)
9.00 – 10.00 Sala Azzurra, Palazzo Affari – Ground Floor
SUICIDE
Speaker: Alan Apter (Israel)
Chair: Lena Eidevall (Sweden)
64
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
Monday 27 August
9.00 – 10.00
Sala Bianca, Palazzo Affari – 2nd Floor
MAKING EVIDENCE PRACTICE A REALITY
Speaker: Miranda Wolpert (United Kingdom)
Chair: Dirk Deboutte (Belgium)
9.00 – 10.00 Sala Grigia, Palazzo Affari – 4th Floor
CONTEMPORARY POINTS OF VIEW ON ADOLESCENT PSYCHOPATHOLOGICAL ONSET: DIAGNOSIS, TREATMENT AND REHABILITATION OF STATES OF
ALTERED SUBJECTIVITY
Speaker: Teresa Carratelli (Italy)
Chair: Colette Chiland (France)
Symposium
9.00 – 11.00 Sala 9, Palazzo Congressi – Ground Floor
THE ASSESSMENT AND TREATMENT OF EATING DISORDERS IN
ADOLESCENCE
Chair: Giorgio Rossi (Italy)
Co-Chair: Martine F. Flament (Canada)
9.00 Attachment in anorexia nervosa - Giorgio Rossi (Italy)
9.40 Prevalence of eating and weight disorders in adolescence. A
comparison between French and US high school students - Martine
F. Flament (Canada)
10.20 Is the eating disorder examination (EDE) a good diagnostic tool for
eating disorders in adolescence? - Nadia Micali (United Kingdom)
65
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
Half - Day Course
9.00-12.00
Sala 4, Palazzo Congressi – Ground Floor
HOW TO WRITE AN ARTICLE FOR SCIENTIFIC JOURNALS
Speakers: Andres Martin (United States) , Bruno Falissard (France), Garry Walter
(Australia) ing Course
Main Lecture
10.00 – 11.00 Auditorium, Palazzo Congressi – Basement Floor
BIPOLAR AND OTHER MOOD DISORDERS: A CRITICAL REVIEW OF THE
CONTEMPORARY ISSUES
Speaker: Gabrielle Carlson (United States)
10.00 – 11.00 Sala Rossa, Palazzo Affari – 1st Floor
LEARNING AND MEMORY
Speaker: Paul Lombroso (United States)
Chair: Robert Pynoos (United States)
Co-Chair: Esti Galili-Weisstub (Israel)
Symposium
11.00 – 13.00
Auditorium, Palazzo Congressi – Basement Floor
GENETIC AND PSYCHOSOCIAL ASPECTS OF EARLY - ONSET SUICIDE IN A
BEDOUIN FAMILY
Chair: Alan Apter (Israel)
Co-Chair: David Brent (United States)
66
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
11.00 Study design - David Brent (United States)
11.20 The bedouin family - Muhammed El Haib
11.40 Psychosocial aspects - Sami Hamdan
12.00 Psychopathology - Ilana Farbstein
12.20 Genetics – Nadine Melhem
12.40 Discussion
Monday 27 August
11.00 – 13.00
Sala Adua 1, Palazzo Affari – 1st Floor
WAR, TERRORISM AND PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS
Chair: Ernesto Caffo (Italy)
Co-chair: Nathaniel Laor (Israel)
11.00 Effects of war on mental health of Lebanese children and adolescents:
prospective outcome and treatment - John Fayyad (Lebanon)
11.30 Lifetime psychopathological effects of a violent war on Burundian
pre-adolescents and parents - Paolo Feo (Italy)
12.00 Psychopathological assessment of Aceh Province pre-adolescents
after armed conflict and tsunami - Enzo Sechi (Italy)
12.30 Posttraumatic reactions among injured children and their caregivers
3 months after the terrorist attack in Beslan - Sara Scrimin (Italy)
11.00 – 13.00 Sala Gialla, Palazzo Affari – 3rd Floor
SERVICE EVALUATION IN CHILD AND ADOLESCENT PSYCHIATRY
Chair: Ioannis Tsiantis (Greece)
Co-Chair: Agnes Vetro (Hungary)
11.00 Treatment pathways in child and adolescent psychiatry: from
cooperation via networking to integrated provision
diagnosis - Christa Schaff (Germany)
67
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
11.20 Programs of evaluation and quality certification for the new services
of children’s and adolescents’ mental health in Greece: the case of
the children’s mental hospital of Attica (CMHA) - Dimitris Georgiadis
(Greece)
11.40 Evaluation of a new established neuropsychiatric outpatient clinic
in a semirural area - George Spiel (Austria)
12.00 Developing of child and adolescent psychiatric education and
research in Hungary - Agnes Vetro (Hungary)
12.20 Discussion
11.00 – 13.00 Sala Nera, Palazzo Affari – 3rd Floor
CURRENT STATE OF FORENSIC CHILD AND ADOLESCENT PSYCHIATRY
Chair: Theo Doreleijers (The Netherlands)
Co-Chair: Giovanni Camerini (Italy)
11.00 Forensic screening and diagnostic assessment in juvenile justice
settings in Europe - Theo Doreleijers (The Netherlands)
11.20 Outcome of specific groups of juvenile offenders - Robert Vermeiren
(The Netherlands)
11.40 Early identification of adolescents at risk of violence: European
Research - Riittakerttu Kaltiala-Heino (Finland)
12.00 Recommendations for treatment of juvenile sex offenders - Jorg
Fegert (Germany)
12.20 Meeting the needs of juvenile offenders in detention - Susan Bailey
(United Kingdom)
12.40 Discussion
68
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
11.00 – 13.00 Sala Rossa, Palazzo Affari – 1st Floor
BIPOLARITY IN YOUTHS: ASSOCIATED BEHAVIOUR AND DIAGNOSES
Chair: David Cohen (France)
Co-Chair: David Coghill (United Kingdom)
Monday 27 August
11.00 Suicidal behaviour and bipolarity - Réal Labelle (Canada)
11.20 Co-occurrence of conduct disorder and mood disorders in a clinicbased sample of young adolescents - Filippo Muratori (Italy)
11.40 Borderline disorder and bipolarity: are they different constructs?
Jean-Marc Guilé (Canada)
12.00 Attention deficit hyperactive disorder (ADHD) and bipolarity - David
Coghill (United Kingdom)
12.20 Discussion
11.00 – 13.00 Sala Azzurra, Palazzo Affari – Ground Floor
NEUROSCIENCE AND PSYCHOANALYSIS: FROM MODELS, TO CLINICS
Chair: Lisa Ouss (France)
Co-Chair: Philippe Jeammet (France)
11.00 Are neuroscientific models and recent findings relevant and for our
clinical practice? - Lisa Ouss (France)
11.20 Neuronal plasticity: a new paradigm bridging neurosciences and
psychoanalysis - Francois Ansermet (Switzerland)
11.40 Psychoanalysis and social cognitive neurosciences: a new framework
for an exchange between psychoanalysis and sciences Nicolas
Georgieff (France)
12.00 Contribution of new scientific data to the psychoanalytic perspective
- Bernard Golse (France)
12.20 Discussion
69
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
11.00 – 13.00 Sala Bianca, Palazzo Affari – 2nd Floor
SELECTIVE MUTISM IN CHILDREN, PREVALENCE, DESCRIPTION AND TREATMENT
Chair: Hanne Kristensen (Norway)
Co-Chair: Ruud Minderaa (The Netherlands)
11.00 What treatment works for children with selective mutism? A
randomized controlled treatment pilot study - Beate Ørbeck
(Norway), Hanne Kristensen (Norway)
11.30 When cognitive behavioural therapy isn’t enough - Sandra Mendlowitz
(Canada)
12.00 Prevalence and description of selective mutism in elementary
school - Louise Sharkey (ireland)
12.30 Discussion
11.00 – 13.00 Sala Viola, Palazzo Affari – 2nd Floor
MANIA SYMPTOMS IN CHILD AND ADOLESCENTS WITH DISRUPTIVE
BEHAVIOUR DISORDERS
Chair: Jordi Sasot (Spain)
Co-Chair: Lawrence Vitulano (United States)
11.00 Attention deficit hyperactivity disorder and pediatric bipolar
disorder: fundamental aspects - Rosa M. Ibáñez (Spain)
11.30 Mania symptoms in child and adolescents with disruptive behaviour
disorders – Jordi Sasot (Spain)
12.00 Differences between prepubertal - versus adolescent onset bipolar
disorder in a Spanish clinical sample - Josè Eugenio de la Fuente (Spain)
12.30 Discussion
70
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
Workshop
11.00 – 13.00 Sala Onice, Palazzo Congressi – Ground Floor
THE DEVELOPMENT AND WELL-BEING ASSESSMENT (DAWBA) IN RESEARCH
AND CLINICAL PRACTICE
Chair: Einar Heiervang (Norway)
Co-Chair: Antonella Delle Fave (Italy)
Monday 27 August
11.00 Background and use of the DAWBA in research and clinical practice
- Einar Heiervang (Norway)
11.20 A survey of child mental health in Italy using the DAWBA - Massimo
Molteni (Italy)
11.40 The DAWBA in a community mental health setting in Denmark Jon Arnfred (Denmark)
12.00 Demonstration of DAWBA online resources, example interviews
and scoring system - Einar Heiervang (Norway)
12.20 Discussion
11.00 – 13.00 Sala Grigia, Palazzo Affari – 4th Floor
HIGH-RISK SAMPLES; THE DEVELOPMENT OF PSYCHOTIC AND BIPOLAR
DISORDERS
Chair: Boris Birmaher (United States)
Co-Chair: Rutger Jan Van der Gaag (The Netherlands)
11.00 Social and family functioning of bipolar offspring – Catrien G.
Reichart (The Netherlands)
11.20 Five-year prospective outcome of psychopathology in the adolescent
offspring of bipolar parents - Manon H.J. Hillegers (The Netherlands)
11.40 The dutch prediction of psychosis study: are adolescents with MCDD
71
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
at high risk for Psychosis? - Patricia Schothorst (The Netherlands)
12.00 Dutch prediction of psychosis study: parameters of social impairment
in adolescents at high risk for psychosis – Myriam Sprong (The
Netherlands)
12.20 Discussion
11.00 – 13.00 Sala 9, Palazzo Congressi – Ground Floor
WORKING WITH PARENTS AND CHILDREN WITH EARLY ONSET MENTAL
DISORDERS
Chair: Ruedi Zollinger (Switzerland)
Co-Chair: Janke Yazgan (Turkey)
11.00 Perinatal psychic disease: treatment of parents’ vulnerability in a
“borning centre” following a multi-disciplinary approach - Maria
Cristina Stefanini (Italy)
11.20 What predicts reactive psychopathology versus resilience in children
of somatically ill parents (cosip): implications for mental health
prevention in a transnational perspective - Georg Romer (Germany)
11.40 Psychiatric diagnosis in parents of children with early onset
psychopathological disorders - Carla Sogos (Italy)
12.00 Adverse childhood experience: the patterns of the impact on social
skills and sexual and emotional life - Donata Bianchi (Italy)
12.20 Discussion
11.00 – 13.00 Sala 104, Palazzo Congressi – 1st Floor
A SHORT TERM MODEL FOR COPING WITH PSYCHO-TRAUMA IN THE VERY
YOUNG AND THEIR PARENTS
Speaker: Hanna Kaminer (Israel)
72
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
Poster Session
12.30 – 14.30
Symposium
Monday 27 August
14.00 – 16.00 Auditorium, Palazzo Congressi – Basement Floor
NEW PERSPECTIVES ON TRAUMA AND DISASTER INTERVENTION
Chairs: Alexander McFarlane (Australia)
Co-Chair: Barry Nurcombe (Australia)
14.00 Evidence based intervention and challenges of trauma research
with children. The school interventions program after the 2002
earthquake in Molise – Barbara Forresi (Italy)
14.20 Child mental health in complex emergencies – William Yule (United
Kingdom)
14.40 Enhanced child-oriented urban resilience following war and disaster
– Nathaniel Laor (Israel)
15.00 A longitudinal study of the impact of childhood experience on adult
psychopathology and cognitive schemas – Alexander McFarlane
(Australia)
15.20 Innovative protocol and evidence based interventions with children
and families following traumatic events – Robert Pynoos (United
States)
15.40 Discussion
73
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
14.00 – 16.00 Sala Adua 1, Palazzo Affari – 1st Floor
FROM BABY TO ADOLESCENT: A PSYCHOPATHOLOGICAL CONTINUITY?
Chair: Vèronique Delvenne (Belgium)
Co-Chair: Dimitrios Georgiadis (Greece)
14.00 From baby to adolescent: a psychopathological continuity? Vèronique Delvenne (Belgium)
14.15 Mood disorders in children and adolescents: a developmental and
ethological perspective - Jean-Marie Gauthier (Belgium)
14.30 Wise babies, difficult children and suicidary adolescents : the future
of children with depressed parents - Anne François (Belgium)
14.45 The uneasiness in the situation of being alone and the separation
anxiety: the semiology from the early childhood to the adolescence
Jean-Marc Scholl (Belgium)
15.00 Psychosis in adolescents and young adults: atypicals give rise to
hope - Nicolas Zdanowicz (Belgium)
15.15 The clinic anger and of the feeling of being overwhelmed: from
psychopathology to the adequate of punishment - Paule Philippe
(Belgium)
15.30 Psychopathology during childhood: hopes from atypical
antipsychotic drugs - Paule Philippe (Belgium)
15.45 Discussion
14.00 – 16.00 Sala Gialla, Palazzo Affari – 3rd Floor
BETWEEN CHILD - AND ADULTHOOD - SPECIAL PSYCHOTHERAPY
TECHNIQUES TREATING SEVERELY DISTURBED ADOLESCENTS
Chair: Philippe Jeammet (France)
Co-Chair: Peter Riedesser (Germany)
74
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
14.00 The ego face to freedom - Philippe Jeammet (France)
14.20 Difficulties in the treatment of a traumatized adolescent with traumacompensating grandiosity fantasies - Peter Riedesser (Germany)
14.40 From blind action to mentalisation – how psychotherapy can be
the “second chance” of severely disturbed adolescents - Annette
Streeck-Fischer (Germany)
15.00 Emergency and crisis intervention for aggressive and violent
behaviours at adolescence – Mario Speranza (France)
15.20 Discussion
Monday 27 August
14.00 – 16.00 Sala Nera, Palazzo Affari – 3rd Floor
NEW DEVELOPMENTS IN FORENSIC PSYCHIATRY AND PSYCHOLOGY
Chair: Klaus Schmeck (Switzerland)
Co-Chair: Giuseppe Sartori (Italy)
14.00 Psychopathological disorders and environmental stress factors in
child sexual abuse trial procedures - Giovanni Camerini (Italy)
14.20 New juvenile law in Switzerland - Ulrich Preuss (Switzerland)
14.40 Neurobiology and the future of forensic assessment – Arne Popma
(The Netherlands)
15.00 Emotional processing in children with externalized disorders Maaike
Cima (The Netherlands)
15.20 Influence of rapid tryptophan depletion on laboratory-provoked
aggression in children with ADHD – Christina Stadler (Germany)
15.40 Discussion
75
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
14.00 – 16.00 Sala Rossa, Palazzo Affari – 1st Floor
DEPRESSION AND ANXIETY FROM PRESCHOOL TO SCHOOL AGE
Chair: Joan L. Luby (United States)
Co-Chair: Carla Sogos (Italy)
14.00 Preschool depression: new research findings validating the disorder
Joan L. Luby (United States)
14.20 Clinical trajectories in depressive disorders from preschoolers to
school age children - Carla Sogos (Italy)
14.40 The wide spectrum of mood disorder in childhood and related
problems: case studies - Lucia Margari (Italy)
15.00 Anxiety and depression in selective mutism - Flavia Capozzi (Italy)
15.20 Discussion
14.00 – 16.00 Sala Azzurra, Palazzo Affari – Ground Floor
POSITIVE PSYCHOLOGY AND WELL-BEING PROMOTION IN ADOLESCENCE
Chair: Antonella Delle Fave (Italy)
Co-Chair: Barbara Forresi (Italy)
Discussant: David Brent (United States)
14.00 Gender differences in coping with school failure: A longitudinal
perspective – Ingrid Brdar (Croatia)
14.20 The cross-cultural investigation of optimal experience in learning:
implications for individual development and educational policies
Antonella Delle Fave (Italy)
14.40 Quality of experience in daily life, drug use and future goals in
adolescents: positive development and health implications - Teresa
Freire (Portugal)
15.00 Intervention for promoting psychological well-being in adolescence
a controlled study - Fedra Ottolini (Italy)
15.20 Discussion
76
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
14.00 – 16.00 Sala Bianca, Palazzo Affari – 2nd Floor
ADOLESCENCE: A PERIOD OF VULNERABILITY TO DEVELOP RISKY
BEHAVIOUR
Chair: Olivier Halfon (Switzerland)
Co-Chair: Monique Bolognini (Switzerland)
Monday 27 August
14.00 Cognitive and emotional deficits and self defeating behaviour in
conduct disordered adolescents - Philippe Stephan (Switzerland)
14.30 Substance use initiation among violent and non-violent adolescents
- Monique Bolognini (Switzerland)
15.00 Chronic emotional stress in adolescent rats: impact on alcohol and
cocaine consumption - Benjamin Boutrel (United States)
15.30 Discussion
14.00 – 16.00 Sala Viola, Palazzo Affari – 2nd Floor
AUTISM: BRIDGING THE GAPS BETWEEN NEUROSCIENCES AND PSYCHOANALYTIC PERSPECTIVES
Chair: Jean-Marc Guilè (Canada)
Co-Chair: Didier Houzel (France)
14.00 Towards an integrated clinico-biological approach to autism - Sylvie Tordjman (France), David Cohen (France), Bernard Golse (France)
14.20 Dynamic processing of social cues in autism spectrum disorder Martin Debbané (France), Stephan Eliez (France)
14.40 About Infantile Autism: the superior temporal sulcus between
neurosciences and psychoanalysis - Bernard Golse (France)
15.00 Gaze processing, oxytocin and the amygdale theory in autism
Jean-Marc Guilè (Canada), David Cohen (France)
15.20 Dismantling and attacks on attention in autistic syndromes - Didier
Houzel (France)
15.40 Discussion
77
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
14.00 – 16.00 Sala 4, Palazzo Congressi – Ground Floor
HELPLINES AND INTERNET: INNOVATIVE INTERVENTION IN CHILD AND
ADOLESCENT MENTAL HEALTH
Chair: Annie Gaudière (France)
Co-chair : Thomas Müller (Belgium)
14.00 Are helplines effective when dealing with child and adolescent
problems? The experience of 114 emergency helpline - Ernesto
Caffo (Italy), Gian Luigi Lepri, Barbara Forresi (Italy)
14.20 Innovative approaches to meeting the mental health needs of
children - Thomas Müller (Belgium)
14.40 Childline a model for an active listening helpline - Aine Lynch (Ireland)
15.00 Helpline - Connection 801 801 1177 concerning the psychosocial
health of children and adolescents: data from the first 24
months of its operation and repeat caller to the helpline - Vasso
Vassilopoulou (Greece)
15.20 Discussion
Workshop
14.00 – 16.00 Sala Onice, Palazzo Congressi – Ground Floor
SCREENING AND ASSESSMENT OF INFANT PATHOLOGY: A DIAGNOSTIC
AND THERAPEUTIC CHALLENGE
Chair: Filippo Muratori (Italy)
Co-Chair: Claude Bursztejn (France)
14.00 Toward a very early screening of autism: reliability of social,
emotional and communication clues 9-14 months of old infantsClaude Bursztejn (France)
78
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
14.20 Autism: is its stability a function of the age of diagnosis – Filippo
Muratori (Italy)
14.40 Therapeutic management of very proud infant emotional and
developmental disorders – Gisèle Apter (France)
15.00 Results of a research of a psychotherapeutic intervention parents/
very young children with behavioural problems – Francisco Palacio
Espasa (Switzerland)
15.20 Discussion
Monday 27 August
14.00 – 16.00 Sala Grigia, Palazzo Affari – 4th Floor
ASSESSMENT AND TREATMENT OF COMORBID ADHD AND LEARNING
PROBLEMS
Chair: Giuseppe Chiarenza (Italy)
Co-Chair: Ciro Ruggerini (Italy)
14.00 Executive functions, language and learning skills in children
born at 23-25 weeks gestation in the 1990s: A Swedish National
Prospective Follow-Up Study - Farooqi Aijaz (Sweden)
14.30 Speech, language and learning disabilities distributed source
imaging of single-letter regarding aloud in healthy and dyslexic
children - Giuseppe Chiarenza (Italy)
15.00 ADHD and specific learning disabilities: clinical overlap and
neuropsychological differences - Enzo Sechi (Italy)
15.30 Discussion
14.00 – 16.00 Sala 9, Palazzo Congressi – Ground Floor
DEVELOPING OUTCOME FOCUSED SERVICES AND BUILDING LEADERSHIP
CAPACITY IN CHILD MENTAL HEALTH
Chair: Miranda Wolpert (United Kingdom)
79
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
Co-Chair: Massimo Molteni (Italy)
14.00 A model of outcome evaluation using the CORC approach in the
UK and Norway - Miranda Wolpert (United Kingdom)
14.30 The use of standardised clinical assessment (using the DAWBA)
alongside outcome evaluation - Einar Heiervang (Norway)
15.00 Developing leadership capacity in child mental health – Bob Foster
(United Kingdom)
15.30 Discussion
14.00 – 16.00 Sala 104, Palazzo Congressi - 1st Floor
DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS
Chair: Stefano Palazzi (Italy)
Co-Chair: Roberto Canitano (Italy)
14.00 Co-morbidity in Asperger Syndrome vs. high functioning autism
Stefano Palazzi (Italy)
14.20 Outcome in Autism Spectrum Disorders – Mats Cederlund (Sweden)
14.40 The stability of a new symptom model in autism: evidence from the
ADI-R - Nastaja Van Lang (The Netherlands)
15.00 The usefulness of the DSM symptom model: evidence from the
ADI-R Maretha De Jonge (The Netherlands)
Meet the Expert
16.00 – 17.00
Sala Adua 1, Palazzo Affari – 1st Floor
Joseph Sergeant (The Netherlands)
Chair: Thomas Achenbach (United States)
Co-Chair: Ari Rothenberger (Germany)
80
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
16.00 – 17.00 Sala Rossa, Palazzo Affari – 1st Floor
Philippe Jeammet (France)
Chair: Anna Fabrizi (Italy)
Co-Chair: Beate Herpertz - Dahlmann (France)
16.00 – 17.00 Sala 4, Palazzo Congressi – Ground Floor
Miranda Wolpert (United Kingdom)
Chair: Dirk Deboutte (Belgium)
Co-Chair: Gabriele Masi (Italy)
16.00 – 17.00 Herman Van Engeland
Monday 27 August
16.00 – 17.00 Sala 9, Palazzo Congressi – Ground Floor
Lawrence Scahill (United States)
Chair: Patricia Howlin (United Kingdom)
Co-Chair: Isabel Hernandez-Otero (United Kingdom)
Sala 104, Palazzo Congressi – 1st Floor
Eli Lilly Satellite Symposium
16.00 – 18.00
Auditorium, Palazzo Congressi – Basement Floor
ADHD: INTEGRATING TREATMENT PERSPECTIVES, supported by Eli Lilly & C.
Chair: Timothy Wilens (United States)
16.00 Welcome and opening remarks - Timothy Wilens (United States)
16.15 Psychoeducational approaches to treatment - Rosemary Tannock (Canada)
16.30 Psychosocial approaches to treatment - Suzy Young (United Kingdom)
81
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
17.00 Psychopharmacological treatment options - Timothy Wilens (United States)
17.30 Discussion
16.00 – 18.00 Sala Bianca, Palazzo Affari – 2nd Floor
PRESCRIPTION OF ANTIDEPRESSANTS
Chair: Joaquin Fuentes (Spain)
Speakers: A.J. Allen (United States), Kelly Posner (United States), David Brent
(United States)
Debate
16.00 – 18.00 Sala Grigia, Palazzo Affari – 4th Floor
REGULATION MEDICINE: USA VS EUROPE
Chair: Benedetto Vitiello (United States)
Speakers: Eric Taylor (United Kingdom), Laurence Greenhill (United States),
Pietro Panei (Italy)
Meet the Expert
17.00 – 18.00
Sala Adua 1, Palazzo Affari – 1st Floor
Barry Nurcombe (Australia)
Chair: Jan Buitelaar (The Netherlands)
Co-Chair: Renzo Guerrini (Italy)
17.00 – 18.00 Sala Gialla, Palazzo Affari – 3rd Floor
Alan Apter (Israel)
Chair: Lena Eidevall (Sweden)
Co-Chair: Robert King (United States)
82
SCIENTIFIC PROGRAM - MONDAY, 27 AUGUST
17.00 – 18.00 James Hudziak (The Netherlands)
Chair: Mita Mancini (Italy)
Co-Chair: Martine Flament (Canada)
Sala Nera, Palazzo Affari - 3rd Floor
17.00 – 18.00 Sala Rossa, Palazzo Affari – 1st Floor
Gabrielle Carlson (United States)
Chair: Neil Ryan (United States)
Co-Chair: Johannes Hebebrand (Germany)
Monday 27 August
17.00 – 18.00 Sala Azzurra, Palazzo Affari – Ground Floor
Boris Birmaher (United States)
Chair: David Cohen (France)
Co-Chair: Dimitris Anagnostopoulos (Greece)
17.00 – 18.00 Sala Viola, Palazzo Affari – 2nd Floor
Paul Lombroso (United States)
Chair: Bruno Falissard (France)
Co-Chair: Eugenia Soumaki (Greece)
Main Lecture
18.00 – 19.00
Auditorium, Palazzo Congressi – Basement Floor
UNIPOLAR DEPRESSION IN YOUNG PEOPLE: MECHANISMS AND PROCESSES
IN THE ONSET AND COURSE OF DISORDER
Speaker: Ian Goodyer (United Kingdom)
20.00 – 22.00 Monday Evening - MOVIE SESSION
Auditorium Palazzo dei Congressi
83
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
Clinical Consultation Breakfast
8.00 – 9.30
Sala 101, Palazzo Congressi – 1st Floor
ADHD
Speakers: Laurence Greenhill (United States), Joseph Sergeant (The
Netherlands)
Training Course
8.30 - 17.00 Sala Azzurra, Palazzo Affari – Ground Floor
ADHD: DIFFICULT QUIESTIONS AND PRACTICAL ANSWERS
Chair: Eric Taylor (United Kingdom)
8.30 - 17.00 SUICIDE
Chair: Alan Apter (Israel)
Sala Verde, Palazzo Congressi – 2nd Floor
8.30 - 17.00 Sala Arancione, Palazzo Affari – Basement Floor
UNDERSTANDING AND INTERVENING WITH CHILDREN, FAMILIES AND
COMMUNITIES EXPOSED TO TRAUMA AND DISASTER
Chairs: William Yule (United Kingdom), Nathaniel Laor (Israel)
State of the Art Lecture
9.00 – 10.00 Auditorium, Palazzo Congressi – Basement Floor
COGNITIVE BEHAVIOUR THERAPY: PAST, PRESENT AND FUTURE
Speaker: Philip J. Graham (United Kingdom)
Chair: Miranda Wolpert (United Kingdom)
84
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
9.00 – 10.00 Sala Gialla, Palazzo Affari – 3rd Floor
SUBSTANCE USE AND ABUSE – NEW DEVELOPMENTS IN RESEARCH AND
INTERVENTIONS
Speaker: Ambros Uchtenhagen (Switzerland)
Chair: Lawrence Scahill (United States)
9.00 – 10.00
Sala Nera, Palazzo Affari – 3rd Floor
MULTICULTURAL ASSESSMENT OF CHILD AND ADOLESCENT PSYCHOPATHOLOGY: RESEARCH FINDINGS AND CLINICAL APPLICATIONS
Speaker: Thomas Achenbach (United States)
Chair: Anna Fabrizi (Italy)
Tuesday 28 August
9.00 – 10.00
Sala Rossa, Palazzo Affari – 1st Floor
EVIDENCE BASED APPROACH: EARLY IDENTIFICATION OF MENTAL ILLNESS
IN CHILDREN AND ADOLESCENTS
Speaker: Laurie Flynn (United States)
Chair: Kathleen Ries Merikangas (United States)
9.00 – 10.00 Sala Bianca, Palazzo Affari – 2nd Floor
ETHICS
Speaker: Per-Anders Rydelius (Sweden)
Chair: Tiberiu Mircea (Romania)
9.00 – 10.00 Sala Viola, Palazzo Affari – 2nd Floor
CURRENT TREATMENTS FOR DEPRESSION IN CHILDREN AND ADOLESCENTS
Speaker: Neil Ryan (United States)
Chair: James Anthony (United States)
85
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
9.00 – 10.00 Sala Onice, Palazzo Congressi – Ground Floor
RETHINKING DIAGNOSIS AND CLASSIFICATION IN THE PERSPECTIVES OF
DEVELOPMENTAL PSYCHOPATHOLOGY: POTENTIAL NEW APPROACHES
TOWARDS DSM V & ICD
Speaker: Rutger Jan Van der Gaag (The Netherlands)
Chair: Miroslaw Dabkowski (Poland)
9.00 – 10.00 Sala Grigia, Palazzo Affari – 4th Floor
AUXILIARY EGO PROCEDURE IN CHILD AND ADOLESCENT DISABILITIES
Speaker: Massimo Papini (Italy)
Chair: Jacques Constant (France)
Half - Day Course
9.00 - 12.00
Sala 4, Palazzo Congressi – Ground Floor
GENOMICS, POST-GENOMICS AND CHILD NEUROPSYCHIATRIC DISEASES
Speakers: Mita Mancini (Italy), Fabio Macciardi (Italy), Peter Szatmari (Canada)
New technologies in complex diseases: from SNP genotyping to CNV analysis
and high throughput sequencing - Mita Mancini (Italy)
Complexities in genomics and post-genomics analysis of psychiatric diseases:
the case of brain imaging genetics – Fabio Macciardi (Italy)
Copy Number Variation as a risk factor in the etiology of Autism - Peter Szatmari
(Canada)
9.00 - 12.00 Sala 104, Palazzo Congressi - 1st Floor
Measuring and validating outcomes in child and adolescent
psychiatry
Chair: Bruno Falissard (France)
86
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
Main Lecture
10.00 - 11.00
Auditorium, Palazzo Congressi – Basement Floor
ALIGNING EVIDENCE AND PRACTICE: A KEY CHALLENGE FOR TWENTY
FIRST CENTURY CHILD PSYCHIATRY
Speaker: Peter Fonagy (United Kingdom)
Chair: Philippe Jeammet (France)
Tuesday 28 August
10.00 - 11.00 Sala Rossa, Palazzo Affari – 1st Floor
THROUGH A GLASS DARKLY: ILLUMINATING THE TROUBLED MIND
Speaker: James Fallon (United States)
87
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
Symposium
11.00 - 13.00
Auditorium, Palazzo Congressi – Basement Floor
BRAIN INHIBITORY SYSTEMS IN ADHD AND TOURETTE SYNDROME
Chair: Flora Vaccarino (United States)
Co-Chair: Paul Lombroso (United States)
11.00 Development of brain inhibitory systems and their possible involvement
in ADHD and Tourette Syndrome (TS) Flora Vaccarino (United States)
11.20 Discussion
11.25 Translational neuroscience: blocking the induction of repetitive
movements - Paul Lombroso (United States)
11.45 Discussion
11.50 Neuroimaging of self-regulatory control in children with Tourette
Syndrome or ADHD - Kerstin J. Plessen (Norway)
12.10 Discussion
12.15 The genetics of Tourette Syndrome and related disorders - Matthew
State (United States)
12.35 Discussion
12.40 Aberrant neural oscillations in Tourette Disorder: implications for
treatment - James Leckman (United States)
11.00 - 13.00 Sala Adua 1, Palazzo Affari – 1st Floor
EARLY ONSET SCHIZOPHRENIA AND BIPOLAR DISORDERS: BORDERS
Chair: Velilla Picazo Jose Mariano (Spain)
Co-Chair: César Soutullo (Spain)
11.00 Prodromes in schizophrenia and bipolar disorders – Antonio Agüero
(Spain)
88
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
11.20 Clinical and neurobiological differences between schizophrenia
and bipolar disorders - Tomás Canntó (Spain)
11.40 Bipolar disorders and ADHD: differences and similarities - Cesar
Soutullo (Spain)
12.00 Schizophrenia and pervasive developmental disorders (PDD) Rafaela Caballero (Spain)
12.20 Discussion
11.00 - 13.00 Sala Gialla, Palazzo Affari – 3rd Floor
PSYCHOPATHOLOGY IN LANGUAGE AND LEARNING DISORDERS
Chair: Anna Fabrizi (Italy)
Co-Chair: Leslie Rescorla (United States)
Tuesday 28 August
11.00 Psychopathological comorbidity in early language disorders:
maternal psychopathology as risk factors - Anna Fabrizi (Italy)
11.20 Examining the association between language delays and
behavioural/emotional problems in children under age 3 - Leslie
Rescorla (United States)
11.40 Psychopathological problems and learning disabilities: adult and
children perspectives - Roberta Penge (Italy)
12.00 Specific language disorders and feeding disorders: a longitudinal
study - Loredana Lucarelli (Italy)
12.20 Discussion
11.00 - 13.00 Sala Nera, Palazzo Affari – 3rd Floor
INNOVATIVE CARE FOR THE INTELLECTUAL DISABILITY
Chair: Giuseppe Chiarenza (Italy)
Co-Chair: Enrico Populin (Italy)
89
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
11.00 The innovative care for the intellectual disability: a project for “the
self-management enforcement program for families in Reggio
Emilia - Ciro Ruggerini, Annamaria Dalla Vecchia (Italy)
11.20 The origins, contents and effects of the document Innovative Care
for Chronic Conditions (WHO , 2002)” - Enrico Populin (Italy)
11.40 A new paradigm of medical care for disabled persons: a multicountry action-learning research initiative - Sunil Deepak (Italy)
12.00 An experience of exchange between European Association for
Disabled Persons: trends and open questions - Yvonne Bonner
(Italy)
12.20 The history of self-help groups in Reggio Emilia: its contribution to
the formation of some co-sharing culture with the public institutions
- Carlo Vasconi (Italy)
12.40 Discussion
11.00 - 13.00 Sala Rossa, Palazzo Affari – 1st Floor
INTERVENTION FOR ACUTE TRAUMATIZED CHILDREN AND ADOLESCENTS:
EXPERIENCES AND TREATMENT-CONCEPTS
Chair: Phyllis Cohen (United States)
Co-Chair: Ruth Feldman (Israel)
11.00 The trauma ambulance for children, adolescents and their families
at the University-Hospital Hamburg-Eppendorf - Andreas Krüger
(Germany)
11.30 Law enforcement-mental health collaboration: the child
development community policing program - Steven Berkowitz
(United States)
12.00 Early intervention in childhood trauma in cooperation with the
administrative body of care - Renate Schepker (Germany)
12.30 Discussion
90
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
11.00 - 13.00 Sala Bianca, Palazzo Affari – 2nd Floor
INTERNATIONAL APPROACHES TO THE ASSESSMENT AND TREATMENT OF
BULLYING
Chair: Young-Shin Kim (United States)
Co-Chair: Oscar Herrero Rodriguez (Spain)
11.00 Bullying in Serbia elementary schools - Milica Pejovic Milovancevic
(Serbia)
11.20 Kirsti Irmeli Kumpulainen (Finland)
11.40 Universal bullying prevention: are the needs of the most
vulnerable met? - Yolanda Pintabona (United Kingdom)
12.00 The role of peer support in addressing the problem of school
bullying - Helen Cowie (United Kingdom)
12.20 Discussion
Tuesday 28 August
11.00 - 13.00 Sala Viola, Palazzo Affari – 2nd Floor
AGGRESSIVE AND SUICIDAL BEHAVIOUR IN ADOLESCENT DEPRESSION
Chair: Maria Jesus Mardomingo (Spain)
Co-Chair: Martina Tomori (Slovenia)
11.00 Adolescent risk factors for episodic and recurrent depression in
adulthood: a 16-year follow-up study - Aro Hillevi (Finland)
11.20 Childhood depression: beyond acute treatment – Graham Emslie
(United States)
11.40 Long term prognosis among adolescent suicide attempters Groholt Berit (Norway)
12.00 Adolescents’ aggressiveness under extraordinary (aggressive)
circumstances - Vojislav Curcic (Serbia and Montenegro)
12.20 Discussion
91
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
11.00 - 13.00 Sala Onice, Palazzo Congressi – Ground Floor
TRAINING OF TRAINEES IN CHILD AND ADOLESCENT PSYCHIATRY IN
PSYCHOTHERAPY
Chair: Ioannis Tsiantis (Greece)
Co-Chair: Jorma Piha (Finland)
11.00 Individual psychodynamic-psychoanalitic Psychotherapy - Ioannis
Tsiantis (Greece)
11.20 Training child and adolescent psychiatrists in Family Therapy
Jorma Piha (Finland)
11.40 The cognitive behavioural psychotherapeutic competences in child
and adolescent psychiatry - Dirk Deboutte (Belgium)
12.00 Symposium on training of trainees in child psychiatry in
psychotherapy - Wrangsjo Bjorn (Sweden)
12.20 Successes and problems faced by Psychoanalytic, Family and Cognitive
Behavioural Psychotherapies – Euthymia D. Hibbs (United States)
12.40 Discussion
Workshop
11.00 - 13.00 Sala Grigia, Palazzo Affari – 4th Floor
PROMOTING THE DEVELOPMENT OF EMOTION REGULATION IN CHILDREN
AND ADOLESCENTS
Chair: Rajeev Banhatti (Croatia)
Co-Chair: Vesna Vidović (Croatia)
11.00 Aspects of emotional development including that of emotion
regulation - Sachin Sankar
92
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
11.45 Emotion disregulation and its causes - Rajeev Banhatti (Croatia)
12.30 Discussion
11.00 - 13.00 Sala 9, Palazzo Congressi – Ground Floor
SCHOOL INTEGRATION AS COMMUNITY CARE: THE ITALIAN MODEL
Chair: Joaquin Fuentes (Spain)
11.00 Dante Besana (Italy)
11.30 Maria Antonella Costantino (Italy)
12.00 Giancarlo Onger (Italy)
12.30 Discussion
Poster Session
Tuesday 28 August
12.30 - 14.30
Symposium
14.00 – 16.00
Auditorium, Palazzo Congressi – Basement Floor
SUBSTANCE USE DISORDER IN EUROPE CONSEQUENCES FOR SERVICES
Chair: Rutger Jan Van der Gaag (The Netherlands)
Co-Chair: Dainius Puras (Lithuania)
14.00 Substance (mis)use disorders & addiction in youth: a problem of
society and services - Rutger Jan Van der Gaag (The Netherlands)
14.25 Substance (mis)use disorders & addiction in youth: dual diagnosis
- Patricia J.M.Van Wijngaarden-Cremers (The Netherlands)
93
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
14.50 Substance (mis)use disorders & addiction in youth: a European
perspective on dual diagnosis and services - Christianne
Couwenbergh (The Netherlands)
15.15 Prevalence of ADHD in substance use disorders patients in Europe
- Geurt Van De Glind (The Netherlands)
15.40 Discussion
14.00 – 16.00 Sala Adua 1, Palazzo Affari – 1st Floor
INTERDISCIPLINARY RESEARCH ON AGGRESSIVE BEHAVIOUR
Chair: Georg Spiel (Austria)
Co-Chair: Dickon Bevington (United Kingdom)
14.00 Differentiation (in Types) of children and adolescent with Conduct
disorder-using a person centred approach - Georg Spiel (Austria)
14.20 Bridging the gap between child and society: the Viennese Social
Competence Training (ViSC) to prevent bullying at school - C. Spiel
14.40 Using an extended cartoon methodology to study pupil’s
understanding of bullying in eastern and western cultures - Paul
Smith
15.00 The dissocial lifeline from childhood to adolescence-clinical aspects
in forensic psychiatry - O. Bilke
15.20 Discussion
14.00 – 16.00 Sala Gialla, Palazzo Affari – 3rd Floor
NEW PERSPECTIVES ON PARENT AND INFANT TRAUMA
Chair: Gisèle Apter (France)
Co-Chair: Joan L. Luby (United States)
94
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
14.00 Maternal history of trauma, mother-infant distorted interactions Gisèle Apter (France)
14.20 Parental stress experienced during the neonatal period and its
implications on the intergenerational transmission attachment
representations - Blaise Pierrehumbert (Switzerland)
14.40 Babies, mothers, cultures and migrations: a clinical perspective - Ta
ïeb Ferradji (France)
15.00 Reflecting on a three steps infant trauma theory - Bernard Golse
(France)
15.20 Discussion
Tuesday 28 August
14.00 – 16.00 Sala Nera, Palazzo Affari – 3rd Floor
EPIDEMIOLOGICAL COMMUNITY STUDIES: AN OVERVIEW OF RECENT
SURVEYS
Chair: Giovanni De Girolamo (Italy)
Co-Chair: Kathleen Ries Merikangas (United States)
14.00 Prevalence and correlates of mental disorders among adolescents
in Italy: the prisma study - Massimo Molteni (Italy)
14.20 The Mexican adolescent mental health survey - Corina Benjet
(Mexico)
14.40 Prevalence of mental disorders and predictors for substance use
disorders among adolescents in Taiwan - Susan Shur-Fen Gau
(Taiwan)
15.00 Incidence and risk factors for depressive disorders in the first three
decades of life - Roselind Lieb (Switzerland)
15.20 Prevalence of mental disorders in the national comorbidity survey
adolescent study (NCS-A) - Kathleen Ries Merikangas (United
States)
15.40 Discussion
95
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
14.00 – 16.00 Sala Rossa, Palazzo Affari – 1st Floor
NOVEL RESEARCH ON FUNCTIONAL DEFICITS IN ADHD
Chair: Per-Anders Rydelius (Sweden)
Co-Chair: Joseph Biederman (United States)
14.00 Educational and occupational deficits in ADHD subjects - Joseph
Biederman (United States).
14.20 Combined oros methylphenidate in atomoxetine partial responders:
results of an ongoing clinical trial - Timothy E. Wilens. (United
States)
14.40 New insights into the comorbidity between ADHD and major
depression in adolescent girls - Joseph Biederman (United States)
15.00 Towards defining neuroanatomical profiles of bipolar disorder
and ADHD: a controlled MRI morphometric study - Nikos Makris
(Greece) 15.20 Discussion
14.00 – 16.00 Sala Bianca, Palazzo Affari – 2nd Floor
CHILD AND ADOLESCENT MENTAL HEALTH IN SOUTH EAST EUROPE
Chair: Milica Pejović Milovančević (Serbia and Montenegro)
Co-Chair: Eugenia Soumaki (Greece)
14.00 Child and adolescent mental health in South East Europe - Milica
Pejović Milovančević (Serbia and Montenegro)
14.20 Challenges of promoting and protecting mental health of children
and adolescents in Serbia - Veronika Ispanovic (Serbia and
Montenegro)
14.40 Situation of CAMH policies, services and training in B&H – Marija
Burgic-Radmanovic (Bosnia and Herzegovina)
15.00 Developing child and adolescent mental health network in R. of
Macedonia – Maria Raleva (Macedonia)
96
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
15.20 Policies and practices for children and youth mental health
promotion and prevention in Bulgaria – Vaska StanchevaPopkostadinova (Bulgaria)
15.40 Discussion
14.00 – 16.00 Sala Viola, Palazzo Affari – 2nd Floor
RECENT COGNITIVE AND NEURAL ADVANCES IN AUTISM RESEARCH
Chair: Nancy Minshew (United States)
Co-Chair: Kevin Pelphrey (United States)
Tuesday 28 August
14.00 Neuropsychological functioning in children with autism disorder:
further evidence for disordered complex information-processing Nancy Minshew (United States)
14.20 Development of categorization & facial knowledge in individuals
with autism - Kevin Pelphrey (United States)
14.40 FMRI of the mirror neuron system in autism spectrum disorder: a
disturbance in the mechanism for understanding the world of
others - Susan Bookheimer (United States)
15.00 A multimodal imaging approach to the neurobiology of autistic
spectrum disorder - Declan Murphy (United Kingdom)
15.20 Discussion
14.00 – 16.00 Sala 4, Palazzo Congressi – Ground Floor
APPLICATION OF THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING,
DISABILITY AND HEALTH (ICF) IN CHILD AND ADOLESCENT PSYCHIATRIC
DISORDERS
Chair: Eberhard Schulz (Germany)
Co-Chair: Dante Besana (Italy)
97
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
14.00 Development of an ICF core set for psychiatry disorders in children
and adolescents - Klaus Hennighausen (Germany)
14.30 Psychosocial level of functioning and quality of life in children and
adolescents with autism – Monica Biscaldi (Germany)
15.00 Psychosocial level of functioning and quality of life in children
and adolescents with anorexia nervosa - Christian Fleischhaker
(Germany)
15.30 Discussion
Workshop
14.00 – 16.00 Sala Onice, Palazzo Congressi – Ground Floor
Alcohol and violence: the European project CHALVI
Chair: Ambros Uchtenhagen (Switzerland)
Speaker: Umberto Nizzoli (Italy)
14.00 – 16.00 Sala Grigia, Palazzo Affari – 4th Floor
NEW APPROACHES IN TESTIMONY AND CHILD ABUSE
Chair: Barry Nurcombe (Australia)
Co-Chair: Giuseppe Sartori (Italy)
14.00 Neural maturation in childhood: implications for testimony Giuseppe Sartori (Italy)
15.30 Discussion
98
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
14.00 – 16.00 Sala 104, Palazzo Congressi – 1st Floor
WORKING WITH CHILDREN IN SYSTEMS OF CARE
Chair: Frank Oberklaid (Australia)
14.00 Objectives-based mental health promotion in secondary schools
14.30 Policy and service challenges in children’s mental health - new
paradigms urgently needed - Frank Oberklaid (Australia)
15.00 The epidemiology of mental health - Anne Mette Skovgaard
(Denmark)
15.30 Discussion
Meet the Expert
Tuesday 28 August
16.00 – 17.00
Sala Adua 1, Palazzo Affari – 1st Floor
Peter Fonagy (United Kingdom)
Chair: James Anthony (United States)
Co-Chair: Annette Streeck-Fischer (Germany)
16.00 – 17.00 Sala Gialla, Palazzo Affari – 3rd Floor
Ambros Uchtenhagen (Switzerland)
Chair: Rutger Jan Van der Gaag (The Netherlands)
Co-Chair: Kari Schleimer
16.00 – 17.00 Neil Ryan (United States)
Chair: Fritz Poustka (Finland)
Co-Chair: Nese Erol (Turkey)
Sala Nera, Palazzo Affari – 3rd Floor
99
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
16.00 – 17.00 James Fallon (United States)
Sala Viola, Palazzo Affari – 2nd Floor
16.00 – 17.00 Sala 104, Palazzo Congressi - 1st Floor
Martine F. Flament (Canada)
Chair: Alain Braconnier
Co-Chair: Matthijs Muijen (Denmark)
Symposium
16.00 – 17.00 Sala Grigia, Palazzo Affari – 4th Floor
EUROPEAN PERSPECTIVES FOR CHILD AND ADOLESCENT PSYCHIATRISTS:
SPECIALIST TRAINING, WORKING OPPORTUNITIES AND SERVICE
CONFIGUARATIONS
Chair: Elisa Fazzi (Italy)
Co-Chair: Ettore Guaia (United Kingdom)
14.00 A model of intervention in adolescent inpatients with psychiatric
disorders: special needs and training requirements - Giorgio Rossi
(Italy)
14.20 Integrating the differences: the NHS experience – Ettore Guaia
(United Kingdom)
100
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
14.40 A local CAMHS configuration outreach service and liaison from
adolescents – L. Clerici Withney
15.00 A day unit for adolescents with early onset psychoses - R. Farruggia
(Italy)
15.20 Discussion
16.00 – 18.00
Auditorium, Palazzo Congressi – Basement Floor
DIAGNOSIS, COURSE, AND SYMPTOM PROFILES IN CHILDREN AND
ADOLESCENTS WITH AUTISM AND AUTISM SPECTRUM DISORDERS
Chair: Herman Van Engeland (The Netherlands)
Co-Chair: Patricia Howlin (United Kingdom)
Tuesday 28 August
16.00 The diagnostic validity of two autism screening questionnaires
- Reinhold Rauh (Germany)
16.30 Diagnostic criteria profiles, early indicators and attendant symptoms
in childhood autism and Asperger’s Syndrome - Monica Biscaldi
(Germany)
17.00 Results from diagnostic examinations of participants with Asperger
Syndrome and high-functioning autism - Inge Kamp-Becker
(Germany)
17.30 Discussion
Clinical Case Conference
16.00 – 18.00 Sala Rossa, Palazzo Affari – 1st Floor
The Adolescent and his parent: a community of suffering:
psychotherapeutical perspectives
Speaker: Véronique Delvenne (Belgium)
101
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
16.00 – 18.00 Sala Onice, Palazzo Congressi – Ground Floor
THE ETHICAL RELATIONSHIP BETWEEN SCIENTIFIC JOURNALS AND
COMMERCIAL INTERESTS
Chair: Thomas Anders (United States)
Co-Chair: Larry Cimino (United States)
Speakers: Patricia Howlin (United Kingdom), Garry Walter (Australia),
Alessandro Liberati (Italy)
Meet the Expert
17.00 – 18.00
Sala Adua 1, Palazzo Affari – 1st Floor
Philip J. Graham (United Kingdom)
Chair: Giancarlo Rigon (Italy)
17.00 – 18.00 Sala Gialla, Palazzo Affari – 3rd Floor
Laurence Greenhill (United States)
Chair: Joseph Biederman (United States)
Co-Chair: A.J. Allen (United States)
17.00 – 18.00 Sala Nera, Palazzo Affari – 3rd Floor
Rutger Jan Van der Gaag (The Netherlands)
Chair: Catherine Barthélemy (France)
Co-Chair: Mats Cederlund (Sweden)
17.00 – 18.00 Laurie Flynn (United States)
Chair: Bruno Falissard (France)
102
Sala Bianca, Palazzo Affari – 2nd Floor
SCIENTIFIC PROGRAM - TUESDAY, 28 AUGUST
17.00 – 18.00 Per-Anders Rydelius (Sweden)
Chair: Paz Toren (Israel)
Co-Chair: Alessandro Liberati (Italy)
Sala Viola, Palazzo Affari – 2nd Floor
17.00 – 18.00 Sala 4, Palazzo Congressi – Ground Floor
Thomas Achenbach (United States)
Chair: Concetta Pastorelli (Italy)
Co-Chair: Vladislav Ruchkin (United States)
Main Lecture
Tuesday 28 August
18.00 – 19.00
Auditorium, Palazzo Congressi – Basement Floor
SERGE LEBOVICI MEMORY LECTURE
Speaker: Philippe Jeammet (France)
Chair: Colette Chiland (France)
103
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
Clinical Consultation Breakfast
8.00-9.30
Sala 101, Palazzo Congressi – 1st Floor
TRAUMA
Speakers: Robert Pynoos (United States), Nathaniel Laor (Israel)
State of the Art Lecture
8.30-10.00
Auditorium, Palazzo Congressi – Basement Floor
IMPROVING INTERVENTION RESEARCH FOR YOUNG CHILDREN WITH ASD
Speaker: Patricia Howlin (United Kingdom)
Chair: Maretha De Jonge (The Netherlands)
8.30-10.00 CHILDREN, WAR AND TRAUMA
Speaker: John Fayyad (Lebanon)
Chair: Alan Apter (Israel)
Sala Gialla, Palazzo Affari - 3rd Floor
8.30-10.00 Sala Nera, Palazzo Affari – 3rd Floor
AN UPDATE ON ASPERGER DISORDER
Speaker: Peter Szatmari (Canada)
Chair: Catherine Barthélemy (France)
8.30-10.00 Sala Rossa, Palazzo Affari – 1st Floor
ADHD CRITERIA IN FUTURE CLASSIFICATION SYSTEMS: IS THERE A NEED
FOR MODIFICATIONS?
Speaker: Luis Augusto Rohde (Brazil)
Chair: A.J. Allen (United States)
104
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
8.30-10.00 Sala Azzurra, Palazzo Affari - Ground Floor
STRENGTHS AND PITFALLS OF GENETIC TECHNOLOGIES TO INVESTIGATE
COMPLEX NEUROPSYCHIATRY DISEASES
Speaker: Fabio Macciardi (Italy)
Chair: Matthew State (United States)
8.30-10.00 Sala Bianca, Palazzo Affari – 2nd Floor
COMORBIDITY-RESEARCH AND PRACTICES
Speaker: Eric Taylor (United Kingdom)
Chair: Gabrielle Carlson (United States)
8.30-10.00 Sala 4, Palazzo Congressi – Ground Floor
ARE SOPHISTICATED STATISTICAL TOOLS REALLY USEFUL IN CHILD AND
ADOLESCENT PSYCHIATRY RESEARCH?
Speaker: Bruno Falissard (France)
Chair: Robert Vermeiren (The Netherlands)
Wednesday 29 August
8.30-10.00 Sala Verde, Palazzo Congressi – 2nd Floor
SLEEP DISORDERS
Speaker: Thomas Anders (United States)
Chair: Andres Martin (United States)
105
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
Workshop
9.00-11.00
Sala Onice, Palazzo Congressi – Ground Floor
INTERFACE BETWEEN THE LACK OF MENTAL HEALTH CARE FOR CHILDREN
AND ADOLESCENTS AND DEPRIVATION OF LIBERTY - BRIDGING THE GAPS
BETWEEN: RIGHT TO MENTAL HEALTH CARE AND ITS IMPLEMENTATION
Chair: T. Simmins (The Netherlands)
9.00-11.00 Sala Grigia, Palazzo Affari – 4th Floor
PROVIDING AN UMBRELLA: THE INTRODUCTION OF DBT TO AN
ESTABLISHED ADOLESCENT INPATIENT UNIT
Chair: Christine Simons (Australia)
Main Lecture
10.00-11.00
Auditorium, Palazzo Congressi – Basement Floor
IS THE CHILD AND ADOLESCENT PSYCHIATRIST BRIDGING GAPS ?
Speaker: Colette Chiland (France)
Chair: Bernard Golse (France)
10.00-11.00 Sala Rossa, Palazzo Affari - 1st Floor
THE IMPACT OF CHILD TRAUMA ON ADULT DEVELOPMENT
Speaker: Alexander McFarlane (Australia)
Chair: James Fallon (United States)
106
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
Symposium
11.00-13.00
Auditorium, Palazzo Congressi – Basement Floor
DONALD COHEN SYMPOSIUM
Chairs: Ernesto Caffo (Italy), James Leckman (United States)
11.00 The vision and the mission of Donald Cohen - Robert King (United States)
11.20 War and trauma - Nathaniel Laor (Israel)
12.00 Research - Flora Vaccarino (United States) - Paul Lombroso (United States)
12.20 Training - Andres Martin (United States)
12.40 Discussion
11.00-13.00 Sala Gialla, Palazzo Affari - 3rd Floor
EPILEPSY IN AUTISM SPECTRUM DISORDERS
Chair: Roberto Canitano (Italy)
Co-Chair: David Cohen (France)
Wednesday 29 August
11.00 Epilepsy and mental retardation in autism: a meta-analysis - David
Cohen (France)
11.20 EEG abnormalities, epilepsy, regression and psychopathology in
autistic spectrum disorders - Michal Hrdlicka (Czech Republic)
11.40 Autism spectrum disorders and epilepsy - Roberto Canitano (Italy)
12.00 Clinical characteristics of children with autistic spectrum disorder
and epilepsy and discussion on treatment options - Maria Teresa Lax-Paricall (United Kingdom)
12.20 Discussion
107
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
11.00-13.00 Sala Nera, Palazzo Affari – 3rd Floor
KIDS MAKE SENSE: BRIDGING CLINICAL, SIGNAL ANALYSIS, AND NEUROSCIENCE MODELS OF THE EXPERIENTIAL SHAPING OF BRAIN AND MIND,
USING MUSIC AND FILM EXAMPLES
Chair: J. Gerald Young (United States)
11.00 Signal analysis and the developing brain: music as a complex signal
array - E. Ochsner
11.30 Developing neural circuits: learning emotional language, musical
elements, and adaptive behaviors - J. Gerald Young (United States)
12.00 Music and the transmission of cultural codes influencing decisionmaking and the genesis of adaptive behaviors - F. Spagnolo (United
States)
12.30 Discussion
11.00-13.00 Sala Rossa, Palazzo Affari – 1st Floor
OBSERVATION OF FETAL AND INFANT MOTOR BEHAVIOUR: A WINDOW
FOR EARLY DIAGNOSIS OF DEVELOPMENTAL DISORDERS: A SYMPOSIUM
IN HONOUR OF ADRIANO MILANI COMPARETTI
Chair: Giovanni Cioni (Italy)
11.00 Introduction - Giovanni Cioni (Italy)
11.20 The effect of prenatal maternal stress on learning and memory at 6
years of age - E.J.H. Mulder (The Netherlands)
11.40 Early sign in rett disorder: does behavioural observation lead to an
earlier diagnosis? - Christa Einspieler (Austria)
12.00 General movements in infants with autism spectrum disorder Helen
Phagava
108
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
12.20 The innovative contribution of Milani Comparetti in Child
rehabilitation - Adriano Ferrari (Italy)
12.40 Discussion
11.00-13.00 Sala Azzurra, Palazzo Affari – Ground Floor
DIVERSE APPLICATIONS OF THE ACHENBACH SYSTEM OF EMPIRICALLY
BASED ASSESSMENT (ASEBA)
Chairs: Thomas Achenbach (United States), Concetta Pastorelli (Italy)
11.00 Longitudinal relations between externalizing and internalizing
syndromes across adolescence: a six years italian study using
Achenbach system – Giovanni MariaVecchio (Italy)
11.20 A cross-cultural study on youth self-report: a comparison study
between Italy and Bolivia – Carlo Tramontano (Italy)
12.00 Children’s cognitive performance and CBCL/4-18: a study on a
normal sample – Eleonora Cannoni (Italy)
12.20 Gender differences in adolescent problems: effects of problem type,
informant, and culture - Leslie Rescorla (United States)
12.40 Discussion
Wednesday 29 August
11.00-13.00 Sala Bianca, Palazzo Affari – 2nd Floor
TEMPERAMENT AND PERSONALITY DEVELOPMENT IN CHILDHOOD
Chair: Eva Moehler (Germany)
Co-Chair: Ursula Pauli-Pott (Germany)
11.00 The diagnostic and prognostic potential of Cloninger’s
biopsychosocial model of personality in 3-11 year old children Kirstin Goth (Germany), Klaus Schmeck (Switzerland)
109
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
11.20 Does interparental conflict predict the development of behavioural
inhibition and behaviour problems in early childhood?
- Ursula Pauli-Pott (Germany)
11.40 Can mothers predict behavioural inhibition in early infancy? - Eva
Moehler (Germany)
12.00 Infant temperament and information processing in a visual
categorization task - Eva Vonderlin (Germany)
12.20 Discussion
11.00-13.00 Sala Viola, Palazzo Affari – 2nd Floor
BRIDGING THE GAPS IN SERVICE PROVISIONS CAMHS IN UE
Chair: Miranda Wolpert (United Kingdom)
Co-Chair: Nima Forouher (United Kingdom)
11.00 Confronting and discussing the actual clinical practice within child
and adolescent mental health services in countries of the European
Union - Nima Forouher (United Kingdom)
11.20 Child mental health and EU enlargement: challenges and
opportunities - Dainius Puras (Lithuania)
11.40 Bridging the gaps in service provision - Bob Foster (United Kingdom)
12.00 New methods for evaluating the diagnostic application routes for
underage patients with psychiatric diagnosis - Lorenza Bondonio (Italy)
12.20 Discussion
11.00-13.00 Sala 4, Palazzo Congressi – Ground Floor
FINDINGS BY YOUNG INVESTIGATORS IN BIOLOGICAL CHILD AND
ADOLESCENT PSYCHIATRY
Chair: Florian Daniel Zepf (Germany)
Co-Chair: Louise Christina Poustka (Germany)
110
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
11.00 YIBcap - About the Idea of YIBcap - Florian Daniel Zepf (Germany)
11.20 Does malnutrition lead to neurological soft signs in patients with
anorexia nervosa? – Roland Burghardt (Germany)
11.40 Fluoxetine, paroxetine and amoxetine induce apoptosis in
embryonal neuronal rat cells in vitro – Ulrich Schaz (Switzerland)
12.00 Diffusion tensor imaging of the social brain in autism - Louise
Christina Poustka (Germany)
12.20 Different molecular genetic approaches to ADHD - Tobias Renner
(Germany)
12.40 Discussion
11.00-13.00 Sala Verde, Palazzo Congressi – 2nd Floor
MONITORING PHARMACOLOGICAL THERAPIES
Chair: A.J. Allen (United States)
Co-Chair: Michael Haberhausen (Germany)
Wednesday 29 August
11.00 Aripiprazole: average daily dose and serum concentration in adolescent patients with schizophrenia - Christian Bachmann (Germany)
11.30 Therapeutic drug monitoring in child and adolescent
pharmacotherapy - Hans-Willi Clement (Germany)
12.00 Serum levels of atomoxetine in adults and adolescents – Michael
Haberhausen (Germany)
12.30 Discussion
11.00-13.00 Sala Arancione, Palazzo Affari – Basement Floor
ADOLESCENCE AT RISK
Chair: Dimitris Anagnostopoulos (Greece)
Co-Chair: Helen Cowie (United Kingdom)
111
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
11.00 Development as a risk during adolescence - Füsun Çuhadaroðlu
Çetin (Turkey) 11.20 Attention deficit hyperactive disorder and adolescent suicide - Iris Manor
(Israel)
11.40 Bullying behaviours as predictors of adolescents at risk - Doa Habib
(Egypt)
12.00 Academic pressure as a risk factor of the adolescents’ depression Helen Lazarus
12.20 Discussion
Workshop
11.00-13.00 Sala Onice, Palazzo Congressi - Ground Floor
EVIDENCE BASED FAMILY THERAPIES FOR BEHAVIOUR DISORDERED
ADOLESCENTS IN THE NETHERLANDS: FIRST RESULTS
Chair: René Breuk (The Netherlands)
11.00 The implementation and the cultural adjustment of Functional Family therapy - René Breuk (The Netherlands)
11.30 Implementing a randomized experimental design researching a clinical intervention: an evaluation of Multisystemic Therapy (MST)
in the Netherlands - Sander Van Arum (The Netherlands)
12.00 Multidimentional Family Therapy: a perspective from daily practice - Kees Mos (The Netherlands)
12.30 Discussion
112
SCIENTIFIC PROGRAM - WEDNESDAY, 29 AUGUST
11.00-13.00 Sala Grigia, Palazzo Affari – 4th Floor
OVERCOMING CHALLENGES IN CONDUCTING MULTI-NATIONAL CLINICAL
TRIALS IN CHILD AND ADOLESCENT PSYCHIATRY
Chair: Adelaide Robb (United States)
Co-Chair: Bernadka Dubicka (United Kingdom)
11.00 Ethical and Clinical Issues in Designing Pediatric Psychiatry Trials - Philippe Auby
11.30 ADORE: How we achieved a successful trial of ADHD evaluation and treatment in the EU - David Coghill (United Kingdom)
12.00 Psychiatric scales in international clinical trials: ensuring inter-rater reliability – Margaretta Nylias (United States)
12.30 Discussion
Closing Ceremony
Auditorium, Palazzo Congressi – Basement Floor
Wednesday 29 August
13.00 – 14.30
113
POSTER PRESENTATION
August 26th
Poster Session 1: ADHD - Clinical Phenomenology; ADHD –
Pharmacotherapy; Disruptive Behavior Disorders, Forensics & Juvenile
Justice; Pediatric-Psychiatry Interface, Sleep; Psychopharmacology; School,
Bullying; Substance Abuse, Alcohol, Gambling S.1.1
S.1.2
Carina Freitas
ADHD in a Portuguese child development centre clinic – a review
of the first 12 months
S.1.3
Huei-Shyong Wang, Nai-Chi Ko
Aggression and impulsivity in ADHD adolescents comorbid
Tourette syndrome
S.1.4
Cintia Salgado, Marcia Toledo, Sylvia Ciasca
Comparing the diagnoses and attention training in ADHD children
subtypes
S.1.5
Fredrik Ulberstad, Petter Knagenhjelm, Peter M. Wehmeier, Torsten
Norlander
Objective description of cognitive behavioural phenotypes in
114
Chinnaiah Yemula, Suyash Prasad,Nicola Savill, Leigh Mathieson,
Lynne Poole
The family burden of Adhd in UK children and adolescents:
an open label randomised comparison between atomoxetine
and standard current therapy in UK children and adolescents with
Adhd
attention-deficit/hyperactivity disorder (ADHD) and tracking of
treatment effects using an artificial neural network (ann) classifier
S.1.6 Asma Bouden, Meghaieth, Radhouen Fakhfakh, Mohamed Halayem
Prevalence of ADHD in a Tunisian general population
S.1.7
Ivo Paclt, Kopeckova
ADHD polymorphism in case control study of 100 subjects 6 to 10
age
S.1.8 Sun-woo Jung, Yeni Kim, Sang Choel Choi, Jinyoung Yeo, Hyo-Won
Kim, Soo-Churl Cho, Boong-Nyun Kim, Jun-Won Hwang
Biogenetic temperament and character profiles of clinical and
subthreshold attention-deficit/hyperactivity disorder in a korean
community sample
S.1.9
Daryl Efron, Valerie Sung, Harriet Hiscock, Emma Sciberras
Sleep problems in children with ADHD: associations with child
quality of life, daily functioning, caregiver mental health, and
family functioning
S.1.10 Young Hui Yang, Boong-Nyun Kim
Screening of ADHD using child behavior checklist & ADHD rating
scale in Korean community-based samples
S.1.11 Maria Lorenzo, Liam Kennedy
A 2-year assessment of treatment prescribed to patients with
ADHD and its impact on clinical severity across 10 european
countries. Results from attention deficit/ hyperactivity disoder
observational research in Europe (adore)
115
S.1.12 Maria Lorenzo, Liam Kennedy
A 2-year assessment of treatment prescribed to patients with
ADHD and its impact on quality of life across 10 european
countries. Results from attention deficit/ hyperactivity disoder
observational research in europe (adore)
S.1.13 Manfred Doepfner, Charlotte Hanisch, Christopher Hautmann, Julia
Plack, Ilka Mayer
Eficacy and safety of a new modified release methyphenidate
preparation
S.1.14 Anja Taanila, Tuula Hurtig, Jouko Miettunen, Hanna Ebeling, Irma
Moilanen
Impact of ADHD symptoms on the adolescents’ psychosocial
well-being: a study of the northern Finland birth cohort 1986
S.1.15 Tania Abou Abdallah, Jean-Marc Guilé, Monique Plaza, David Cohen
Test-retest reliability of an attention assessment battery in ADHD
children and adolescents: a systematic review
S.1.16 Yeni Kim, Soo-churl Cho, Jae-won Kim, Boong-nyun Kim, Soo-Young
Bang
Associations between attention deficit hyperactivity disorder,
depression, and suicide in Korean female adolescents
S.1.17 P. Petrov, R Shishkov, D Karadjova, A Ignatova
Estimation of the prevalence of attention deficit hyperactivity
disorder among the children in school age in the varna region,
Bulgaria
116
S.1.18 Tobias Edbom ,Jan-Olov Larsson, Mats Granlund, Paul Lichtenstein,
Kerstin Malmberg
Attention deficit hyperactive disorder and sense of coherence in
teenagers
S.1.19 Tobias Renner, Susanne Walitza, Astrid Dempfle, Marcel Romanos,
Helmut Schafer, Manfred Gerlach, Andreas Warnke, Klaus-Peter Lesch
Findings in molecular genetics of ADHD
S.1.20 Ji Hoon Kim, Lee Jung Sub, Kim In Ju, Kim Seong Jang
Voxel based statistical analysis of regional cerebral glucose
metabolism in children with attention-deficit hyperactivity
disorder
S.1.21 Paolo Curatolo, Gabriele Masi, Alessandro Zuddas, Filippo Calamoneri,
Lucia Margari, Grazia Dell’Agnello, Francesca Mancini, Andrea Rossi,
Maria Lorenzo
Results of the adore study in italy: symptoms severity, and
treatment.
S.1.22 Kerstin Malmberg, Hanna-Linn Wargelius, Paul Lichtenstein, Lars
Oreland, Jan-Olov Larsson
ADHD and disruptive behaviour symptoms and polymorphism in
mao-a and 5-htt-genes
S.1.23 Allan Hvolby, Niels Bilenberg, Jan Joergensen
Actigraphic reports of sleep difficulties in children with ADHD
S.1.24 Nahit Motavalli Mukaddes, Humen Elmi, Osman Abali
Attention deficit hyperactivity disorder ( ADHD) in children and
adolescent with hearing impairment
117
S.1.25 Hidemi Iwasaka, Iida, Takako Onishi, Hideki Negoro, Kanae Kishino,
Housaku Ohta, Mitsuhiro Uratani, Makiko Yono
The effectiveness of parent training program for children with
attention-deficit /hyperactive disorder (adhd) in Japan
S.1.26 Iuliana Dobrescu, Iuliana Eparu, Irina Jipescu
Correlations between family psychiatric history and ADHD
S.1.27 Dimiter Terziev, Nadia Polnareva, Svetla Staykova
Comorbidity in a clinical sample of children with hkd
S.1.28 Shin Yunmi
Use and cost of medical care for children with ADHD in South
Korea
S.1.29 Robaey Philippe, Yong-Liang Ge
Behavioral and electromyographic study of motor activity in 6-9
years old children with ADHD during selective and non selective
response inhibition tasks
S.1.30 Sarah Buckley, Suzanne Guerin, John Hillery, Philip Dodd, John Mc
Evoy
A study of the usefulness of the attention - distractibility, inhibition
- excitation classroom assessment scale for identifying symptoms
of attention deficit hyperactivity disorder in children in a special
school in Ireland
S.1.31 Dongwon Shin
Corporal punishment of the mother of the ADHD children is related
to the level of the maternal depression
118
S.1.32 Darius Leskauskas, Kuzmickas Kestutis
First study on ADHD prevalence and relevant cultural influences in
lithuanian primary school pupils
S.1.33 Paria Hebrani, Behdani, Fariba Arabgol
Gender differences in comorbid disorders with attention-deficit/
hyperactivity disorder (ADHD)
S.1.34 Paria Hebrani, Fariba Arabgol, Fatemeh Behdani
Prevalnce of attention-deficit/hyperactivity disorder in preschool
age children in mashad city of Iran
S.1.35 Fatemeh Behdani, Paria Hebrani
Evidence of familial association between attention deficit
hyperactive disorder and major depressive disorder in probands of
ADHD
S.1.36 Dalsgaard Søren, Obel Carsten , Olsen Jørn , Henriksen Tine Brink ,
Linnet Karen Markussen , Thomsen Per Hove
Maternal alcohol consumption during pregnancy and the
association with ADHD in offspring - a birth cohort study
S.1.37 Abdollahian Ebrahim , Vosough Iraj , Amini M.Reza
Prevalence of attention deficit hyperactivity disordr in pre-school
age children in Mashhad
S.1.38 Shim Sehoon
Impact of adenotonsillar hypertrophy on attention deficit
hyperactivity and sleep in children
S.1.39 Trangkasombat Umaporn
ADHD and comorbidities in Thai children
119
S.1.40 Cho Soo-Churl , Kim Jae-Won , Hwang Jun-Won , Yoo Hee-Jeong , Shin Min-Sup , Kim Boong-Nyun
Association between alpha-2a-adrenergic receptor gene and
attention deficit hyperactivity disorder: a case-control and familybased association study in a Korean sample
S.1.41 Yang Su-Jin , Cheong Seongshim , Hong Sungdo, Lee Juyeon
Parent versus teacher reports of attention deficit hyperactivity
disorder in south Korea school-based mental health
S.1.42 Luis Augusto Rohde, Carlos Renato Moreira Maia, Breno Matte,
Henrique Tschoepke Ludwig
Switching from mph-ir to mph-sodas in ADHD: an open trial
S.1.43 Ying-Sheue Chen, IK Shan, Ju-Wei Hsu, Ying-Chiao Lee
A comparison of extended osmotic-release methylphenidate
and immediate-release methylphenidate on divided attention in
children with ADHD
S.1.44 R. Escobar, A. Montoya, I. Gilaberte, A. Hervas, M.J. Mardomingo, P.
Polavieja
Newly ADHD diagnosed patients in a randomized, double-blind,
placebo-controlled study in Spain: children perspectives versus
parents perspectives on qol
S.1.45 Pär Svanborg, Gunilla Thernlund, Per A Gustafsson, Bruno Hägglöf,
Lynne Poole, Björn Kadesjö
Psychoeducation as add on to atomoxetine in a double-blind
placebo-controlled study assessing quality of life in swedish
children and adolescents
120
S.1.46 Ralf W Dittmann, Peter M Wehmeier, Martin Lehmann, Alexander
Schacht,Thomas Wagner, Gerd Lehmkuhl
Effectiveness and tolerability of atomoxetine in children and
adolescents with ADHD, as perceived by patients, parents, and
physicians: findings from two open-label studies
S.1.47 P. Curatolo, G Dell’Agnello, D Maschietto, G DeRenoche, F Mancini
Quality of life of pediatric patients with attention deficit
hyperactivity disorder and oppositive defiant disorder: an italian
double-blind placebo-controlled study with atomoxetine
S.1.48 Cheon Seok Suh, Subin Park, Hee-Ryung Wang, Jaesuk Jung, Chang
Moo Jeon, Bongseog Kim, Hanik K. Yoo
Oros (osmotic-controlled release oral delivery system)
methylphenidate improves the quality of life in children and
adolescents with attention deficit hyperactivity disorder plus
seizure disorders
S.1.49 M. Gerwe, B. Schauble, L. Hargarter, N. Klose, F. Mattejat
Transition from immediate-release methylphenidate (ir-mph) to
extended-release methylphenidate (orosâ®-mph) is associated
with an improvement in quality of life in patients with ADHD results from an open label naturalistic trial (42603-att-4001)
S.1.50 Thomas Spencer, Chris Kratochvil, R. Bart Sangal, Charles Bailey, David
Dunn, Charles Casat, Jeffrey Newcorn, Dustin Ruff, Peter Feldman
Five-year effects of atomoxetine on growth in children with ADHD
S.1.51 Peter Feldman, Humberto Quintana, Douglas Kelsey, Edward Cherlin,
David Duesenberg, Mark Bangs, Ramsey Janet, Albert Allen
121
Transition from psychostimulants to atomoxetine in pediatric and
adolescent patients with attention-deficit/hyperactivity disorder
S.1.52 Ann Rogers, Jeffrey Newcorn, Shuyu Zhang, Louise Levine
Atomoxetine treatment response in patients with ADHD naïve to
previous pharmacotherapy
S.1.53 Cheon Seok Suh, Jun Won Huang, Bong Seok Kim, Soo Churl Cho
Changes of depression and subjective quality of life in parents
of children with ADHD following treatment: 2-months follow-up
study
S.1.54 David Pierce, Sharon Wigal, Catherine Dixon, James McGough
Pharmacokinetics of methylphenidate transdermal system in
children with ADHD
S.1.55 Sharon Wigal, James McGough, Howard Abikoff, John Turnbow,
Timothy Wigal, Kelly Posner, Eliot Moon
Behavioral effects of methylphenidate transdermal system in
children
S.1.56 Somnath Banerjee, C Chandola, Senerath J Perera
ADHD: comorbidity and polypharmacy
S.1.57 Yanki Yazgan ,Joseph Biederman, Sandra Kooij, Cathy Barr
Hemodynamic differences between ADHD adults and controls
and effects of methylphenidate
S.1.58 Paolo Curatolo, Augusto Pasini, Elisa D’Agati, Claudio Paloscia, Oliver
Tucha, Klaus W Lange
Effect of methylphenidate on neurological soft signs and motor
learning
122
S.1.59 Craig Donnelly, Daniel Geller,Frank Lopez, Richard Rubin, Jeffrey
Newcorn, Virginia Sutton, Rosalie Bakken, Martin Paczkowski, Douglas
Kelsey
Atomoxetine treatment for pediatric patients with ADHD and
comorbid anxiety
S.1.60 Paula Trzepacz, David Williams, Peter Feldman, Jennifer Witcher, Jan
Buitelaar
Cyp2d6 metabolizer status and atomoxetine dosing in children
and adolescents with ADHD
S.1.61 Sonia Frediana,Jan Buitelaar, Shuyu Zhang, Rodney Moore, Louise
Levine
Atomoxetine treatment for ADHD: predictors of relapse
S.1.62 Thomas Spencer, David Dunn, Donald Gilbert, D. Milton, Peter Feldman,
Albert Allen
Atomoxetine treatment of ADHD in children with comorbid
tourette syndrome
S.1.63 Philippe Robaey, Luc Proteau
Methylphenidate effects on corrections of selection and execution
errors in ADHD children during aiming movement
S.1.64 Grazia Dell’Agnello, Douglas Kelsey, Virginia Sutton, Kory Schuh,Calvin
Sumner
Once-daily atomoxetine for ADHD: update on evening and morning
behavior
S.1.65 Frank Haessler ,Eberhard Schulz, Klaus Hennighausen, Jan Klatt
Saftey aspects of treatment with extended-release methylphenidate
agents
123
S.1.66 Pär Svanborg, Gunilla Thernlund, Per A Gustafsson, Bruno Hägglöf,
Lynne Poole, Björn Kadesjö
Atomoxetine improves quality of life and patient and family
functioning - results from a double-blind placebo-controlled study
in swedish children and adolescents
S.1.67 Sharon Wigal,Timothy L. Wigal, James J. McGough, Kelly Posner, Scott
H. Kollins, Alex Michaels, Simon J Tulloch
Analog classroom study of amphetamine and atomoxetine in
youths with attention-deficit/hyperactivity disorder (ADHD)
S.1.68 Faraone Stephen V.,Thomas J. Spencer
Comparing the efficacy of medications for attention deficit/
hyperactivity disorder (ADHD) using meta-analysis
S.1.69 Biederman Joseph,Suma Krishnan, Robert L. Findling
Efficacy and safety of lisdexamfetamine (ldx) in children aged 6 to
12 years with attention-deficit/hyperactivity disorder (ADHD)
S.1.70 Karl-Johan Myrén, Lynne Poole, Pär Svanborg
Atomoxetine’s effect on societal costs in Sweden - a 10 week
double blind randomized placebo controlled clinical trial
S.1.71 Peter Hoare, Suyash Prasad, Leigh Mathieson, Nicola Savill, Lynne
Poole on behalf of the SUNBEAM study group.
An open label randomised comparison between atomoxetine
and standard current therapy in uk children and adolescents with
ADHD: results from the child rated harter self perception profile
S.1.72 Montoya Alonso , Escobar R, Gilaberte I, Polavieja P, Lachno D, Alda JA,
Artigas J, Cardo E, Gastaminza X
Norepinephrine transporter blockade assessment through urine
124
dihydroxyphenylglycol to norepinephrine (dhpg/ne) ratio: a
biomarker of ADHD pharmacologic treatment
S.1.73 Montoya Alonso , Escobar R, Gilaberte I, Polavieja P, Vazquez I, Hervàs A,
Mardomingo M, Canto T, Garcia M, Herreros O, Gutierrez JR, Mulas F
Continued improvement in newly diagnosed children and
adolescents outpatients with attention-deficit/hyperactivity
disorder: a randomized, double-blind, placebo-controlled trial of
atomoxetine
S.1.74 Schlander Michael , Schwarz Oliver , Hakkaart-van-Roijen Leona,
Jensen Peter S., Persson Ulf , Santosh Paramala , Trott Goetz-Erik
Treatment strategies for attention-deficit/hyperactivity disorder
(ADHD): european cost-effectiveness estimates based on the nimh
mta study
S.1.75 Cheon Keun-Ah
Catechol-o-methyltransferase (comt) val 108/158 met polymorphism
and response to methylphenidate treatment in korean children with
ADHD
S.1.76 Brussel Wim, Katinke van Dijk
One year therapeutic results of atomoxetine in dutch ADHDchildren
S.1.77 Arabgol Fariba , Panaghi Leily , Hebrani Paria
Reboxetine versus methylphenidate in the treatment of children
and adolescents with attention deficit hyperactivity disorder.
S.1.78 May Britt Drugli, Bo Larsson, Graham Clifford
125
Changes in social competence in young children treated because
of conduct problems as viewed by multiple informants
S.1.79 Marcia Adriaanse, Maria Teresa Faixedas, Theo Doreleijers, Robert
Vermeiren, Gemma Renart, Marta De Puig
Antisocial behaviour and mental health; during middle adolescence
in a community sample
S.1.80 Simone Gonçalves de Assis, Raquel Vasconcellos C. Oliveira; Joviana
Quintes Avanci; Renata Pires Pesce
Behavior problems in brazilian children and physical severe
parental violence
S.1.81 Luciana Anselmi, Fernando Barros, Cesar Piccinini, Maycoln Theodore,
Ana Menezes, Cora Araujo, Luis Augusto Rohde
Continuity of behavioural and emotional problems from preschool years to initial adolescence:a birth cohort
S.1.82 Sanja Zivotic, Aneta Lakic, Sonja Pantovic, Ana Jovanovic, Vesna
Milovanovic, Milorad Vukasinovic
Maternal depression and conduct disorders in children
S.1.83 Nils Duits
Quality of juvenile forensic mental health reports
S.1.84 Fegert Jorg Maichaelc
Quality of psychiatric expert statements in sex crime cases
S.1.85 Renate Schepker
Quality in forensic assessment of young immigrants, with special
reference to traumatized asylum seekers
126
S.1.86 Stefano Costa, Laura Gessaroli, Mimi Tavormina, Giancarlo Rigon
Psychopathological aspectes and therapeutic factors in the
community treatment of juvenile delinquents
S.1.87 Matsuura Naomi
Evaluation of cumulative interactions of risk factors for delinquency
in a juvenile correctional facility in Japan
S.1.88 Schmeck Klaus, Camerini G.B., Zanoli M., Berto D., Rossi L.
Forensic child and adolescent psychiatry
S.1.89 Cisca Aerts, Gert Kroes
Home treatment in families with ASD Bridging the gap between
the family members: a pilot study
S.1.90 M. Nisell, M. Öjmyr-Joelsson, B. Frenckner, P-A. Rydelius, K. Christensson
Psychosocial issues in families that have a child with imperforate
anus
S.1.91 Yongsil Kweon, Hae-kook Lee, Chung-Tai Lee
A preliminary study for standardization of the psq-k (pediatric sleep
questionnaire-Korean) in Korean children
S.1.92 Elisabeth Thiadens, Else de Haan, Yanda van Rood, Mirte Bakker, Marc
Benninga, Bert Derkx, Frits Boer
Short term cognitive behaviour therapy for children and adolescents
with functional abdominal pain, a pilot study
S.1.93 Domenico Romeo, Matteo Cioni, Laura Battaglia, Maria Cristina Scoto,
Domenico Mazzone
Cognitive functions in children with congenital hemiplegia
127
S.1.94 Sang Choel Choi, Jun-Won Hwang, Soo-Churl Cho
Behavioral characteristics in boys with duchenne/becker muscular
dystrophy in Korea
S.1.95 K.E. Siomos, Odisseas Mouzas, N.V. Angelopoulos
Prevalence of insomnia and correlation with psychopathology of
Greek adolescents students
S.1.96 Krister Fredin, Bruno Hägglöf
Child and parent attitudes to diabetes. A six-year-follow-up study
S.1.97 Lotta Wiberg, Bernice Aronsson
Asylum-seeking children with severe withdrawal behaviour:
collaboration between children’s medicine and psychiatry
S.1.98 Anke Hinney, Johannes Hebebrand
Polygenic inheritance of obesity
S.1.99 Eeva Aronen, Jari, Troberg Anna-Maria, Tarminen Jussi
Sleep in child psychiatric inpatients and normative children - a
complementary view
S.1.100 Maria C. Marcelino, Joao Marcelino
A better understanding
S.1.101Florence Schmitt, Paivi Santalahti, Sami Saarelainen, Georg Romer, Jorma Piha
Cancer families with under-age children: factors associated with perceived family functioning: a comparative study in Finland
128
S.1.102 Ruge Moeller Lene, Østergaard John R
Narcolepsy with cataplexy, five cases of treatment with venlafaxine in children
S.1.103Petersen Solveig , Hägglöf Bruno , Bergström Erik
Recurrent pain and mental health in young schoolchildren
S.1.104Ruge Moeller Lene , Østergaard John R.
Diagnosing and treating children with narcolepsy
S.1.105Shin Min-Sup, Cho Soo-Churl , Cho Tae-Jun, Ha Il-Soo, Yoon Myung-
Sook , Lee Kyung- A
Development of the quality of life scale for children with renal failure
S.1.106Denis Lafortune
Psychotropic medication and poly prescription in Quebec’s (Canada) youth care centers
S.1.107Hans-Willi Clement, Olaf Sommer, Philip Heiser, Ernst von Dobschutz, Eberhard Schulz
Formation of free radicals in the rat brain after acute and chronic antipsychotic treatment.
S.1.108 Philip Heiser, Hans-Willi Clement, Eberhard Schulz, Jorgen-Christian
Krieg, Helmut Vedder
Effects of different antipsychotics on the survival of human neuronal
and immune cells in vitro
S.1.109 Alan Apter, Sefi Kronenberg, David Brent, Nadine Melham, Avi Weizman, Amos Frisch
The l form of the 5htt polymorphism may be a genetic marker
129
of response to citalopram in children and adolescents with
depression and/or anxiety
S.1.110 Nyilas Margaretta, Forbes Robert
Tolerability of aripiprazole in the treatment of adolescents with
schizophrenia
S.1.111 McNicholas Fiona , Motala Farhana
Transient ischaemic attack in 11 year old with tourette’s treated
with risperidone and clonidine
S.1.112 Veronika Ispanovic, Milica Pejovic Milovancevic, Ana Radojkovic
Psychosocial interventions with adolescents at risk
S.1.113 Yolanda Pintabona, Clare Roberts, Rachael Williams, Robert Kane
Mental health and adolescent health risk outcomes of a schoolbased prevention program
S.1.114 Anne Mari Undheim, Anne Sund
Bullying among young adolescents in Norway
S.1.115 Lygeri Iliopoulou
A pilot prevention program for high school students against racism
and social exclusion
S.1.116 Lee Hobun
Factors related to violent behavior in Korean adolescent
S.1.117 Westling Allodi Mara, Rydelius Per-Anders
Ambivalence and neglect: a survey of Swedish teachers’ attitudes
about gifted children and their needs
130
S.1.118 Allahverdipour H., MacIntyre, R ., Hidarnia, A., Shafii, F., Kazemnegad, A.,
Azad Fallah, P.
Assessing protective factors against drug abuse among high school
students: self-control and the extended parallel process model
S.1.119 K.E. Siomos, Odisseas Mouzas, N.V. Angelopoulos
Addiction to the use of internet and sleep disorders in greek
adolescents: a preliminary study
S.1.120 Jouko Miettunen, Trmanen, Peter B.Jones, Graham Murray, Pirjo Maki,
Hanna Ebeling, Anja Taanila, Matti Joukamaa, Juha Veijola
Association of cannabis use with prodromal features of psychosis
and behavioural problems in adolescence
S.1.121 Norbertas Skokauskas
Adolescent pathological gambling in kaunas, Lithuania
S.1.122 Solja Niemela, A Sourander, Henrik Elonheimo, Ping Wu, Kari
Poikolainen, Hans Helenius, Jorma Piha, Kirsti Kumpulainen, Fredrik
Almqvist
What predicts illicit drug use versus police registered drug
offending? Findings from the Finnish from a boy to a man “birth
cohort study”
S.1.123Koo Young Jin , Paeng Jin Chul , Joo Eun-Jeong , Kang Ung-Gu , Kim Young Sik
Brain neuroadaptive changes in adolescents with internet addiction : an 18fdg-pet study with statistical
parametric mappinganalysis
S.1.124Guerra Alegre Teresa,Trujillo Alejandra
131
The behaviour problems are the variables that better predicts the diagnosis of the ADHD
S.1.125Milica Pejovic Milovančević, Popovic Deusic, Veronika Ispanovic, Ana Radojkovic
A school-based study on suicidal behavior and violence in adolescents
S.1.127Christian Bachman, Michael Haberhausen, Monika Heinzel-
Gutenbrunner, Helmut Remschmidt, Frank M. Theisen
High Intraindividual Variability Of Olanzapine Serum Levels In Adolescent Patients
S.1.128Romero Soledad, Francisco de Sande, Cristian Zeni, Boris
Birmaher, David Axelson, Benjamin Goldstein, MaryKay Gill, Michael Strober, Jeffrey Hunt
Clinical And Demographics Characteristics In Children And Adolescent With Bipolar Disorder And Combined Attention-
deficit/hyperactivity Disorder
S.1.129 M. C. Taborda-Simões, Vale-Dias Maria da Luz
The power of teachers’ ratings in predicting adolescents’ antisocial
behaviour
S.1.130Mehdi Bennouna- Greene, Jacques Schick, Pascale Willem, Claude
Bursztejn
Methylphenidate prescription increase in France: a survey in the
Alsace region during the period 2004-2006
132
August 27th
Poster Session 2: Autism Spectrum Disorders; Development; Developmental Disorders & Mental Retardation; Epidemiology & Services; Epilepsy;
Infancy; Learning Disorders, Language Disorders; Neuropsychiatry & Neuropsychology S.2.1
Hekim Ozlem, Tezan Bildik, Afig Berdeli, Cahide Aydn, Muge Tamar, Serpil Erermis, Eyup Ercan, Burcu Ozbaran, Saniye Korkmaz Cetin
Tdo2 gene polymorphism in Turkish children with autism
S.2.2
Sobharani Sungum-Paliwal, Mahesh Paliwal, Ashok Roy
Autism spectrum disorder & learning disability integrated care pathway
S.2.3
Judith K. Sinzig
Neuroimaging in autistic children with and without comorbid hyperactivity and attention problems
S.2.4
Chamak Brigitte, Bonniau Béatrice, Jaunay Emmanuel, Cohen David
Autobiographical writings by autistic persons: a systematic study
S.2.5
Leon Sloman, Jonathan Leef, Annthony Folino
Child social interaction and parental self-efficacy. Simultaneous groups for children with asperger’s and their parents
S.2.6
Giacobini MaiBritt, Bremer Anna, Anderlid Britt-Marie, Selander Åsa, Staaf Johan, White Irene, Nordgren Ann, Borg Åke, Brondum-Nielsen Karen, Dahl Nicklas, Barbaro Michela,
Mahmoud Mansouri Mahmoud, Nordenskjöld Magnus, 133
Schoumans Jacqueline
Screening for gene dose imbalances of autism candidate genes in patients with autism spectrum disorders (ASD) using tiling resolution array-cgh and two-color mlpa
S.2.7
Peter Szatmari, Michelle Liu, Andrew Paterson
Gender differences in autism
S.2.8
Noriaki Matsushima, Dai Miyawaki, Kaduhiro Takahashi, Hisashi Tsuji, Futoshi Suzuki, Kohji Kaneko, Takeshi Kawaguchi, Nobuo Kiriike
Evaluation of attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorder: comparisons among multiple informants
S.2.9
Saino Hitoshi, Kawai Takehiko, Kurokawa Shinji, Denda Kenzo
Executive functions of pervasive developmental disorder
S.2.10
David Cohen, Didier Périsse, Claire Amiet, Isabelle An, Angèle Consoli
Epilepsy among disruptive behaviors in adolescents with autism: a retrospective study
S.2.11 Kaartinen Miia, Kaija Puura, Jari Hietanen
Children with autism have impairments in social functioning
S.2.12 Maretha de Jonge, Chantal Kemner, Herman van Engeland
Broader phenotypic traits in parents of children with asd: a study with the fhi-r
134
S.2.13 Yesim Taneli, Yesim Ozarda Ilcol, Ismail Hakki Ulus
Molecular genetic investigation of apolipoprotein e polymorphism
in pervasive developmental disorder
S.2.14
Cristina Vagnoni, Teresa Sebastiani, Flavia Giannotti, Flavia
Cortesi, Antonella Cerquiglini, Paola Bernabei
Video-polysomnographic study of sleep in autistic children with and without developmental regression
S.2.15
Gülsen Erden, Melda Akçakýn
Comparing the intelligence profiles of chýldren with pervasive developmental disorder (PDD) and specific learning disability (SLD)
S.2.16 Sara Melo, Graça Fernandes
Asperger syndrome - different comorbidities, distinct approaches
S.2.17 Guinchat Vincent, Rondan Cecilie, Ouvrier Catherine, Assouline Brigitte, Devillard Françoise, Jouk pierre Simon, Guillem Pascale
Do perinatal factors affect the clinical expression of autism?
S.2.18
Veneselli E., Cocchi E., Battaglia F.M., Viganò M., Follo R.,
Parlatini V.
Asperger syndrome and high functioning autism: cognitive profiles and comorbidity
S.2.19
Laurence Robel, Fabrice Laroche, Celia Fortin, Bérangère
Rousselot-Pailley, Anne Philippe, Laurence Colleaux,
Marie-Odile Krebs, Nicolas Ramoz, Bernard Golse
Homeogenes triplet repeats are not related to the genetic vulnerability to autism and schizophrenia
135
S.2.20
Kenji J. Tsuchiya, Kaori Matsumoto, Shu Takagai, Shiro Suda, Masatsugu Tsujii, Taishi Miyachi, Kazuhiko Nakamura, Norio Mori, Nori Takei
Advanced paternal age associated with high-functioning autism
S.2.21 Göker Bahar, Unal Fatih
Childhood disintegrative disorder: findings on fourteen children
S.2.22
Tuula Hurtig, Helena Haapsamo, Marja-Leena Mattila, Katja
Jussila, Sanna Kuusikko, Marko Kielinen, Sirkka-Liisa Linna, Hanna Ebeling, Irma Moilanen
Psychiatric disorders in children and adolescents with asperger syndrome or high-functioning autism
S.2.23 Catherine Mcelearney, Louise Shake
Medication use in autism & psychiatric co-morbidity - a survey of a community based service
S.2.24 Christine Freitag, Melanie Häberlen, Alexander von Gontard, Wolfgang Reith, Christoph Krick
Motion perception in autism: a functional mri study
S.2.25
Hee Jeong Yoo, In Hee Cho, Soon Ae Kim, Mira Park, Young Sik
Lee, In Ki Sohn, Geon Ho Bahn, Soo Young Bhang
Association of cyclooxygenase-2 (cox-2) and inducible nitric
oxide synthase (inos) genes with autism spectrum disorders in korean trios
S.2.26 Giacomo Vivanti, Aparna Nadig, Sally, J. Rogers
Visual attention and imitation impairment in autism
136
S.2.27
In Hee Cho, Hee Jeong Yoo, Soon Ae Kim, Mira Park, Young Sik
Lee, In Ki Sohn, Geon Ho Bahn
Association of mu-opioid 1 receptor gene with autism spectrum disorders in Korean trios
S.2.28
Kaori Matsumoto
Diagnostic agreement between clinical diagnosis and the Japanese version of the adi-r for autistic disorder in a clinical setting
S.2.29 H.Ouennich Belhajyahia, A.Benamor; H.Labbassi,N.Abdrabbou, N. Khelil, N. Ellouze, N.Mraihi, N.Gueddana
“Life skills” as a bridge to pass from adolescence to adulthood
S.2.30
Leena Pihlakoski, Andre Sourander, Minna Aromaa, Paivi Rautava, Hans Helenius, Matti Sillanpaa
Does antenatal and postnatal parental psychological distress, and recognized need of help predict preadolescent’s psychiatric symptoms? The finnish family competence cohort study
S.2.31 Ängarne-Lindberg Teresia , Wadsby Marie
Fifteen years after parental divorce: mental health and life events
S.2.32 Salviato Cinzia, Gatta Michela, Sale Eleonora, Bertossi Ezio, Condini Antonio
Adolescence and gender idendity
S.2.33 Elvan Iseri, Nermin Gürhan, Azize Atlý Özbaþ
Imagination and gender preference for first- born baby during pregnancy and comparision after delivery
137
S.2.34
Jungwoo Son
The correlation between the score of strengths and difficuilies questionnaire and children’s affect/self-esteem in Korean rural province.
S.2.35
Alexandra Jubin, Maya Suter, Philippe Stephan, Bernard
Plancherel, Monique Bolognini, Mathias Romailler, Pascal Weinguni, Olivier Halfon
How do adolescents cope with daily life problems: validation of constructive thinking inventory
S.2.36
Roberta Di Scipio, Federica Giovannone, Ester Patruno, Anna Fabrizi
Patterns and functional emotional assessment in children with multisystem developmental disorders
S.2.37 Kulygina Mayya
On the threshold of adulthood: the problems of students’ psychosocial development
S.2.38
Roberta Simas, Bernard Golse
Reflecting about the connections between empathy and
intersubjectivity: contributions from psychopathology, neuroscience and psychodynamic perspectives
S.2.39 Gatta Michela, Salviato Cinzia, Bertossi Ezio,Condini Antonio
Educational intervention and psychopathology in adolescence
S.2.40 Dagbjörg Sigurðardóttir
Emotional and physical health of adopted foreign children in Iceland
138
S.2.41 Plinio Ferraz, Pedro, Marisdalva Stump, Ana Claudia Caldeira
Brazilian teenagers with mental retardation, late diagnosis and treatment of phenylketonuria(pku) and their outcome
S.2.42
Sumire Yamaguchi, Ciro Ruggerini
Assessment of the care system for the intellectually disabled
in Japan based on who evaluation models: a narrative-based approach
S.2.43
Flavia Capozzi Valentina Ivancich Biagini, Letizia Marchetti, Alessia Tosco, Roberta Penge
Study of representational skills in children with mild mental retardation
S.2.44 Vesna Zulčić-Nakić, Mirela Kapidžić, Nermina Kravić, Azra Arnautović
Demografic profile of adolescents after artifical abortions
S.2.45 Christina Papaeliou, Nikitas Polemikos, Elena Fryssira
Communicative, cognitive and language abilities in children with Williams syndrome and Down syndrome
S.2.46
Ulla Heikura, Anja Taanila, Sirkka-Liisa Linna, Anna-Liisa Hartikainen, Paivi Olsen, Lennart Von Wendt, Marjo-Riitta Jarvelin
Variations in aetiological and sociodemographic factors associating with intellectual disability between two birth cohorts in northern finland with an interval of 20 years
S.2.47
Victor Sevastyanov, Svetlana Shuvarova, Elena Borisova
Whether there is a specificity of children-parental relations in families, bringing up the child with deviations in mental development?
139
S.2.48 Flavia Capozzi, Angela Romano, Daniela Tardiola, Nadia Capriotti, Paola Rampoldi
Early adversity and developmental dyslexia
S.2.49
Belaise C., Ruini C., Ottolini F., Albieri E., Bravi S., Guidi J.,
Tomba E., Fava GA., Caffo E.
The relationship of psychological well-being to distress in adolescence
S.2.50 Inger-Lise Sæther
Social and emotional problems, language impairments, and chronic illness in children with 22q11 deletion syndrome (DS)
S.2.51
Einar Heiervang, Kjell Morten Stormark, Astri Lundervold, Mikael Heimann, Robert Goodman, Anne Ullebo¸ Maj-Britt Posserud, Kerstin Plessen, Ingvar Bjelland
Psychiatric disorders in Norwegian 8- to 10-year-olds: a survey of prevalence, risk factors and service use
S.2.52
S.2.53
Aijaz Farooqi, Bruno Hagglof, Leif Gothefors, Gunnar Sedin, Fredrik Serenius
Mental health and social competencies in 10- to 12 -year-old children born at 23-25 weeks’ gestation in the 1990s: a Swedish national prospective follow-up study
Lawrence Vitulano, Karen Bearss, Michael Vitulano, Lawrence Scahill, Joseph Woolston
Dissemination of evidenced based treatment into the community
S.2.54 Sari Fröjd, R. Kaltiala-Heino, M. Marttunen
Who are the adolescents dropping out of longitudinal surveys
140
S.2.55
Kenji Nomura, Toshirou Sugiyama, Toru Yoshikawa, Hiroyuki Kimura, Yasuaki Arai, Yuko Tanaka, Hitoshi Kaneko, Satomi
Murase, Shuji Honjo
Psychiatric problems of children in child welfare institutions in Japan
S.2.56 Tuulikki Trias, Hanna Ebeling, Varpu Penninkilampi-Kerola, Irma Moilanen
Inter-twin relationships and mental-health
S.2.57
Astrid Janssens, Kathy Uvin, Dirk Deboutte
What do they need, what can they give: a needs assessment on
the collaboration between child welfare and child and adolescent psychiatry
S.2.58 Marianne Mørdre, Eili Sponheim, Berit Grøholt, Inger Helene Vandvik, Ingrid Spurkland, Anne Myhre
The course of psychiatric disorders from childhood to adulthood
S.2.59
Hiroshi Hayakawa, Kodaira, Yukiko Suzuki, Hiromi Hirakuri, Kikue Inoue, Koki Ueno, Kazuhiko Saito
Trend of new patients in department of child and adolescent psychiatry of kohnodai hospital, national center of neurology and psychiatry, Japan
S.2.60
Kurt Albermann, Ruth Gurny, Silvia Gavez, Barbara Los-Schneider, Kitty Cassée, Christine Gäumann
A cross-sectional study: prevalence of children in families with parents suffering from mental illness in a Swiss population
141
S.2.61
Olafur Gudmundsson, Pall Magnusson, Bertrand Lauth, Gisli Baldursson, Evald Saemundsen
Prevalence of psychiatric disorders of 5-year-olds in Iceland - a pilot study
S.2.62
Michael Coughlin, John Sharry, michael Drumm, Suzanne Guerin, Carol Fitzpatrick
A clinical evaluation of the parents plus programme, a training course for parents of children with behavioural and/or developmental problems
S.2.63 Anne-Lise Holmesland
Cross disciplinary teamwork within the health, social and educational services.
S.2.64 Shin Min-Sup
The attitude toward serious mental illness in Korean high school student
142
S.2.65
Paivi Santalahti, Julia Gledhill, Virginia Davies, Anne Mc Fayden, Barry Whitlow, Demetrios Economides
The experiences of women following termination of pregnancy for ultrasound-detected fetal abnormality. A qualitative study
S.2.66
Hanne Elberling, Anne Mette Skovgaard, Allan Linneberg
The prevalence and predictors of mental health disturbances in preschool children - a longitudinal study in the Copenhagen child cohort
S.2.67
Juulia Paavonen, Jukka Partanen, Maria Valaste, Kimmo Vehkalahti, Anja Riitta Lahikaine
Television viewing is associated with psychiatric symptoms in 5 to 6 -year-old children
S.2.68 Yi-Jin Guo, Pei-Min Shin, Ya-Ping Liang,Hao-Jan Yang
The effect of mother’s nationality on the behavioral syndromes of children
S.2.69 Georgina C. Hughes, Jill Pullen
Beyond psychiatric diagnosis: a multidimensional description of the functioning of adolescent inpatients and their families
S.2.70
Antonio Pascotto, Carmela Bravaccio, Filomena Salerno, Francesca Formicola, Carla Lembo, Marta Calderaro, Miriam Polizi, Antonella Gritti
Screening of emotional and behavioral problems in 7-10 year-
old children living in campania
S.2.71
Caio Abujadi, Cesar Moraes, Sylvia Ciasca, Maria Valeriana Moura-
Ribeiro
Number of specialists and vacancies for residents in child
psychiatry: a way to assess the quality of assistance to the
Brazilian people
S.2.72
Olle Lindevall, Christina Dalmanm, Cecilia Magnusson, , Clara Gumpert
Child- and adolescent mental health service utilization: preliminary results from a population-based register in
Stockholm county, Sweden
143
S.2.73
Milena Skocic, Vesna Vidovic, Lovorka Brajkovic, Aleksandra Kargacin
Perceived stress, family functioning and defense mechanisms in a sample of Croatian medical students
S.2.74 Anja Haaland, Ansgar Berg, Einar Heiervang
Association between psychopathology and low blood pressure in Norwegian primary school children
S.2.75
Ilgi Ertem, Bahar Emine Bingoler, Canan Gok, Sema Ozbas, Hilal Ozcebe, Ufuk Beyazova
Evaluation of a training program on child development for community health providers in turkey
S.2.76
Niels Bilenberg, Solvejg Kristensen, Charlotte Maria Jensen, Trine N. Winding
Comparison of responders and non responders in an epidemiological survey
S.2.77 Bente Gjærum , Grete Andrup, Janson Harald
Soft neurological signs (SNS) in a Norwegian population sample 4 to 16 years
S.2.78
144
Gerasimos Kolaitis,Stavroula Diareme, Emanuel Tsalamanios, Irini Lympinaki, Sophia Anasontzi, Elena Paliokosta, Alkis Tsiantis, John Tsiantis
Mental health needs of children and adolescents with parents who suffer from multiple sclerosis: results from a controlled study in Greece
S.2.79
Aliki Grigoriadou, Antigoni Grammenou, Fotini Drouga, Konstantina Ikosipentarhou, Lydia Kontogeorgopoulou
A school based mental health prevention and promotion programme for adolescents
S.2.80 Brendan Doody,Lydon Alma
In-patient units: their evolving role in the continuum of care model
S.2.81 Konstantia Ladopoulou
Cross-cultural differences with respect to child and adolescent psychiatric consultation in thrace, Greece
S.2.82 Tatiana Morozova, Svyatoslav Dovbnya, Evgeniya Ermolayeva
Suport for vulnerable families - posibility to prevent institualization for children
S.2.83
Takahiro Yoshizumi, Satomi Murase
Properties of intrusive memories and their relationship with avoidant tendencies in a community sample using college students
S.2.84 Pahlavanzadeh Saeid
Association between mood status of nurses with personal and social characteristics
S.2.85 Darghal Mohamedi, Chafik Essaidi
Epilepsy in mental retardation
145
S.2.86
Victor Sevastyanov, Natalia Glazunova, Lioudmila Vostrova, Svetlana Shuvarova, Irina Yumasheva
The efficacy of idebenon for treating speech disorders in children with epilepsy
S.2.87 Eui-Jung Kim, Hyang Woon Lee
The quality of life of children and adolescents with epilepsy
S.2.88
Anu-Katriina Pesonen, Kati Heinonen, Niina Komsi,
Marjatta Heikka, Sture Andersson, Leena Laine, Eija Reen, Sirkka-
Liisa Vepsalainen, Katri Raikkonen
Premature birth: experience of adequate support in infant growth and nutrition associated with fewer maternal
symptoms of depression and more secure infant attachment
S.2.89
Tania Abou Abdallah, Jean-Marc Guile, Claude Menuisier, Monique Plaza, David Cohen
Are attention-deficit-hyperactivity disorder and visual attention impairments related to early nurturing disturbances?
S.2.90
Marja Laava, Airi Ahola-Häkkilä, Elli-Maija Salokangas, Tarja Ukura, Pirjo-Liisa Kurki
Video home training in family therapy with infants and small children
S.2.91 Susanne Landorph, Anne Mette Skovgaard
Feeding problems, eating disorders and comorbidity in an infant psychiatric population
S.2.92 Hitoshi Kaneko, Haya Sechiyama, Yasuko Sasaki, Kenji Nomura, Nobuaki Tanaka, Satomi Murase, Shuji Honjo
146
The relationship between attachment representations and depressive symptomatology in pregnant Japanese women
S.2.93 Hao-Jan Yang, Pei-Min Hsin, Guo Yi-Jin, Ya-Ping Liang
Parental bonding in children of indigenous mothers and children of immigrant mothers
S.2.94
Marit S. Indredavik, Torstein Vik, Kari Anne I. Evensen, Jon Skranes, Ann-Mari Brubakk
Perinatal morbidity and psychiatric symptoms in low birth weight adolescents
S.2.95 Shin Yee Jin
Brain pet findings of young children with severe attachment disturbance and quasi-autistic behavior patterns
S.2.96
Kirsten Moller-Pedersen, Liv Hundevadt, Guri Dahler, Rigmor Grette Moe, Svenn Torgersen
Regulatory disorders in toddler-hood - hyperactivity in early school age?
S.2.97
Else Marie Olsen, Anne Mette Skovgaard, Birgitte Weile, Torben Jørgensen
Failure to thrive and feeding problems in infancy: risk factors and age of onset at the copenhagen child cohort
S.2.98 Doris Nilsson, Carl-Göran Svedin, Marie Wadsby
Trauma and dissociation among Swedish adolescents. Evaluation of questionnaires
147
S.2.99 Anu-Katriina Pesonen, Kati Heinonen, Anna-Liisa Järvenpää, Timo Strandberg, Katri Raikkonen
Risk factors for infant sleeping difficulties
S.2.100 Prachi Shah, Connie Almeida
An infant mental health approach to evaluating young children with behavior problems
S.2.101
Laurence Robel, Laurence Vaivre-Douret, Xavier Neveu, Piana H., Bruno Falissard, Bernard Golse
How do children with specific language impairment discriminate between face identities and facial expressions?
S.2.102
Carlotta Gentili, Mariagrazia Mazzocco, Rossella Montucchielli, Elisabetta Poverini, Adriana Bernardi, Lorenza De Luca
A child psychiatry services and school integrated intervention for early investigation and treatment of learning disability in pre-scholar and scholar age
S.2.103
Annalisa Monti
Orthographic acquisition in Italian shallow orthography: computational processes in children with typically developing and dyslexics
S.2.104 Sylvia Maria Ciasca, Ricardo Franco Lima, Iramaia Massoni
Depression symptoms and neuropsychological functions in children with learning difficulties
S.2.105 Klaus Hennighausen, Tanja Rinker, Cathrin Richter, Verena Maas, Eberhard Schulz, Michael Schecker
148
Abnormal frequency discrimination in children with specific language impairment (SLI) as indexed by mismatch negativity (MMN)
S.2.106 Ivanka Zivcic-Becirevic, Nada Anic
Behavioural-cognitive treatment of children with reading difficulties
S.2.107 Sylvia Maria Ciasca, Maria de Lourdes Tabaquim, Cesar Moraes, Simone Capellini, Patricia Crenitte
Learnig disabilities and psychiatric disorders
S.2.108 Anna Fabrizi, Enza Mazzei, Roberta Di Scipio, Maria Bianca Chiappa
Emotional development in early language disorders
S.2.109 Natasa Potocnik Dajcman, Rok Holnthaner, Simona Koser, David Gosar
Psychiatric comorbidity in children with learning disorders
S.2.110 Heiser Philip, Eberhard Schulz, Alan Apter
Serotonin in child and adolescent psychiatry
S.2.111 Dagma Abramides, Luciana De-Vitto, Celia Giacheti, Danilo Moretti-Ferreira, Antonio Richieri-Costa
Sotos syndrome and neurpsycholinguistics abilities
149
S.2.112 Luciana Paula Maximino De-Vitto, Sandra Regina Barbosa de Souza, Celia Maria Giacheti, Roberta Garcia, Antonio Richieri-
Costa, Dagma Vernturini Marques Abramides
Velocardiofacial syndrome: performance in the token test
S.2.113 Dagma Venturini Marques Abramides, Marcia Ferro, Lilian D`Aquino Tavano, Sandra Regina Barbosa de Souza, Luciana Paula Maximino De-Vitto
Social performance in patients with velocardiofacial/del 22q11.2 syndrome
S.2.114 James Swain, James Leckman, Linda Mayes, Ruth Feldman, Elizabeth Hoyt, Pilyoung Kim, Robert Schultz
Baby cry and picture activations of parent brains vary with gender, experience, and dyadic relationship
S.2.115 Gottfried Maria Barth, Matthias Nickola, Matthias Gass, Timo Lesnik, Daniela Horvath, Sonja Schmid, Melanie Mayer, Gunther Klosinski
Parasympathetic and sympathetic nervous system in respect of mental health
S.2.116 Gerasimos Kolaitis
Multicentre research programme edig: “ethical dilemmas due to prenatal and genetic diagnostics”
S.2.117 Luciana Paula Maximino De-Vitto, Dagma Venturini Marques Abramides, Celia Maria Giacheti, Mariza Ribeiro Feniman, Danilo 150
Moretti-Ferreira, Adriano Yacubian-Fernandes, Antonio Richieri-
Costa
Language skills and neuropsychological performance in patients with sotos syndrome
S.2.118
Mazzone Luigi , Maheu Françoise S., Merke Deborah P , Pine Daniel S., Ernst Monique
Increased amygdala activation in adolescents with congenital cortisol deficiency:a fmri study with congenital adrenal hyperplasia
S.2.119 Mia Danielson, Maria Dunerfeldt
Variations in assesment of neuropsychiatric disorders in children
S.2.120 P. Gabusi, U. Incasa, S. Valeriani, S. Finelli
Complexity: the person between exceptionality and singularity, or samuele, pupil with neurological congenital syndrome
S.2.121
Luigi Mazzone, Domenico Mazzone, Laura Battaglia, Domenico Marco Romeo
Cognitive and behavioural assessment of alpha-thalassemic children and quality of life of their mothers
S.2.122
Monika Althaus, Gomarus Wijers, Lambertus J. Mulder, Ruud B. Minderaa, Yvonne Groen
Performance monitoring in attention deficit hyperactivity disorder (ADHD) and high functioning autism (HFA)
151
S.2.123
Paolo Brambilla, Federeica Contardo, Danielle Londero, Consuelo Desinano, Eva Pascoli, Sonia Rigo, Dora Zago, Matteo Balestrieri, Franco Fabbro
Teach rehabilitation intervention in children with autism: an Italian experience at IRCCS E. Medea
S.2.124 Isabella de Souza, Gabriel Coutinho, Paulo Mattos
Internalizing symptoms and learning disabilities: the relevance of
this issue in clinical practice
152
August 28th
Poster session 3: Anxiety Disorders, OCD, Tourettes; Bipolar Disorder;
Depression & Suicide; Eating Disorders; Instruments & Measurement;
Psychosis; Treatment; Trauma, Abuse, Refugees
S.3.1
1Karin Melin, Tord Ivarsson
Outcome in obsessive compulsive disorder (OCD) at 12-mounth
follow-up
S.3.2
Yeni Kim, Soo-Churl Cho, Boong-nuyn Kim, Soo-Young Bang
Relationship between inattention/hyperactivity and anxiety in
community children samples
S.3.3
Kazuhiko Saito
Relationship between school refusal and “hikikomori” in Japan
S.3.4
C Huyser, L Wolters, E de Haan, D Veltman, F Boer
The pediatric obsessive compulsive disorder, a neurodevelopmental
disorder?
S.3.5
Gustafsson Per, Ivarsson Tord, Nelson Nina
Salivary cortisol in children and adolescents with OCD
S.3.6
Bakker Mirte
The whole-body startle reflex in anxious children
S.3.7
Askenazy Florence, Dupuis Gaelle, Lestideau Karine, Dor Emmanuelle,
Myquel Martine
Auditory hallucinations in pre-pubertal children, a one year follow
-up. A symptom of anxiety disorders?
153
S.3.8
Natasa Jokic-Begic, Anita Lauri Korajlija, Tanja Jurin
Gender and age differences in anxiety sensitivity, anxiety, and
depression among school children in Croatia
S.3.9
Sharkey Louise, McNicholas Fiona
Prevalence and description of selective mutism in elementary
school
S.3.10 Edward Ornitz, Michelle Craske, Bruce Naliboff, Allison Waters
Fear potentiated startle and risk for anxiety
S.3.11 Kitty Dahl, Tord Ivarsson, Per Hove Thomsen, Robert Valderhaug
Nordic long-term OCD treatment study (nordlots)
S.3.12 Boong Nyun Kim, Soo Churl Cho, Min Sup Shin
Association study of child and adolescent chronic tic disorder/
tourette’s disorder and dopamine related genes
S.3.13 Dong-Ho Song, Wook Jin Oh, Eun Hye Ha, Ye Jin Shin, Joo Young Kim,
Won Chul Shin, Hyung Seok So
Effect of cognitive-behavioral treatment in children with anxiety
disorder
S.3.14 Dong-Ho Song, Joo Young Kim, Won Cheol Shin, Yee Jin Shin, Jin
Kyun Park, Hyung Seok So
Adult outcome of Tourette disorder
S.3.15 Eyyup Sabri Ercan,Burcu Ozbaran, Eralp Bellibas, Serpil Erermis,
Nagehan Bukusoglu, Tezan Bildik, Cahide Aydin
Evaluation of children’s behavioral styles between ages of 4-7 who
were diagnosed as separation anxiety disorder
154
S.3.16 Lawrence Vitulano, Karen Bearss, Michael Vitulano, Lawrence Scahill,
Joseph Woolston
Cognitive-behavioral
therapy
for
disruptive
behavior:
adolescents with Tourette’s syndrome
S.3.17 M. Liakopoulou, D. Anagnostopoulos, S. Korlou, K. Sakellariou, E.
Kapsimali, V. Kondyli, J. Sarafidou
Family psychiatric history of children and adolescents with
obsessive-compulsive disorder
S.3.18 Marianne Aalberg, Simon-Peter Neumer, Kristin Martinsen, Martina Gere
Group treatment of children with anxiety disorders – a pilot study
S.3.19 Yukiko Kano, Kono, Kurie Shishikura, Chizue Konno, Hitoshi Kuwabara,
Mami Takano, Masataka Ohta
Relationship of tics, obsessive-compulsive symptoms, and
impulsivity in patients with Tourette syndrome
S.3.20 Ki-Hwan Yook
Bipolar youth with and without comorbid anxiety disorder
S.3.21 Vanessa Sanchez-Gistau, Margarita Garcia-Amador, Montserrat Vila,
Eduard Vieta, Josefina Castro-Fornieles
Psychiatry morbidity in children and adolescent bipolar offspring:
preliminary results
S.3.22 Lilian Zoellner
Self-harm among young people in Denmark in 2002 and 2007
155
S.3.23 Janos Csorba, Zsuzsa Sörfozo, Péter Steiner, Beáta Ficsor, Éva Harkány,
Zsuzsa Babrik, Marianna Solymossy
Subtypes via coping. Hungarian adolescent outpatients suffering
from suicidal behaviour
S.3.24 Erika Maruyama, Tatsuo Ujiie
Change in friendship stressors and depressive symptoms during
adolescence
S.3.25 Yang Yeol Kim, Jae-Won Kim, Jun-Won Hwang, Min-Sup Shin, BoongNyun Kim, Soo-Churl Cho
Ces-d and siq as a discriminant screening instruments of depression
in adolescents: a large community-based epidemiological study
based on the disc-iv
S.3.26 Shoko Hamada, Satomi Murase, Takashi Murakami, Kazunori Otaka,
Hitoshi Kaneko, Takahiro Yoshizumi, Shuji Honjo
Deliberate self-harm among Japanese high school students
S.3.27 Moon Seok Woo, Seo Jeong Seok, Nam Beom Woo
Risk factors influencing the impulse of suicidal attempts in
adolescence
S.3.28 Byrne Sinead, Fitzpatrick Carol, McNicholas Fiona, Cassidy Carol,
Morgan Sophia
Deliberate self-harm in Irish young people
S.3.29 Yuko Furuhashi, Shusuke Furuhashi
Motives for self-harm differ in self-injury and self-poisoning: a
comparative prospective study of 33 cases of university students
in Japan
156
S.3.30 Linnea Karlsson, Olli Kiviruusu, Jouko Miettunen, Matti Holi, Titta
Ruuttu, Virpi Tuisku, Mirjami Pelkonen, Mauri Marttunen
Comorbidity and the outcome of depression in adolescent
psychiatric outpatients
S.3.31 Katerina Papanikolaou, Vassiliki Hantzara, Maria Belivanaki, Vassiliki
Kyrlaki, Maria Ioannidi, Aggeliki Giachni, Magda Liakopoulou, Ioannis
Tsiantis, Vlassios Tomaras
Suicide attempters in a Greek general pediatric hospital
S.3.32 Joviana Q. Avanci, Simone G. Assis, Rachel V.C. Oliveira
Depression in adolescence. A study about the psychosocial aspects
in a school sample of Rio de Janeiro, Brazil
S.3.33 Paivi Santalahti, Solja Niemela, Larri Toivanen, Kaija Ikaheimo, Hans
Helenius, Jorma Piha, Andre Sourander
Changes in children’s depressive symptoms. A 16-year comparison
from Finland
S.3.34 Cat Tuong Nguyen, Louise Fournier
Contextual factors of depression among young Canadians: results
from the national longitudinal survey of children and youth (NLSCY)
S.3.35 Enikõ Kiss, Ildikó Baji, László Mayer, Dóra Skultéti, Ágnes Vetró
Agreement between self and proxy measures of quality of life of
depressed and healthy children
S.3.36 Ian Shochet, Astrid Wurfl
The efficacy and effectiveness of the resourceful adolescent
program: a school based resilience building program to prevent
adolescent depression
157
S.3.37 Shin Yunmi
Childhood psychopathology predictors of depression
adolescence: a 8-year population-based follow-up study
in
S.3.38 Marie-Kaarin Korhonen, Ilona Luoma,Raili Salmelin, Tuula Tamminen
Maternal prenatal and concurrent depressive symptoms:
associations with adolescents’ emotional and behavioral
problems
S.3.39 Carla Sogos, Flavia Cortesi, Carla D’Agostini Costa, Flavia Giannotti,
Bruna Mazzoncini
Sleep disturbance in depressed children
S.3.40 Lilian Zoellner
Values, visions and coping in the lives of young people who harm
themselves
S.3.42 Coulon Nathalie , Godart Nathalie Jeammet Philippe
Social phobia in anorexia nernosa
S.3.43 Wentz Elisabet , Gillberg Christopher , Gillberg Carina , Anckarsäter
Henrik, Råstam Maria
Eighteen-year follow-up of adolescent-onset anorexia nervosa
S.3.44 Fusün Çuhadaroðlu, G. Senses-Dinc
A case of anorexia nervosa with dynamics of intrafamilial
adoption
S.3.45 Bea Pászthy, Peter Svec, Barna Vásárhelyi, Tury Ferenc, Treszl András
Investigation of regulatory t cells in adolescents with anorexia
nervosa
158
S.3.46 Hrdlicka Michal, Beranova Irena, Zamecnikova Renata
Mirtazapine in the treatment of adolescent anorexia nervosa: case
– control study
S.3.47 M. Graell Berna, A. Villaseñor Monterroso, Mar Faya Barrios, Carmen
Martínez Cantarero, G. Morandé Lavin
Evaluation of the personality features of adolescents with eating
disorders
S.3.48 Ana Sepulveda, Jenna Whitney, Janet Treasure
Development and validation of an eating disorders symptom
impact scale for families with an adolescent with eating disorders
S.3.49 Sánchez-Gistau Vanessa, Immaculada Baeza Pertegaz, Castro J.,
Martinez Esteve, Deulofeu Ramon, Saura Begoaa, Vanessa Cassulà, Vila
Montse, Bernardo Miquel
Plasma homovanillic acid levels in adolescents with bulimia
nervosa
S.3.50 Hasse Karlsson, Pohjiolainen, Pirjo Rasanen, Harri Sintonen, Risto
Roine
Cost-effectiveness of treatment of adolescent eating disorders
S.3.51 Mieko Aoki
The follow-up survey on the wishes to be slender and mental
health of young women in Japan at the end of teenager and late
twenties
S.3.52 Mieko Aoki
The comparison between Japanese and Indonesian adolescent
women to be slimmer and mental health GHQ scores showed
159
S.3.53 Chaim Huyser, Maartje Snoek, Anne-Marie Krebber, Frits Boer,
The mandometer method: starting a new eating disorder treatment
unit, preliminary findings
S.3.54 Anna Cieslukowska, Izabela Lucka
Childhood-onset anorexia nervosa and obsessive-compulsive
disorder in male adolescent patient - profile of neurocognitive
functioning: a case report
S.3.55 Jean-Philippe Raynaud, Marie Tardy, Franck Hazane, Helene Grandjean,
Jean-Philippe Raynaud
Alexithymia in teenagers with anorexia nervosa and their parents:
a case-control study
S.3.56 Fiona Mc Nicholas, Barbara Dooley, Leonie Keogh, Sinead Ahern,
Ciaran Coyle, Aoife Whelan
Eating problems in children and adolescents: an epidemiological
study of Irish adolescents
S.3.57 Josefa Canals, Carolina Sancho, Oscar Asorey, Maria Victoria Arija
Epidemiology of eating disorders: a two year follow up in an
spanish school adolescents
S.3.58 Marija Anderluh, Kate Tchanturia, David Collier, Janet Treasure
Lifetime course of eating disorders: do childhood obsessivecompulsive personality type traits shape the lifetime symptoms?
S.3.59 Sigita Lesinskiene, Nadezda Ranceva, Arunas Barkus
Heart rate and qt interval alteration in anorexia nervosa: metaanalysis and clinical picture
160
S.3.60 Basak Alpas, Melda Akcakin,Sedat Isikli,Gulsen Erden,
Comparison of the Vineland adaptive behavior scales - survey form
-(Vineland - ii)’s scores of Turkish babies, from birth to 11 months,
according to socioeconomic status
S.3.61 Ciro Ruggerini, Stefania Vicini, Francesca Masina, Laura Madonna
Considerations on the gos diagnostic criteria in 14 cases
S.3.62 Mehdi Tehrani-Doost, Shakibaie, Zahra Shahrivar, Shervin Asari, Nasrin
Amiri
Mental problems among Iranian school children using the
strengths and difficulties questionnaire (SDQ) and evaluation of
the psychometric properties of this scale
S.3.63 José Eugenio de la Fuente, Gloria Canalda, Raquel García, María Blanc,
Josefina Castro, Antoni Vallès
Comparison of the cloninger temperament and character inventory
(TCI) and the millon adolescent clinical inventory (MACI) in a sample
of adolescent patients
S.3.64 Michael Couglin, John Sharry, Matthews, Gavin Doherty, Carol
Fitzpatrick
Monitoring mood using mobile phones - a comparative study
S.3.65 Cleary Deirdre, Power Mike, Fitzpatrick Carol, Guerin Suzanne
The relationship between self-reported psychopathology, coping
style and gender
161
S.3.66 Kristensen Solvejg, Bilenberg Niels
The child behavior checklist for ages 1.5-5 (cbcl/1½-5): assessment
and analysis of parent and caregiver-reported behavioral,
emotional and social function in a population-based sample of
danish preschool children
S.3.67 Hong S. David, Kim Ji-Hae, Yang Jae Won, Jang Won Seok, Byun Hee
Jung, Lee Moon Soo, Lee Soyong
Kidscreen-52-hrqol: reliability and validity of the Korean version
S.3.68 Merja Koskelainen, Andre Sourander
The strengths and difficulties questionnaire (the SDQ-Fin) among
finnish children and adolescents
S.3.69 German Eduardo Rueda Jaimes, Paul Camacho, Jose Fidel Latorre,
Alvaro Andres Navarro-Mancilla, Mauricio Escobar Sanchez, Jorge
Augusto Franco Lopez
Validity and reliability of the center for epidemiological studiesdepression (CES-d) in adolescent students from Colombia
S.3.70 Annalisa Monti, Cinzia Pieraccini, Claudia Nardini, Costanza Guerrieri
The scale becs like instrument of monitoring during the treatment
in the children with d. P.s.
S.3.71 Paula Cristina Correia, Anabela Fazendeiro, Filipa Pereira, Isabel
Baltazar, Mónica Grancho, Leonor Goulão, Dina Menino
Portuguese translation of ksads
S.3.72 Sema Kaner, Sener Buyukozturk, Elvan Iseri
Psychometric properties of the Turkish version of the conners
teacher rating scale-revised/short (ctrs-r/s)
162
S.3.73 M.P. Steenhuis, M. Serra, C.A. Hartman, R.B. Minderaa
The reliability of the internet version of the ADHD module of the
diagnostic interview schedule for children (DISC IV)
S.3.74 Betty Van Roy
Simularities and discrepancies between children’s and parents’
assessment of the children’s mental health: a comparison of the
strengths and difficulties questionnaires self-report results with
parents’ reports
S.3.75 Reija Latva, Palvi Kaukonen, JoAnn Robinson, Tarja Sorvali, Raili
Salmelin, Ilona Luoma
Psychopathology and play narratives of children in a clinical
sample
S.3.76 Ivarsson Tord , Larsson Bo
A child behavior checklist (CBCL) obsessive compulsive symptom
scale (OCS) in swedish children and adolescents
S.3.77 Kim Bongseog , Lee Ji-Yeon , Yoo Han-Ik , Kim Jae-Won
The effects of intelligence ability on continuous performance test
S.3.78 Naoufel Gaddour, Bougoffa, Zied Ben Ali, Mondher Letaief, Dirk Kraijer,
Lotfi Gaha
Screening of pervasive developmental disorders in mentally
retarded persons in Tunisia with the Arabic version of the PDD-MRS
scale
S.3.79 Monica Juuhl-Langseth, Aina Holmen
Deficits in working memory, learning and memory tasks in earlyonset psychotic disorders
163
S.3.80 Rianne Klaassen, Dorien Nieman, Hiske Becker, Peter Dingemans,
lieuwe de Haan, Don Linszen
Differentiation between depressive and negative symptoms in
adolescents at ultra high risk (UHR) for psychosis
S.3.81 Yuki Kako, Nobuki Kitagawa, Kenzo Denda, Tsukasa Koyama
The long-term course and outcome of childhood and adolescentonset schizophrenia
S.3.82 Soumitra Shankar Datta, Ajit Kumar, Eilis Kennedy, Clive Adams
What works for childhood onset schizophrenia? A systematic
review of antipsychotic medications
S.3.83 Ignazio Ardizzone, Silvia Perinetti, Chiara Caucci, Teresa I. Carrateklli
First - episode psychotic disorders in adolescence: differential
diagnosis through development and personality
S.3.84 Marta Rapado-Castro, Igor Bombin-Gonzalez
Symptom dimensions and cognitive function in children and
adolescents with first psychotic episode
S.3.85 Margaretta Nyilas, Robert Findling, Robert Forbes, Bartosz Janikovszki,
Ronald Marcus, William Carson
Efficacy of aripiprazole in the treatment of adolescents with
schizophrenia
S.3.86 S. Werneck-Rohrer, M. Schloegelhofer, N. Mossaheb, R.M. Kaufmann,
H.N. Aschauer, G.P. Amminger
Quality of life in a sample of patients with first-episode psychosis
(FEP)
164
S.3.87 Eve Becache, Nicolas Georgieff
About the interrogation by a clinical point of view of a
psychopathological link between child autism and schizophrenia
S.3.88 Juha Veijola, Pirjo Maki, Heli Halonen, Jouko Miettunen, Jaana Laitinen,
Tuija Tammelin, Irma Moilanen, Anja Taanila, Hannu Koponen
Insulin resistance and lipid levels in adolescent subjects at risk for
psychosis
S.3.89 Pirjo Maki, Jouko Miettunen, Anja Taanila, Peter B. Jones, Graham
Murray, Irma Moilanen, Hanna Ebeling, Matti Joukamaa, Juha M.
Veijola
Familial risk and prodromal features of psychosis in adolescents
aged 15-16 years in the Northern Finland 1986 birth cohort
S.3.90 Hee-Young Song, Ji Young Lim, Kyoung A Nam
Searching for the potential: resilience, self-esteem, coping, family
strength, and social support in north Korean adolescent refugees
S.3.91 Helmer B. Larsen, Tine Curtis, Karin Helweg-Larsen, Cecilie P. Pedersen,
Ingelise Olesen, Kristian Sørensen, Marit Eika Jørgensen, Peter
Bjerregaard
Childhood sexual abuse and psychological disturbance among
adolescents in Greenland
S.3.92 Stefania Di Biasi
Relationship between specific adverse life events and childhood
psychopatology
165
S.3.93 Mariagnese Cheli, Sara Giacopuzzi, Cosimo Ricciutello, Rebecca
Rubbini
A multidisciplinary contribute to public services engaged in child
protection: “il faro”, the experience of a specialist centre against
child abuse
S.3.94 Sandra Kaplan, Suzanne Sunday, V Labruna, M Kline, D Pelcovitz, S
Salzinger
Bridging the gap from adolescent to young adult psychopathology:
the impact of physical abuse during adolescence
S.3.95 Ayala Borghini, Carole Muller-Nix, Margot Forcada-Guex, Lyne Jaunin,
Blaise Pierrehumbert, Francois Ansermet
Parental traumatic experience, parent-infant attachment and
interaction 18 months after a premature birth
S.3.96 Stefania Di Biasi, Rosella Ricci, Giulia Crisante, Francesca Piperno
Neuropsychological memory in traumatized children
S.3.97 Fekadu Daniel , Alem Atalay, Hägglöf Bruno
Child abuse in child labor in an urban district, Ethiopia
S.3.98 Madeleine Cocozza, Per Gustafsson, Gunilla Sydsjö
Child protection in Sweden - are routiner assesments reliable?
S.3.99 Leavey JoAnn Elizabeth
Emergence, loss, adaptation and recovery (ELAR)
S.3.100 Semerci Bengi
Child prostitution in Turkey: child women
S.3.101 Ben Amitay Galit
Visual scanning and physiological variables in sexually abused
children and their mothers
166
S.3.102 Jansinsk Donald,Suma Krishnan, Gwendolyn Niebler
Abuse Liability of Intravenous Lisdexamfetamine Dimesylate
S.3.103 Chiara Caucci, Stefania Di Biasi, Ignazio Ardizzone, Teresa Iole
Carratelli
Cinema: a rehabilitation strategy in adolescents with psychiatric
disorders
S.3.104 Jill Pullen, Georgina Hughes
Time and space: the psychotherapist’s role in connecting a
borderline adolescent with her inner and outer world through
continuity, containment and reflection
S.3.105 Mats Karling, Bruno Hagglof
Behavioural impact of hospitalization, associated risk factors
S.3.106 Guerra Alegre Teresa, Diaz-Sibaja Miguel Angel,Isabel Perez
Protocolized parent training program: family satisfaction and family
social climate outcomes
S.3.107 Toren Paz, Wolmer Leo, Laor Nathaniel
Sixteen-session group treatment for children with parental
alienation syndrome and their parents
S.3.108 Angela Dean
Effective behavioural management of aggression generates
reductions in prn sedation
S.3.109 Michael Couglin, Sharry John , Griffin Claire, Guerin Suzanne, Drumm
Michael, Hampson Grainne, Fanning Mary
A multicentre controlled study of an early intervention parenting
program for young children with behavioural and developmental
difficulties
167
S.3.110 Takayo Mukai, Motoko Saeki, Chizuru Saitou
Emotion understanding among institutionalized children in japan
S.3.111 Laura Horowitz, Per-Anders Rydelius, Tomas Ljungberg
A sequential process of conflict progression - interplay of
communicative factors and behavioural strategies
S.3.112 Angela Dean, Suzanne Duke, Michelle George, James Scott
Behavioral management leads to reduction in aggression in a child
and adolescent psychiatric inpatient unit
S.3.113 Tormod Rimehaug, Ingunn Helmersberg, Jorun Borstad
Counteracting “death and decay” when implementing new
prevantative services
S.3.114 Akio Kiyota, Kazuhiko Saito, Nozomi Hayashi, Kyota Watanabe, Masaki
Kodaira, Masahide Usami, Yoshiko Sato, Yoko Kudo, Kamio Yoko
Outcomes of the treatment at the child and adolescent psychiatric
ward: relation to hikikomori (social withdrawal)
S.3.115Anna Fabrizi, Freda Francesca, Caterina Dardia
Symptom, structure and interaction in parent training:
therapeutic or diagnostic program?
S.3.116 Maria Elena Montt, Fritsch Rosemarie
Psychopathology in children of depressed mothers in Santiago,
Chile
S.3.117 Sara Cesi, Francesca Masina, Giovanni B. Camerini
True and false accusations of sexual abuse: a conflictual
separations study
168
DONALD COHEN FELLOWSHIP PROGRAM
The Donald J. Cohen Fellowship is a training program for young scholars
modelled on successful activities at ESCAP European Research Seminars and
IACAPAP and AACAP Congresses and sponsored by Foundation Child.
The program includes:
1. Daily small group meetings with leading experts
2. A poster presentation attended by senior faculty members
3. Seminars presented by Fellows
4. Participation in day-long seminars on research methodology, autism
or pediatric psychopharmacology
5. Social activities
Fellowship activities will not be scheduled at the same time as other highlights
of the Congress. Fellows will also benefit from free registration and free
accommodation at university residences.
ERICE
ERICE (Empowerment and Resilience in Children Everywhere) is an
international collaborative project aimed at improving the lives of Israeli and
Palestinian children. It includes Israeli, Palestinian, European and American
child mental health professionals, and is supported by Foundation Child and
Yale University.
ERICE is led by Shafiq Masalha, PhD, Ruth Feldman, PhD, and Eyad Hallaq,
PhD. The organization is affiliated with a number of leading Israeli, Palestinian,
Italian and American Universities.
Founded in 2004, ERICE has many important goals including the support of
research on the prevalence and nature of childhood disorders in this region
of conflict, the implementation of treatment programs and the establishment
169
of training and degree programs. It is guided by the belief that children
everywhere are to be cherished and that protection of children - as well as
kindness - is a shared human value.
Since its first meeting in Jerusalem in 2004, this group continues to meet both
in the region and in Europe. The last two Italian meetings were in Sicily (2005)
and in Rome (2006), where the ongoing results from the first funded joint
project were presented.
The third Italian meeting of the group will be held in Florence from 23rd to 25th
of August and will take place at the Innocenti Institute. A symposium has been
organized on the occasion of the ESCAP Congress and will review the history,
psychological process and initial accomplishments of ERICE as well as it longterm goals.
ROME GROUP
Between the 16th and 19th of July, 2003, a group of world professional leaders
in the area of child trauma from North America, Australia, Europe and Asia,
gathered in Rome to present their clinical findings and research advances as
well as to seek out a way to integrate these with the current state of knowledge
in this area.
Leading international experts such as Robert Pynoos, Alexander McFarlane,
Barry Nurcombe, James Leckman, Steven Berkowitz, Nathaniel Laor, Claude
Chemtob, Hans Steiner, John Fayyad and Ernesto Caffo took part in this
meeting, entitled “Caring for Children in Times of Maltreatment, War, Terrorism
and Disasters”.
The meeting of this established “Rome Group” was organized under the
auspices of Foundation Child (Italy) and the International Association for Child
and Adolescent Psychiatry and Allied Professions (IACAPAP). As a result of their
deliberations, the experts signed the Declaration of Rome, asking Governments
worldwide for an increased investment in prevention, treatment and research
in the area of caring for children affected by trauma.
170
The mission of the Rome Group is to promote a major understanding of the
severe consequences of childhood exposure to trauma, as well as to develop
effective interventions that focus on the needs of the individual, the family,
and the community and to raise standards of care throughout the world. As a
result, leaders in the field of child trauma are being sought out constantly and
are joining this important group.
The Rome Group met a second time on the occasion of the 16th Congress of
the International Association for Child and Adolescent Psychiatry and Allied
Professions, which took place in Berlin in 2004. During the 13th International
Congress of the European Society for Child and Adolescent Psychiatry they
will present advances in trauma research with children and new intervention
models both in the form of symposia and as a training course.
CHILD HELPLINE INTERNATIONAL
Child Helpline International (CHI) is a global network of telephone helplines
and outreach services for children and young people. Working in over 150
countries, CHI was founded on the belief that children and young people have
rights, and that they alone are the best individuals to identify their problems.
As an organization devoted to securing children’s rights, CHI is committed to
maintaining the spirit of the Convention on the Rights of the Child (CRC). Its
main concern is to respond to children in need of care and protection and voice
their concerns to policy and decision-makers by establishing a global network
of children’s helplines and providing support to individual helplines for children.
During the ESCAP congress CHI will take part in the symposium “Helplines
and Internet: innovative intervention in child and adolescent mental health.”
This symposium is aimed at analyzing the role of helplines in the European
countries and promoting the exchange of data and experiences, particularly
regarding the issue of quality standards and professional skills.
171
LIST OF EXHIBITORS
Palazzo dei Congressi - Passi Perduti – Basement
172
1
Eli Lilly and Company
6
Wisepress
2
Shire
7
British Embassy, NHS, SEPT
3
Janssen- Cilag EMEA
8
Blaguss
4
Qbtech
9
Telefono Azzurro
5
Wiley-Blackwell
10
Fondazione Child
DISCLOSURES OF INTEREST
ACHENBACH THOMAS
President: Research Center for Children, Youth and Families, publisher of
rating instruments
ALBERMANN KURT
Advisory Board: Janssen-Cilag ALEARDY MEGANE
Research Support: Abbott, Bristol-Myers Squibb, Eli Lilly and Co., Janssen
LP, McNeil, New River Pharmaceuticals Inc., Otsuka America Inc., Pfizer,
Shire, Lilly Foundation, NICHD, NUMH, NIDA
Advisory Board: Cephalon Inc., Eli Lilly and Co., Janssen LP, McNeil, New
River Pharmaceuticals Inc., Novartis, Shire, UCB Pharmaceuticals Inc.
Consultation: Cephalon Inc., Eli Lilly and Co., Janssen LP, McNeil, New River
Pharmaceuticals Inc., Novartis, Shire, UCB Pharmaceuticals Inc.
Speaking Fees: Cephalon Inc., Eli Lilly and Co., Janssen LP, McNeil, Novartis,
Shire
BARKLEY RUSSEL
Consulting and speaking: Eli Lilly and Company Co.
Consulting and speaking:
Shire Pharmaceuticals Group plc Pharmaceuticals
Speaking: Novartis Pharmaceuticals Corporation
BANERJEE SOMNATH
Travel and registration for congress: UCB Pharma
Advisory board: Eli Lilly and Company
BIEDERMAN JOSEPH
Research Support : Shire Pharmaceuticals Group plc , Ely Lillly and
173
Company, Pfizer Inc , McNeil Pediatrics Pediatrics, Abbott Laboratories,
Bristol-Myers Squibb, New River Pharmaceuticals, Janssen, Cephalon,
Neurosearch, Stanley Medical Institute, Novartis Pharmaceuticals Eli Lilly
Foundation, Prechter Foundation, r, Forest Laboratories, GlaxoSmithKlinE,
NIMH, NICHD, NIDA
Speaker’s bureaus: Shire Pharmaceuticals Group plc, Eli Lilly and
Company, McNeil Pediatrics , Cephalon, UCB Pharma, Inc., Novartis
Pharmaceuticals Corporation
Advisory Board: Eli Lilly and Company, Shire Pharmaceuticals Group
plc, McNeil Pediatrics, Janssen, Novartis Pharmaceuticals Corporation,
Cephalon
Consultation fees: Shire Pharmaceuticals Group plc, Eli Lilly and Company,
McNeil Pediatrics, Cephalon, Janssen, Novartis Pharmaceuticals
Corporation
BILENBERG NIELS Honoraria and Research Support: Novartis Neuroscience, Denmark
Consulting Fees and Travel Support: Eli Lilly and Company
BONGSEOG KIM
Travel Support : Jassen
BRUSSEL WIM
Advisory Board: Lilly Netherlands, Jansen Cilag Netherlands, UCB Pharma
Netherlands
Travel Support: Lilly Netherlands, Jansen Cilag Netherlands, UCB Pharma
Netherlands
CANALS JOSEFA Grant of the FIS: Instituto de Salud Carlos III, Ministerio de Sanidad
174
CARLSON GABRIELLE Advisory Board: Eli Lilly and Company
Research support: Eli Lilly and Company
Honoraria: Eli Lilly and Company
travel support: Eli Lilly and Company
Advisiory board: Otsuka America Pharmaceutical, Bristol-Myers-Squibb
Research Support: Otsuka America Pharmaceutical, Bristol-Myers-Squibb Grant: Janssen
Honoraria: Shire Pharmaceuticals Group plc, McNeil Pediatrics
CHEN YING-SHEUE CHEN Research Support: Janssen-Cilag, Taiwan
CHEON KEUN-AH
Grant: Jessen Korea
Travel Support: Jessen Korea
COGHILL DAVID Advisory Board: Janssen Cilag
Consulting Fees: Janssen Cilag
Grant: Janssen Cilag
Honoraria: Janssen Cilag
Travel Support: Janssen Cilag
Advisory Board: Eli Lilly and Company
Grant: Eli Lilly and Company
Honoraria: Eli Lilly and Company
Research Support: Eli Lilly and Company
Travel Support: Eli Lilly and Company
Advisory Board: UCB Pharma Grant: UCB Pharma Honoraria: UCB Pharma Advisory Board: Medice /Flynn Pharma 175
Honoraria: Medice /Flynn Pharma Advisory Board: Shire Pharmaceuticals Group plc
Advisory Board: Pfizer Pharmaceuticals
Honoraria: Sanofi Aventis
CORREIA PAULA CRISTINA
Invited by: Janssen
DABKOWSKI MIROSLAW
Travel Support: 2006 San Diego AACAP by Eli Lilly Polska
Dalsgaard Soren
Advisory Board: Eli Lilly and Company
Travel Support: Eli Lilly and Company
Consulting Fees: Eli Lilly and Company
Name of Pharmaceutical Company: Eli Lilly and Company
DELVENNE VÉRONIQUE
First travel invitation to the conference of theESCAP: Eli Lilly and Company
DOBRESCU IULIANA Advisory Board: Eli Lilly and Company
Research Support: Johnson & Johnson, Otsuka America Pharmaceutical,
Eli Lilly and Company
Travel Support: Eli Lilly and Company
Speaker Fee: Eli Lilly and Company, Janssen-Cilag, Ebewe Pharma, SanofiAventis
DONNELLY CRAIG
Serve on Advisory Board: Eli Lilly and Company
Research Support: Eli Lilly and Company
176
Consultant: Eli Lilly and Company
Speaker Bureau: Eli Lilly and Company
Travel support for ESCAP meeting: Eli Lilly and Company
DUBICKA BERNADKA
Attended educational meetings: Eli Lilly and Company
EMSLIE GRAHAM
Grants: Eli Eli Lilly and Company
Grants: Organon, Inc.
Grants: Forest Laboratories, Inc.
Consulting: Eli Lilly and Company
Consulting: GlaxoSmithKline
Consulting: Biobehavioral Diagnostics, Inc.
Speaking: McNeil Pediatrics Consumer and Specialty Pharmaceuticals
ESCOBAR RODRIGO Employee: Eli Lilly and Company
FALISSARD BRUNO
Consulting Fees: Eli Lilly and Company
Consulting Fees : Janssen Cilag
Consulting Fees: Servier Consulting Fees: SANOFI-Aventis Consulting Fees: Pierre-Fabre Consulting Fees: BMS FARAONE STEPHEN V.
Consultant, speaker’s bureau, and research contract: McNeil Pediatrics
Consultant, speaker’s bureau, and research contract: Shire
Pharmaceuticals Group plc
177
Advisory board: McNeil Pediatrics
Advisory board: Eli Lilly and Company
Advisory board: Shire Pharmaceuticals Group plc
Advisory board: Novartis
FEGERT JÖRG M.
Research: Janssen, Medice, Lilly and Company, AstraZeneca Pharmaceutical
LP
Dsmb:Pfizer Pharmaceuticals
travel grants: Sanofi-Aventis, Bayer, Bristol-MS, Johnson & Johnson,
Celltech/USB, Lilly and Company, Medice, Novartis Pharmaceuticals
Corporation, Pfizer Pharmaceuticals, Ratiopharm, Sanofi-Synthelabo; VFA
& Generikaverband, the Vatican, NIMH, AACAP, DFG, EU and European
Academy
consultant: Sanofi-Aventis, Bayer, Bristol-MS, Johnson & Johnson, Celltech/
USB, Lilly and Company, Medice, Novartis Pharmaceuticals Corporation, Pfizer
Pharmaceuticals, Ratiopharm, Sanofi-Synthelabo; VFA & Generikaverband,
the Vatican, NIMH, AACAP, DFG, EU and European Academy
FORBES ANDY
Employee: Otsuka Pharmaceutical Development & Commercialization
GIACOBINI MAIBRITT
travel support: Jansen - Cilag
GREENHILL LAURENCE L.
research grant: Eli Lilly and Company, Forest Pharmaceuticals, Shire
Pharmaceuticals Group plc, Otsuka America Pharmaceutical, Bristol-Myers
Squibb, Novartis Pharmaceuticals Corporation research support: Eli Lilly and Company, Forest Pharmaceuticals, Shire
Pharmaceuticals Group plc, Otsuka America Pharmaceutical, Bristol-Myers
Squibb, Novartis Pharmaceuticals Corporation 178
advisory boards - Data and Safety Monitoring Boards: Janssen
Pharmaceuticals, Pfizer Pharmaceuticals
NovartisNovartis Pharmaceuticals, Eli Lilly and Company, Wyeth
consulting fees: Eli Lilly and Company,Novartis Pharmaceuticals
Corporation, Pfizer Inc, Wyeth, Janssen-Cilag
honoraria: Eli Lilly and Company,Novartis Pharmaceuticals Corporation,
Pfizer Inc, Wyeth, Janssen-Cilag
travel support: Eli Lilly and Company, Janssen-Cilag, Pfizer Inc
HAAPSAMO HELENA
Research: Alma och K.A. Snellman foundation, Emil Aaltonen foundation
and Childpsychiatry foundation in Finland
HAESSLER FRANK
Advisory Board: Eli Lilly and Company GmbH Germany Research Support: Eli Lilly and Company GmbH Germany Consulting Fees: Janssen-Cilag Research Support: Janssen-Cilag Consulting Fees: Novartis Pharma GmbH Research Support: Novartis Pharma GmbH Travel Support : Novartis Pharma GmbH Honoraria: Bayer Vital GmbH Research Support: Bayer Vital GmbH Travel Support: AstraZeneca Pharmaceutical LP
Honoraria: UCB Pharma
HAWKRIDGE SUSAN
Consulting fees: NGO: Children for Tomorrow
Employee : Government Department Department of Health, Western Cape
Province, South Africa
Local conference registration fee: Lundbeck SA 179
HOARE PETER
Advisory Board: Eli Lilly and Company, Janssen-Cilag
Honoraria: Eli Lilly and Company, Janssen-Cilag
Travel Support: Eli Lilly and Company, Janssen-Cilag
Advisory Board: UCB Pharma
Honoraria: UCB Pharma
HRDLICKA MICHAL
Travel Support : Janssen – Cilag,
Advisory Board: Eli Lilly and Company
Honoraria: Eli Lilly and Company
ISERI ELVAN
Congress registiration: Eli Lilly and Company
IVARSSON TORD Speaker at psychopharmacology course: Pfizer Pharmaceuticals
Speaker at course on childhood aggression: Janssen-Cilag
KARLSSON LINNEA
Some members of our reserach group have received personal grants from
non-prfot research organizations (the Academy of Finland and the Yrjö
Jahnsson Foundation)
KIM BUNG-NYUN Travel Support : Janssen
LAFORTUNE DENIS
Grant: Conseil de recherche en sciences humaines du Canada
180
LAMBERT NELLE
Research: de Donald Cohen Fellowship
LEVENTHAL BENNETT Research: Lilly and Company, Abbott Laboratories, Bristol-Myers- Squibb,
Shire Pharmaceuticals, Forrest
Speaker: Lilly and Company, GSK Consulting: Lilly and Company, Janssen LORENZO MARIA
Employee: Eli Lilly and Company
MALMBERG KERSTIN Travel Support: Jansen-Cilag
MATSUMOTO KAORI
Grant: Ministry of Health, Labour and Welfare)partial (SUPPOSED TO
RECEIVE)
MCFARLANE ALEXANDER
Speakers Honoraria: Wyeth
Shareholder: Brain Resource Company
MCNICHOLAS FIONA
Advisory board: Eli Lilly and Company
Travel support: Eli Lilly and Company, janssen-Cilag
Honoraria: Janssen Cilag
MICHEL FRED
Advisory Board: Johnson & Johnson
181
MOILANEN IRMA Advisory Board: Eli Lilly and Company Strattera Finland
Consultation Fee for participating a meeting: Eli Lilly and Company Strattera
Finland
Travel support: participation in AACAP Congress, Toronto in 2005:
Eli Lilly and Company Strattera Finland
MOREIRA MAIA CARLOS RENATO
Travel support: Novartis Pharmaceuticals Corporation MONTOYA ALONSO
Employee: Eli Lilly and Company and Company
NAMYSLOWSKA IRENA
Research: Jansen-Cilag Polska
Travel support to the 15 European Congress of Psychiatry: Pharmaceutical
Company Krka - Poland.
OUENNICH BELHAJYAHIA HELA
Research: ONFP(national office of family and population inTunisia,
International spanish Agency of cooperation(AECI)
Owens Judith
Grants: Separcor, Eli Lily and Company, Cephalon, J&J, Boehringer-Ingleheim
Consultant: Shire,Cephalon,Johnson&Johnson,Sanofi-Aventis,McNeil,
Boehringer-Ingleheim
Speakers Bureau: Johnson&Johnson, Eli Lilly and Company, Sanofi-Aventis
Advisory Board:Select Comfort, Eli Lilly and Company, Cephalon, Pfizer
182
PALAZZI STEFANO
covered for travel, hotel and conference fees to participate in the San Diego
AACAP 2006: Eli Lilly and Company
PIHLAKOSKI LEENA Advisory board: UCB Pharma
PIERCE DAVID
Employee: Shire Pharmaceuticals
ROHDE LUIS AUGUSTO Travel Support for the ESCAP meeting: Novartis Pharmaceuticals
Corporation
Advisory Board: Novartis Pharmaceuticals Corporation, Janssen-Cilag, Eli
Lilly and Company
Research Support: Novartis Pharmaceuticals Corporation, Bristol-MayersSquibb
Grant for the ADHD program: Novartis Pharmaceuticals Corporation,
Janssen-Cilag, Eli Lilly and Company
Honoraria as speaker: janssen-Cilag, Novartis Pharmaceuticals corporation,
Eli Lilly and Company
SCHMECK KLAUS
Advisory Board: Janssen Cilag, Eli Lilly and Company
Research Support: UCB pharma
SCHMITT FLORENCE
Grant: This study is part of an international multi-site research project,
supported by a grant from the European Union in its 5th Framework
Program “Quality of Life” (QLGT-2001-02378): “Mental Health
Prevention in a Target Group at Risk: Children of Somatically Ill Parents
(COSIP)”.
183
SCHEPKER RENATE
Honoraria for presentations: AstraZeneca Pharmaceutical LP Janssen-Cilag
Support for conferences: AstraZeneca Pharmaceutical LP, Desitin, JanssenCilag, Eli Lilly and Company
by fees for industrial exposition: Medice, Novartis Pharmaceuticals
Corporation, Pfizer Inc, ratiopharm, TAD
SHUR-FEN GAU SUSAN
Supported trials: Eli Lilly and Company, Janssen-Cilag
THOMAS SPENCER
Advisory Board: Shire Laboratories, Inc, Eli Lilly and Company, GlaxoSmith Kline, McNeil Pharmaceutical, Novartis Pharmaceuticals, New River
Pharmaceuticals, Cephalon, the National Institute of Mental Health.
SVANBORG PÄR
full time employee Eli Lilly and Company
study fully sponsored: Eli Lilly Sweden
TANNOCK ROSEMARY
Advisory Board: Eli Lilly and Company, Consulting Fees: Eli Lilly and Company, Pfizer Inc, McNeil Pediatrics
Honoraria: Eli Lilly and Company, Pfizer Inc, McNeil Pediatrics, Shire
Pharmaceuticals Group plc Canada, Janssen-Ortho Research Support: Eli Lilly and Company, Novartis Pharmaceuticals
Corporation
Travel Support: Eli Lilly and Company
Unrestricted Educational Grant: Shire Pharmaceuticals Group plc Canada Speaker’s Bureau: Eli Lilly and Company, McNeil Pediatrics
184
PINTABONA YOLANDA Grant: Office of Mental Health, Department of Heath, Government of
Western Australia Grant : Western Australian Health Promotion Foundation, Healthway
SOUZA ISABELLA
travel support to go to a congress in Germany: Novartis Pharmaceuticals
Corporation
TERZIEV DIMITER
Travel Support: janssen-cilag
Accommodation: janssen-cilag
Registration fee: janssen-cilag
Honoraria: janssen-cilag
TRZEPACZ PAULA
Employee: Eli Lilly and Co, Indianapolis IN
Shareholder: Eli Lilly and Co, Indianapolis IN
VAN DE GLIND GEURT Unrestricted Educational Grant: Eli Lilly & Company, Janssen Pharmaceutica,
Shire Pharmaceuticals Group plc, UCB pharma, Janssen Cilag.
VAN DER GAAG RUTGER JAN
Research Support: Eli Lilly and Company Advisory Board: Eli Lilly and Company
Educational grants: Eli Lilly and Company
YAZGAN YANKI advisory board: Eli Lilly and Company
advisory board: Janssen Cilag
honoraria: Eli Lilly and Company
185
honoraria Janssen Cilag
Travel Support BristolMyers Squibb YOUNG SUSAN
Speaker: Janssen-Cilag
Research grants: Janssen-Cilag
VETRÓ ÁGNES
Consulting Fees: Eli Lilly and Company Hungaria
WARNKE ANDREAS
Honoraria: Janssen-Cilag
Research Support: Janssen-Cilag
Honoraria: Novartis Pharmaceuticals
Research Support: Novartis Pharmaceuticals Honoraria: Eli Lilly and Company
Research Support: Eli Lilly and Company
Honoraria: AstraZeneca Pharmaceutical LP
Research Support: AstraZeneca Pharmaceutical LP Honoraria: Medice Research Support: Medice WEHMEIER PETER M.
Employee: Eli Lilly and Company
Shareholder: Eli Lilly and Company
WILENS TIMOTHY
Grant support: Abbott Laboratories, Cephalon, Ortho-McNeil, Eli Lilly and
Company, National Institute on Drug Abuse (NIDA), Neurosearch, Shire
Laboratories Inc.
Speaker bureaus: Ortho-McNeil, Novartis Pharmaceuticals, Shire
Laboratories Inc.
186
Consultant: Abbott Laboratories, Cephalon, Janssen, National Institute
on Mental Health (NIMH), Ortho-McNeil, Eli Lilly and Company, National
Institute on Drug Abuse (NIDA), Novartis, Pfizer, Shire Laboratories Inc.
ZUDDAS ALESSANDRO
Advisory Board: Eli Lilly and Company, UCB, Shire, Astra Zeneca,
Research Grants: Eli Lilly and Company 187
INDEX BY NAME
188
Aalberg Marianne
155
Abdollahian Ebrahim
119
Abou Abdallah Tania
116, 146
Abramides Dagma Venturini Marques
150, 151
Abujadi Caio
143
Achenbach Thomas
80, 85, 103, 109
Aerts Cisca
127
Aijaz Farooqi
79, 140
Albermann Kurt
142
Allahverdipour Hamid.
131
Allen A.J.
82, 102, 104, 111, 122, 123
Al-Mamum Abdulla
188
Althaus Monika
151
Anagnostopoulos Dimitris
83, 111
Anderluh Marija
160
Anders Thomas
47, 56, 60, 102, 105
Ängarne-Lindberg Teresia
137
Anselmi Luciana
126
Ansermet Francois
69, 166
Anthony James
85, 99
Apter Alan
40, 52, 64, 66, 82, 84, 104, 130, 149
Apter Gisèle
79, 94, 95
Arabgol Fariba
126
Ardizzone Ignazio
164, 167
Armellini Marco
54
Arnfred Jon
71
Aronen Eava
128
Auby Philippe
113
Azkenazy Florence
153
Bachmann Christian
111, 132
Bailey Susan
51, 68
Bakker Mirte
128, 153
Banaschewski Tobias
49
Banerjee Somnath
122
Banhatti Rajeev
92, 93
Barkley Russell
44
Barthelemy Catherine
46, 56, 102, 104
Basak Alpas
161
Bayer Christophe Pierre
53
Becache Eve
165
Behdani Fatemeh
119
Belaise Carlotta
140
Ben Amitay Galit
160
Bengi Semerci
166
Benjet Corina
95
Berit Groholt
91, 141
Berkowitz Steven
90
Besana Dante
93, 97
Bevington Dickon
94
Bianchi Donata
72
Biederman Joseph
46, 96, 102, 123, 124
Bilenberg Niels
117, 144, 162, 174
Bilke O.
94
Birmaher Boris
41, 43, 63, 71, 83, 132
Biscaldi Monica
98, 101
Bjorn Wrangsjo
92
Bollea Giovanni
43
Bolognini Monique
77, 138
Bondonio Lorenza
110
189
190
Bongseog Kim
121, 163
Bonner Yvonne
90
Bookheimer Susan
97
Boong Nyun Kim
115, 116, 120, 153, 154, 156
Borghini Ayala
166
Bouden Asma
115
Boutrel Benjamin
77
Braconnier Alain
100
Brambilla Paolo
152
Brdar Ingrid
76
Brent David
59, 64, 66, 67, 76, 82, 130
Breuk René
112
Brussel Wim
126
Buckley Sarah
118
Buitelaar Jan
60, 82, 123
Burghardt Roland
111
Burgic-Radmanovic Marija
96
Bursztejn Claude
78, 82
Byrne Sinead
156
Caballero Rafaela
89
Caffo Ernesto
43, 52, 60, 62, 67, 78, 107
Cain Sharon
57
Camerini Giovanni
68, 75, 127
Canals Josefa
160
Canitano Roberto
80, 107
Cannoni Eleonora
109
Cannto Tomas
89
Capozzi Flavia
76, 139, 140
Carli Lucia
50
Carlson Gabrielle
66, 83, 105
Carratelli Teresa
65, 167
Caucci Chiara
164, 167
Cederlund Mats
80, 102
Chamak Brigitte
133
Cheli Mariagnese
166
Cheon Keun-Ah
125, 175
Cheon Seok Suh
121, 122
Chiarenza Giuseppe
44, 79, 89
Chiland Colette
58, 65, 103, 106
Cho In Hee
189
Cho Soo-Churl
120, 122, 128, 129, 153, 154, 156
Ciasca Sylvia Maria
114, 143, 149
Cieslukowska Anna
160
Cima Maaike
75
Cimino Larry
60, 102
Cioni Giovanni
64, 108
Clement Hans-Willi
111, 129, 130
Cocozza Madeleine
166
Coghill David
49, 59, 60, 69, 113
Cohen David
69, 77, 83, 107, 116, 133, 134, 146
Cohen Phyllis
58, 90
Constant Jacques
86
Cooper Paul
60
Correia Paula
162
Cortese Samuele
56, 57
Costa Stefano
127
Costantino Antonella Maria
54, 61, 93
Coughlin Michael
142
Couglin Michael
161, 167
Coulon Nathalie
158
Couwenbergh Christianne
94
Cowie Helen
91, 111
191
192
Csorba Janos
156
Çuhadaroðlu Çetin Füsun
112, 158
Curatolo Paolo
59, 117, 121, 123
Ćurčić Vojislav
91
Dabkowski Miroslaw
51, 86
Dagbjörg Sigurðardóttir
139
Dahl Kitty
154
Dajčman Natasa
149
Dalla Vecchia Annamaria
90
Dalsgaard Søren
119
Danielson Mia
151
Daryl Efron
115
De Girolamo Giovanni
46, 58, 95
De Jonge Maretha
80, 104, 135
De la Fuente Josè Eugenio
70, 161
De Plato Giovanni
54
De Souza Isabella
152
Dean Angela
167, 168
Debbané Martin
77
Deboutte Dirk
65, 81, 92, 141
Deepak Sunil
90
Grazia dell’Angello
117, 124
Deirdre Cleary
161
Delle Fave Antonella
71, 76
Delvenne Vèronique
74, 101
Di Biasi Stefania
165, 166, 167
Di Scipio Roberta
138, 149
Dimiter Terziev
118
Dittmann Ralf W.
121
Do Carmo Marcelino Maria
129
Dobrescu Iuliana
118
Doepfner Manfred
116
Doody Brendan
145
Domenico Romeo
128
Donnelly Craig L.
51, 123
Doreleijers Theo
68, 126
Doris Nilsson
148
Drugli May Britt
126
Dubicka Bernadka
113
Duketis Eftichia
155
Dunerfeldt Maria
151
Eidevall Lena
64, 82
Einspieler Christa
108
El Haib Muhammed
67
Elberling Hanne
143
Emslie Graham
91
Erol Nese
54, 99
Ertem Ilgi
144
Eyup Sabri Ercan
133
Fabrizi Anna
30, 81, 85, 89, 138, 149, 168, 191
Falissard Bruno
42, 59, 66, 83, 86, 102, 105, 148
Fallon James
87, 100, 106
Faraone Stephen V.
124
Farbstein Ilana
67
Farruggia R.
101
Fava Giovanni
140
Fayyad John
45, 61, 67, 104,
Fazzi Elisa
100
Fegert Jörg
48, 68, 127
Fekadu Daniel
166
Feldman Peter
122, 123
Feldman Ruth
52, 90, 150, 169
193
194
Feo Paolo
67
Ferradji Taïeb
95
Ferrari Adriano
109
Ferraz Plinio
139
Fiona McNicholas
130, 154, 156, 160
Flament Martine F.
65, 83, 100
Fleischhaker Christian
98
Flynn Laurie
85, 102
Foley Sue
57
Fonagy Peter
40, 44, 87, 99
Forouher Nima
110
Forresi Barbara
61, 73, 76, 78, 98
Foster Bob
80, 110
Francois Anne
74
Frediana Sonia
123
Fredin Krister
128
Fredrik Ulberstad
114
Freire Teresa
76
Freitag Christine
136
Freitas Carina
114
Fröjd Sari
141
Fuentes Joaquin
40, 43, 46, 82, 93
Gabusi Piero
151
Gaddour Naoufel
163
Galili-Weisstub Esti
66
Gatta Michela
138, 139
Gaudière Annie
78
Gauthier Jean-Marie
74
Gentili Carlotta
148
Georgiadis Dimitrios
54, 74
Georgieff Nicolas
69, 165
Gerasimos Kolaitis
53, 145, 150
German Eduardo Rueda Jaimes
162
Giacobini MaiBritt
134
Gjærum Bente
144
Gökler Bahar
136
Goldstein Benjamin
132
Golse Bernard
45, 69, 77, 95, 106, 136, 138, 148
Goodyer Ian
40, 59, 63, 66, 83
Goth Kirstin
109
Gottfried Maria Barth
150
Graham Philip J.
58, 84, 102
Greenhill Laurence
40, 42, 43, 64, 82, 84, 102
Grigoriadou Aliki
145
Guaia Ettore
100
Gudmundsson Olafur
142
Guerra Alegre Teresa
132, 167
Guerrini Renzo
82
Guilé Jean-Marc
69, 77, 116, 146
Guinchat Vincent
135
Gülsen Erden
135, 161
Guo Yi Jin
143, 147
Gutierrez-Casares Jose R.
63, 125
Haaland Anja
144, 192
Haapsamo Helena
55, 136
Haberhausen Michael
111, 132
Habib Doa
112
Hadley Leanne
50
Haessler Frank
124
Hägglöf Bruno
45, 56, 60, 121, 124, 128, 129, 140,166, 167
Halfon Olivier
77, 138
Hamada Shoko
156
195
196
Hamdan Sami
67
Hao-Jan Yang
143, 147
Hawkridge Sue
53
Hayakawa Hiroshi
141
Hebebrand Johannes
47, 48, 83, 128
Hebrani Paria
119, 126
Hee Jeong Yoo
49, 120, 137, 192,
Hee-Young Song
165
Heiervang Einar
71, 80, 140, 144
Heikura Ulla
139
Heiser Philip
129, 130, 149
Henderson John
45
Hennighausen Klaus
98, 124, 149
Hernández-Otero Isabel
81
Herpertz - Dahlmann Beate
47, 81
Herrero Rodriguez Oscar
91, 125
Hibbs Euthymia D.
92
Hillegers Manon H. J.
71
Hillevi Aro
91
Hinney Anke
48, 128
Peter Hoare
125
Hitoshi Saino
134
Hobun Lee
131
Holmesland Anne-Lise
142
Holtkamp Kristian
48
Hong S. David
162
Horowitz Laura
168
Houzel Didier
77
Howlin Patricia
42, 44, 81, 101, 102, 104
Hrdlicka Michal
107, 159,
Hubertus Adam
53
Hudziak James J.
59, 64, 83
Huges Gheorgina
143, 167
Hurtig Tuula
116, 136
Huyser Chaim
160
Hvolby Allan
117
Ibàñez Rosa M.
70
Inger-Lise Sæther
140
Iseri Elvan
138, 162
Ispanovic Veronika
96, 130, 132
Ivanenko Anna
57
Ivarsson Tord
153, 154, 163
Iwasaka Hidemi
118
Jansinski Donald
167
Janssens Astrid
141
Jeammet Philippe
60, 69, 74, 75, 81, 87, 103
Jean Philppe Raynaud
160
Joao Marcelino
129
Johnsen Lars Inge
56
Jokic-Begic Natasa
154
Jose Mariano Velilla Picazo
88
Joviana Q. Avanci
126, 157
Jubin Alexandra
138
Jungwoo Son
138
K.E. Siomos
128, 131
Kaartinen Miia
135
Kaminer Hanna
72
Kamp-Becker Inge
101
Kaneko Hitoshi
147, 156
Kano Yukiko
155
Kaplan Sandra
166
Karling Mats
167
197
198
Karl-Johan Myrén
124
Karlsson Hasse
159
Karlsson Linnea
157, 180
Kato Nobumasa
49
Ki-Hwan Yook
155
Kim Ji Hoon
117
Kim Yeni
115, 116
Kim Young Shin
91
King Robert
82, 107
Kiss Enikő
157
Kiyota Akio
168
Klaassen Rianne
164
Klasen Fionna
53
Korhonen Marie-Kaarin
158
Koskelainen Merja
162
Kravic Nermina
139
Kristensen Hanne
70
Kruger Andreas
90
Kulygina Mayya
138
Kumpulainen Kirsti Irmeli
91, 131
Kuwabara Hitoshi
49, 155
Kweon Yongsil
127
Laava Marja
146
Labelle Réal
69
Konstantia Ladopoulou
145
Lafortune Denis
129
Landorph Susanne
147
Laor Nathaniel
40, 42, 61, 67, 73, 84, 104, 107, 167
Larsen Helmer B.
165
Lasa Alberto
58
Latva Reija
163
Lax-Paricall Maria Teresa
107
Lazarus Helen
112
Leavey Joann Elizabeth
57, 166
Lecendreux Michel
57
Leckman James F.
47, 52, 59, 62, 88, 107, 150
Lepri Gian Luigi
78
Lesinskiene Sigita
160
Leskauskas Darius
119
Leventhal Bennett L.
73
Liakopoulou M.
155, 157
Liberati Alessandro
60, 102, 103
Lieb Roselind
95
Lilian Zoellner
155, 158
Lombroso Paul
43, 66, 83, 88, 107
Lorenzo Maria
115, 116, 117
Luby Joan L.
41, 46, 76, 94
Lucarelli Loredana
89
Lygeri Lliopoulou
130
M. Graell Berna
159
Macciardi Fabio
42, 43, 45, 63, 86, 105
Magnus Ragnhild Elise
56
Maki Pirjo
131, 165
Makris Nikos
96
Malmberg Kerstin
117
Mancini Mita
83, 86
Manor Iris
112
Marcia Adriaanse
126
Mardomingo Maria Jesus
59, 64, 91, 120, 125
Margari Lucia
77, 117
Margret Nisell
127
Marit S. Indredavik
147
199
200
Marta Rapado-Castro
164
Martin Andres
41, 66, 105, 107
Martin Gerwe
121
Maruyama Erika
156
Masalha Shafiq
52
Masi Gabriele
81, 117
Matsumoto Kaori
136, 137
Matsushima Noriaki
134
Matsuura Naomi
127
Mattila Marja - Leena
55
Maximino De-Vitto Luciana Paula
150, 151
Mazet Philippe
54
Mazzone Domenico
128, 151
Mazzone Luigi
151
McCarthy Paul
58
McElearney Catherine
136
McFarlane Alexander
44, 61, 73, 106
Meins Elizabeth
50
Melhem Nadine
67, 130
Melin Karin
153
Melo Sara
135
Mendlowitz Sandra
70
Merikangas Kathleen Ries
85, 95, 70
Micali Nadia
57, 65
Michel Fred
50
Mieko AOKI
159
Miettunen Jouko
116, 131, 157, 165
Militerni Roberto
49, 50
Minderaa Ruud
70, 151, 163
Minshew Nancy J.
59, 97
Mircea Tiberiu
85
Moehler Eva
109, 110
Mohamedi Darghal
146
Moilanen Irma
55, 116, 136, 141, 165,
Moller-Pedersen Kirsten
147
Molteni Massimo
71, 80, 95
Monica Juuhl-Langseth
163
Monti Annalisa
148, 162
Montoya Alonso
120, 125
Moon Seok Woo
156
Mordre Marianne
141
Morozova Tatiana
145
Mos Kees
112
Muijen Matthijs
45, 61, 100
Mukai Takayo
168
Mulder E.J.H.
108
Muller Thomas
78
Muratori Filippo
69, 78, 79
Murphy Declan
97
Nahit Motavalli Mukaddes
117
Namyslowska Irena
51
Nanba Eiji
49
Nelson Charon
50
Nguyen Cat Tuong
157
Niemela Solja
131, 157
Nils Duits
127
Nizzoli Umberto
98
Nomura Kenji
141, 147
Nurcombe Barry
51, 64, 73, 82, 98
Nylias Margaretta
113
Oberklaid Frank
99
Ochsner E.
108
201
Olle Lindevall
144
Olsen Else Marie
147
Onger Giancarlo
93
Ørbeck Beate
70
Ornitz Edward
154
Ottolini Fedra
76, 140
Ouennich Belhajyahia Hela
202
Ouss Lisa
69
Owens Judith A.
56
Paavonen Juulia
143
Paclt Ivo
115
Palacio Espasa Francisco
50, 52, 79
Palazzi Stefano
80
Panei Pietro
82
Papaeliou Christina
139
Papanikolaou Katerina
157
Papini Massimo
86
Pär Svanborg
121, 124
Paramala Santos
57, 125
Pascotto Antonio
143
Pastorelli Tina
103, 109
Pászthy Bea
158
Pauli-Pott Ursula
109, 110
Paz Toren
103, 167
Penge Roberta
89, 139
Per A Gustafsson
121, 124, 153, 166
Persico Antonio M.
56, 59
Pesonen Anu-Katriina
146, 148
Petrov Petar
116
Pfanner Pietro
46, 62
Phagava Helen
108
Philippe Paule
74
Pierce David
122
Pierrehumbert Blaise
95, 166
Pignatiello Antonio
57
Piha Jorma Dirk
92, 129, 131, 157
Pihlakoski Leena
137
Pintabona Yolanda
91, 130
Plessen Kerstin
88, 140
Popma Arne
75
Populin Enrico
89, 90
Posner Kelly
46, 61, 82, 122, 124
Poustka Fritz
99
Poustka Louise Christina
110, 111
Preuss Ulrich
75
Pullen Jill
143, 167
Puras Dainius
93, 110
Pynoos Robert
42, 45, 61, 66, 73, 104, 170
Radobuljac Maja
196
Raleva Maria
96
Rapoport Judith
47, 59
Rask Charlotte Ulrikka
196
Rauh Reinhold
101
Reichard Catrien G.
196
Renate Schepker
90, 127, 184
Renner Tobias
111, 117
Rescorla Leslie
89, 109
Riedesser Peter
53, 74, 75
Rigardetto Roberto
13, 55
Rigatelli Marco
45, 60
Rigon Giancarlo
11, 52, 102, 127
Riittakerttu Kaltiala-Heino
68
203
204
Rimay Timea
197
Rimehaug Tormod
168
Robaey Philippe
118, 123
Robb Adelaide
113
Robel Laurence
136, 148
Rodrigo Escobar
177
Rogers Ann K.
122
Rohde Luis Augusto
48, 49, 61, 104, 120, 126, 183
Rojo Luis
58
Romanchuk Oleh
197
Romani Maria
52
Romer Georg
72, 129
Romero Soledad
132
Rossi Giorgio
65, 100
Rothenberger Ari
80
Ruchkin Vladislav
48, 103
Ruge Moeller Lene
129
Ruggerini Ciro
79, 90, 139, 161
Ruiz-Làzaro Pedro Manuel
57, 58
Russel Jennifer
197
Ryan Neil
14, 83, 85, 99
Rydelius Per-Anders
58, 85, 96, 103, 127, 131, 168
Sabatello Ugo
197
Saeid Pahlavanzadeh
146
Saito Kazuhiko
141, 153, 168
Salviato Cinzia
138, 139
Sánchez-Gistau Vanessa
155, 159, 162
Sang Choel Choi
115, 128
Santalahti Paivi
129, 142, 157
Sartori Giuseppe
75, 98
Sartorius Norman
47, 58
Sasot Jordi
70
Scahill Lawrence
41, 47, 81, 85, 141, 155
Scepker Renate
197
Schaff Christa
67
Schaz Ulrich
111
Schlander Michael
51, 125
Schleimer Kari
99
Schmeck Klaus
75, 109, 127, 183
Schmitt Florence
129, 183
Scholl Jean-Marc
74
Schothorst Patricia
72
Schulz Eberhard
97, 124, 129, 130, 149
Scrimin Sara
67
Sechi Enzo
11, 48, 67, 79
Sepùlveda Ana Rosa
58, 159
Sergeant Joseph
42, 80, 84
Serrano Eduardo
197
Sevastyanov Victor
140, 146,
Shah Prachi
148
Shahini Mimoza
197
Shankar Datta Soumitra
164
Sharkey Louise
70, 154
Sharon Wigal
122, 124
Shim Sehoon
119
Shin Dongwon
118
Shin Min-Sup
120, 129, 142, 156
Shin Yee Jin
147, 154
Shin Yunmi
118, 158
Shochet Ian
157
Shur-Fen Gau Susan
95, 184
Sikorski John B.
48, 61
205
206
Simas Roberta
138
Simmins Tatjana
106
Simmons Christine
198
Simone Gonçalves de Assis
126, 157
Sinzig Judith K.
55, 133, 193
Siviero Marco Fabio
198
Skocic Milena
144
Skokauskas Norbertas
131
Skovgaard Anne Mette
99, 143, 147
Skree Ingunn
56
Sloman Leon
133
Smith Paul
94
Sogos Carla
72, 76, 158
Solveig Petersen
129
Solvejg Kristensen
198
Song Dong-Ho
154
Soumaki Eugenia
11, 53, 54, 83, 96
Soutullo Cesar
61, 88, 89
Spagnolo F.
108
Spencer Michael
198
Spencer Thomas
122, 123, 184
Speranza Mario
11, 52, 53, 75
Spiel Georg
68, 94
Sprong Myriam
72
Srabstein Jorge
40, 63
Stadler Christina
75
Stancheva-Popkostadinova Vaska
97
Stankovic Miodrag
198
Starling Jean
57
State Matthew W.
198
Steenhuis Mark Peter
163
Stefanini Maria Cristina
11,72
Stellermann Kerstin
53
Stepahn Philippe
198
Strauss Mark
198
Streeck-Fischer Annette
75, 99
Sungum-Paliwal Sobharani
133
Sun-Woo Jung
115
Swords Deirdre
198
Syofan Sri Sofyani
198
Szatmari Peter
104, 134
Szobot Claudia
198
Taanila Anja
116, 131, 139, 165
Tamas Zsusanna
198
Tamminen Tuula
11, 158
Tannok Rosemary
198
Tansella Michele
198
Target Mary
45, 58
Tasdemir Gokce Nur
198
Taylor Eric
41, 64, 82, 84, 105
Tehrani-Doost Mehdi
161
Thidens Elisabeth
198
Tobias Edbom
117
Tomori Martina
11, 91
Tordjman Sylvie
77
Toren Paz
103, 167
Tramontano Carlo
109
Trias Tuulikki
141
Trzepacz Paula
123, 185
Tsiantis Ioannis
12, 53, 61, 67, 92, 145, 157
Tsuchiya Kenji J.
136
Uchtenhagen Ambros
85, 98, 99
207
208
Umaporn Trangkasombat
120
Umesh Bawa
53, 188
Undheim Anne Mari
130
Vaccarino Flora
41, 43, 45, 59, 88, 107
Vagnoni Cristina
135
Van Arum Sander
112
Van De Glind Geurt
94
Van Der Gaag Rutger Jan
55, 71, 86, 93, 99, 102
Van Engeland Herman
12, 81, 101, 135
Van Hoof de Brujin Marie-Josè
199
Van Lang Nastaja
80
Van Roy Betty
163
Van Wijngaarden-Cremers Patricia
93
Vasconi Carlo
90
Vassilopoulou Vasso
54, 78
Vecchio Giovanni Maria
109
Veijola Juha
131, 165
Velila Picazo José Mariano
199
Veneselli Edvige
133
Vermeiren Robert
68, 105, 126
Vetro Agnes
12, 67, 68, 157, 186
Victor Sevastyanov
140, 146
Vidovic Vesna
92, 194
Vitiello Benedetto
61, 82
Vitulano Lawrence A.
48, 70, 141, 155
Vivanti Giacomo
137
Vladislav Ruchkin
48, 103
Vlajkovic Jelena
199
Vonderlin Eva
110
Walter Garry
66, 102
Warnke Andreas
11, 64, 117, 186
Wentz Elisabeth
158
Werneck-Rohrer Sonja
164
Westling Allodi Mara
131
Wiberg Lotta
128
Wilens Timothy
81, 82, 186
Wilkinson Paul
199
Williams Richard
46, 61
Withney L.Clerici
101
Wolmer Leo
167
Wolpert Miranda
65, 79, 80, 81, 84, 110
Yamaguchi Sumire
14, 139
Yan Zhu
199
Yang Su-Jin
120
Yang Yeol Kim
156
Yanki Yazgan
123, 185
Yazgan Janke
72
Yemula Chinnaiah
114
Yesim Taneli
135
Ying-Sheue Chen
120, 175
Yoo Jeong Hee
199
Yoshizumi Takahiro
145, 156
Young J. Gerald
199
Young Hui Yang
115
Young Susan
186
Young-Shin Kim
91, 193
Yuki Kako
164
Yuko Furuhashi
156
Yule William
40, 44, 45, 61, 73, 84
Zalsman Gal
199
Zanetti Tatiana
58
Zdanowicz Nicolas
74
209
210
Zepf Florian Daniel
200
Zivcic-Becirevic Ivanka
149
Zivotic Sanja
126
Zollinger Ruedi
11, 72
Zuddas Alessandro
117, 187
PROGRAM PLANNER
Please use this form to help plan your daily schedule
Saturday, 25 August
Sunday, 26 August
212
PROGRAM PLANNER
Please use this form to help plan your daily schedule
Monday, 27 August
Tuesday, 28 August
213
PROGRAM PLANNER
Please use this form to help plan your daily schedule
Wednesday, 29 August
214
215